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SUMMARY 
 
Eukaryotic genomes are organized inside the cell nucleus in a structured macromolecular 
DNA-protein polymer named chromatin, formed by single discrete unites called Nucleosomes. 
The packing of the genetic information into chromatin allows the efficient regulation of several 
nuclear processes, such as gene expression and transcription, DNA replication, cell cycle pro-
gression, chromosome segregation and DNA damage repair. Chromatin comes in two flavors: 
a transcriptionally active, more loosened state, called euchromatin and a transcriptionally silent 
or low expressed, more compact state, called heterochromatin. The assembly of silent chroma-
tin or heterochromatin is fundamental for the regulation of every nuclear process and it is 
driven in most Eukaryotes by the deposition and the read-out of the histone H3 lysine 9 meth-
ylation (H3K9me) post-translational modification (PTM). H3K9me on the nucleosome is spe-
cifically bound by chromatin readers called chromodomains (CD) and this recognition is fun-
damental for the downstream processes that lead to the formation of heterochromatin and shut 
down the expression of single genes or entire gene clusters. Despite several studies have been 
done on different chromodomains binding to H3K9me histone tail peptides, to date there was 
no structural information on how chromodomains interact with their natural binding partners, 
the H3K9me3 Nucleosomes. In a preliminary structural study carried out in our laboratory we 
solved the cryo-electron microscopy (Cryo-EM) structure of the chromodomain of the fission 
yeast Chp1 protein (Chp1CD) in complex with an H3K9me nucleosome. The structure showed 
that the Chp1CD interacts not only with the histone H3 tail but also with the histone globular 
domains in the Nucleosome core, primarily with histone H3. Mutations in the residues of 
Chp1CD that form the binding interface with the Nucleosome core (two loops in the β-sheet of 
the domain) caused a drop of the affinity in vitro for the H3K9me Nucleosome, which was 
independent from the histone H3K9me tail interaction. Cells harboring the same Chp1CD loop 
mutations were defective in silencing centromeric transcripts and maintain the deposition of 
the H3K9me mark for heterochromatin formation. This indicated that Chp1CD-nucleosome 
core interaction is fundamental for heterochromatin formation in fission yeast and opened up 
to the possibility that chromodomains could read multiple histone PTMs, on both the recruiting 
histone tail and on the nucleosome core. This study substantially contributes to understand how 
chromodomains interact with chromatin, how much the nucleosome core interaction is con-
served among different CDs and how different chromodomain proteins are regulated at the 
same loci. Understanding how chromodomain readers recognize nucleosomes is fundamental 
to uncover the basics of gene silencing and heterochromatin formation.
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INTRODUCTION 
 
In order to maintain genome stability and to ensure a finely tuned program of gene expression, 
Eukaryotes pack their DNA into a higher order macromolecular complex called chromatin. The 
existence of such organized scaffolds inside the cell nucleus is fundamental to organize the 
relatively big bulk of genetic material in a functional way, allowing for important processes to 
occur such as DNA replication, DNA damage repair and transcription. 
The basic unit composing chromatin is the nucleosome (Kornberg, 1974; Kornberg and 
Thomas, 1974; Luger et al., 1997; Olins and Olins, 1974), a DNA – protein complex consisting 
of four different proteins called histones (H2A, H2B, H3 and H4) forming an octamer (with 
two copies per each histone), wrapped by 146 bp of DNA (the DNA makes 1.67 left-handed 
superhelical turns around the core of histone proteins) (Luger et al., 1997) (Figure 1.1). The 
core of the octamer is formed by a tetramer of histone H3 and H4 (H3-H4)2 that interact in a 
four helix bundle mediated by the H3 fold, and from two associated dimers of histone H2A and 
H2B, that also associate in a four helix bundle with the H3-H4 tetramer at the interface between 
H2B and H4 (Luger et al., 1997) . 
Histones are a family of proteins conserved among Eukaryotes, relatively small (10 to 15 kDa) 
and highly basic, due to the presence of a substantial number of positively charged residues, 
particularly lysines and arginines.  They are characterized by a globular domain that forms the 
central core of the nucleosome octamer and a large unstructured part, commonly called histone 
tail, comprising the first 25-35 residues starting from the N-terminus (Luger et al., 1997). The 
globular domains of each histone are characterized by the presence of a three helix fold with 
two loops in between called histone fold motif. There are also two structured helical parts 
named αN in histone H3 and αC in histone H2B that are external to the canonical globular 
domain, just before the histone unstructured regions (Figure 1.1). Many residues in the histone 
tail and globular domains are post-translationally modified, and many of these modifications 
have fundamental roles in regulating gene expression, replication, repair and chromatin 
organization (Kouzarides, 2007). The high conservation among histone proteins reflects the 
evolutionary selective pressure in keeping the chemical and structural properties of these 
proteins that have to act as scaffold for DNA organization in the nucleus and bind many 
different nuclear factors. 
 
Introduction 
6 
 
 
Figure 1.1: The basic unit of chromatin: the 
Nucleosome core particle 
From (Felsenfeld and Groudine, 2003): the model of 
DNA organization into the chromatin fiber. The DNA is 
first wrapped around a core of eight histone proteins, 
forming the Nucleosome particle (shown on the right), 
the basic unit of chromatin. Nucleosomes are connected 
with each other through the linker DNA, forming the 11 
nm “beads on a string” fiber. Further folding leads to 
the 30 nm fiber organization, and more complex higher 
order structures. Chromatin organizations like the 30 
nm fiber and higher are still under study with the details 
of folding still under debate. From (Luger et al., 1997): 
X-ray Crystal Structure of the Nucleosome core particle 
at 2.8 Å resolution. 146 bp of DNA are wrapped around 
a central core of eight histone proteins: H2A (yellow), 
H2B (red), H3 (blue) and H4 (green). 
 
The nucleosome forms the main structural component organizing the DNA in the nucleus and 
each nucleosomal unit is separated by the next with a linker DNA, whose length is varying 
depending on organisms, tissues and even genome localization (between 20 and 90 bp 
(Szerlong and Hansen, 2011)). The unfolded structure of the chromatin can be imagined with 
a “beads on a string” model, with the linker DNA being the “string” connecting each 
nucleosomal particle with the neighboring (Olins and Olins, 1974, 2003). Within the higher 
order chromatin organization, another histone protein, histone H1 (and histone H5, only in 
some organisms), contacts nucleosomes at the DNA entry/exit site and bridges them together, 
associating in the 30 nm chromatin fiber (Allan et al., 1980; Li and Reinberg, 2011; Lu et al., 
2009; Robinson and Rhodes, 2006; Whitlock and Simpson, 1976). Linker histone H1 (and H5) 
is a large histone protein, with the same properties of the canonical histone forming the 
nucleosome octamer, bigger in size but much less evolutionarily conserved. Histone H1 has a 
similar overall histone protein organization, with an N-terminal and C-terminal unstructured 
domains and a central globular histone fold motif. It associates to the nucleosome, forming the 
chromatosome, to coordinate chromatin organization, and many of the residues at the C-
terminal unstructured region of histone H1 have been characterized to be fundamental in 
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mediating its association and function (Lu et al., 2009). 
It is still a matter of debate which nucleosomes are preferentially associated in vivo, since 
different high order chromatin conformations have been isolated in vitro with and without 
histone H1 (Eltsov et al., 2008; Li and Reinberg, 2011; Maeshima et al., 2010; Schalch et al., 
2005; Song et al., 2014). A recent cryo-electron microscopy (cryo-EM) study suggests that four 
nucleosomes are associated together by the linker DNA forming a zigzag twists back and forth 
among them. These tetrads repetitions are then cross connected by histone H1, which induces 
a left handed twist while folding the 30 nm fiber, supporting the so-called two start model 30 
nm chromatin fiber (Song et al., 2014). 
However, recent small angle X-ray scattering (SAXS) studies revealed that no defined 30 nm 
chromatin fiber exists in vivo and most likely the folding observed in previous in vitro studies 
is merely due to the linker DNA length and the 10 nm fiber self-association properties 
(Maeshima et al., 2014). This however, does not exclude the co-existence of many different 
types of conformations in vivo, including the ones described in the in vitro studies mentioned. 
Each one of the models of 30 nm chromatin fiber proposed might as well be present in the 
interphase chromatin as their folding depend also on the length of the linker DNA between 
nucleosomal units (Robinson et al., 2006). The median DNA linker length for the budding yeast 
S. cerevisiae is 23 bp (Brogaard et al., 2012), but it varies across the genome, due to nucleosome 
positioning variations, nucleosome active remodeling and the binding of transcription factors. 
In budding yeast the two start fiber model would seem to be the most frequent to occur, but it 
can be possible to imagine a wide variety of in vivo 30 nm fiber conformations depending on 
nucleosome spacing and local chromatin factors interacting with the DNA, as well as nuclear 
localization and topological chromosomal architecture. Moreover, histone H1 function in 
chromatin regulation is not very well characterized in all organisms: for example, the budding 
yeast Saccharomyces cerevisiae seems to require H1 to repress spurious recombination of 
ribosomal DNA repeats  (Li et al., 2008), while it is totally dispensable for cell viability, growth 
and mating (Ushinsky et al., 1997).  On the same hand, the fission yeast Schizosaccharomyces 
pombe is totally lacking H1 and the 30 nm chromatin fiber relies on the folding of the 10 nm 
fiber for its own stacking (Wood et al., 2002)⁠. In yeast, the 30 nm chromatin seems to be able 
to self-associate independently of histone H1 presence. 
To add complexity to the picture, also histone tails, particularly a basic patch of residues on 
histone H4 tail, seem to be involved in nucleosome arrays compaction (Dorigo et al., 2003) ⁠. 
This compaction has been shown to be regulated through acetylation of histone H4K16 residue, 
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a common post-translational modification occurring in vivo (Liu et al., 2011; Shogren-Knaak 
et al., 2006). Moreover, this single modification is interfering with the activity of the ACF (ATP 
utilizing Chromatin remodeling and assembly Factor) nucleosome remodeler, even in the 
presence of ATP, indicating its ability to regulate not only the physical assembly of the 30 nm 
fiber but also nucleosome positioning (Hwang et al., 2014) ⁠.  Similarly, also histone H3 tail 
seems to be involved in inter-array nucleosomal interactions, strictly dependent on the state of 
condensation of the nucleosome arrays and the acetylation status of histone H3 tail (Kan et al., 
2007)⁠. The position and the spatial organization of the tails is therefore dependent on 
nucleosome fiber condensation, and post-translational modifications on histone tails might add 
up an additional level of regulation in vivo to determine the higher-order organization of 
chromatin. 
Whether chromatin folds in a defined 30 nm fiber or in an irregular assembly of 10 nm fibers 
in interphase nuclei it is still a matter of debate (Li and Reinberg, 2011; Maeshima et al., 2010) ⁠. 
What is definitely required for the main nuclear processes to occur is a highly dynamic and 
regulated chromatin conformation with different states of compaction and relaxation. 
Chromatin, in fact, comes in two main states, with various intermediates in between: a more 
compacted state, usually with low level of transcription or no transcription occurring, termed 
silent chromatin or heterochromatin, and a loosened state, genetically active, termed active 
chromatin or euchromatin. 
 
Heterochromatin: a general introduction 
 
In 1928, the German botanist Emil Heitz discovered that chromatin appearance was not the 
same in interphase nuclei of liverwort cells after staining using a boiling carmin acetate 
procedure he had devised (Passarge, 1979). In fact he could clearly distinguish more densely 
stained regions, mainly at the periphery of the nucleus, that he termed heterochromatin, in 
contrast to less stained ones, that he named euchromatin. 
It was the first cytogenetic evidence of the existence of differential chromatin states.  Later, 
studies on mitotic chromosomes and interphase polytene chromosomes revealed that by 
staining with particular dyes it was possible to have distinct bands with peculiar patterns 
correlating with alternating domains of heterochromatin and euchromatin (reviewed in 
Bickmore and van Steensel, 2013). 
 On the molecular level there are many features that are distinctive of these two chromatin 
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states: nucleosome positioning, DNA methylation state, histone post-translational 
modifications and protein complexes associated. Euchromatin is characterized as being 
transcriptionally active and replicating throughout the entire S phase, with low levels of DNA 
methylation, usually localized on chromosome arms and  in the inner nuclear regions and  
recombining during meiosis. There are characteristic histone post-translational modifications 
associated with actively transcribed regions such as H3K4 methylation, H3K4/K9 acetylation, 
H3K36 methylation and H3K79 methylation, which are evolutionarily conserved and mark not 
only single gene expression stages but also global developmental patterns in several model 
organisms (Kouzarides, 2007) (Figure 1.2) ⁠. 
On the contrary, heterochromatin is usually genetically inert, with no or very low levels of 
transcription, late replicating in S phase, with no recombination occurring in meiosis, 
characterized by high levels of DNA methylation and clustered at the nuclear periphery (Figure 
1.2).  Even gene distribution varies among the two chromatin states, with gene-rich regions 
being euchromatic and gene-poor regions being often heterochromatic. Many active genes are 
clustered together facilitating the action of the basal trans-acting transcription factors as well 
as chromatin remodeling complexes and histone modifying enzymes which are involved in the 
maintenance of an active gene expression state. In mammalian and bird genomes, gene dense 
regions are usually A/T poor (Bickmore and van Steensel, 2013; Costantini et al., 2006)⁠. Many 
DNA repetitive sequences are heterochromatic, due to the need of repressing their 
recombination potential which could eventually lead to genomic instability. It is the case for 
centromeric repeats in various organisms (like the dg-dh repeats in S.pombe and the α-satellite 
repeats in mammalian cells) and various transposable elements. Heterochromatin is 
characterized by proteins that regulate nucleosomal compaction and gene silencing. The most 
important proteins belong to the conserved family of the Heterochromatin Protein 1 or HP1 
and are the sole proteins structurally characterizing heterochromatin in most organisms 
(Lomberk et al., 2006a) (Figure 1.2).  
 
Introduction 
10 
 
 
Figure 1.2: Chromatin comes in two main states: Euchromatin and Heterochromatin  
From (Gaspar-Maia et al., 2011): overview of the main factors characterizing heterochromatin and euchromatin 
in mammalian cells. The majority of these protein complexes are conserved from yeast to mammals. 
Heterochromatin is characterized by a higher degree of compaction, mediated by its structural component, the 
HP1 proteins. HP1 recognize the H3K9 methylation mark deposited by the Su(Var) 3-9 family SET domain 
methyltransferases (in the image: Suv39H1, Suv39H2,  G9a/GLP, SETDB1, Clr4 in S.pombe). Heterochromatin 
is also characterized by a high degree of CpG DNA methylation (not conserved in yeast) deposited by the de-novo 
DNA methyltransferases Dnmt3a/b and Dnmt3L. Boundaries between heterochromatin and euchromatin are set 
by the removal of the H3K9me mark from the H3K9 de-methylases (in the image: Jmjd1a, Jmjd1c. In S.pombe: 
Epe1). Euchromatin is characterized by a loosened chromatin organization, facilitated by histone acetylation 
(H3K4ac, H3K9ac, H4K16ac, added by the Tip60, p400 complexes) and the deposition of other active 
transcription histone marks, such as H3K4 methylation (deposited by the MLL/COMPASS). Some chromatin 
remodelers, such as the chromodomain – helicase domain Chd1, specifically recognize H3K4 methylation to exert 
their function. Euchromatin is also characterized by low level of DNA CpG methylation. Intermediate states 
between Euchromatin and Heterochromatin may exist, in which the simultaneous deposition of counteracting 
histone marks (such as H3K4 and H3K27 methylation) poises genes in a state of regulated expression that could 
switch between silencing and active transcription in response to external stimuli. It is the case of the H3K27 
methylation, developmentally deposited in facultative heterochromatin by the Polycomb methyltransferases Ezh1 
and Ezh2.  
 
The only notable exception is the budding yeast S. cerevisiae that does not assemble 
heterochromatin through HP1 recognition of nucleosomes. HP1 recognize a distinctive histone 
post-translational mark that is H3K9 methylation, associated with constitutive heterochromatin 
(Bannister et al., 2001; Nakayama et al., 2001). The recognition happens through specialized 
protein-protein interaction of the HP1´s chromodomain (CD) and the histone H3 lysine 9 
methylated residue (Jacobs et al., 2001; Nielsen et al., 2002). Once the recognition is 
established, HP1 proteins can oligomerize through another domain, the Chromoshadow 
domain (CSD), thereby self-associating and compacting adjacent nucleosomes (Nishibuchi and 
Nakayama, 2014; Thiru et al., 2004). Therefore, histone H3K9 methylation is necessary for 
HP1 dependent heterochromatin assembly. There are other histone post-translational 
modifications that are heterochromatin specific, such as H3K27 methylation which is deposited 
by the Polycomb complex PRC2 and is often related to facultative or developmentally 
regulated heterochromatin (Cao et al., 2002; Müller et al., 2002), and global histone H3/H4 
deacetylation (like in case of H3K14 and H3K9 deacetylation, necessary for proper centromeric 
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and MAT locus silencing in S. pombe (Ekwall et al., 1997; Grewal et al., 1998)).   
In Eukaryotes, proper heterochromatin establishment is crucial to maintain genome stability. 
At centromeres, heterochromatin is essential to ensure not only the silencing of centromeric 
repeats, but also to allow the deposition of the centromeric specific variant of histone H3, 
histone CENP-A, necessary for kinetochore assembly and microtubule attachment both in 
mitosis and meiosis. In the fission yeast S. pombe, heterochromatin is required for CENP-A 
initial deposition, but not for its maintenance once it is already in place at the centromere (Folco 
et al., 2008). In fact, deletion mutants of heterochromatin or RNAi factors in S.pombe do not 
coincide with SPB (Spindle Pole Body) attachment defects in mitosis, but have severe SPB 
attachment and chromosome segregation defects in meiosis, where new centromeres have to 
re-established, particularly after Prophase I (Klutstein et al., 2015). Constitutive 
heterochromatin is also found at telomeres, where it is necessary for chromosome ends 
protection alongside with the Shelterin complex, avoiding chromosome end degradation or 
chromosome-chromosome fusion (Kanoh et al., 2005; de Lange, 2009). In S. pombe, the 
Mating type locus (MAT) is constitutively heterochromatic to allow for heterothallic sexual 
reproduction with a single stable mating-type. The heterochromatin protein Swi6 (the S. pombe 
HP1 protein homolog) function has been initially characterized by the Mating type switching 
phenotype that occurred in the Swi mutants (Swi stands for Switching), since the MAT locus 
heterochromatin was completely destabilized and the MAT cassette was de-repressed, causing 
abnormal meiotic recombination at the MAT type locus (Lorentz et al., 1992).  
Constitutive heterochromatin is often located at the periphery of the nucleus, in close contact 
with the nuclear membrane. Many genes that are silenced and heterochromatic are associated 
in Lamina Associated Domains (LADs), in close contact with the Lamin proteins of the nuclear 
membrane lamina (NL) (Padeken and Heun, 2014). Both centromeric and telomeric domains 
are actually clustered together at the nuclear periphery and growing evidences are suggesting 
that the association with the nuclear lamina may play a role in heterochromatin formation and 
maintenance (Bickmore and van Steensel, 2013; Klutstein et al., 2015; Padeken and Heun, 
2014). Other heterochromatin regions, rich in H3K9 methylation, are distributed around the 
nucleolus and are commonly defined as Nucleolus Associated Domains (NADs). It has been 
hypothesized that heterochromatin distribution between the nucleolus (NADs) and the nuclear 
envelope (LADs) occurs randomly, and that both the nucleolus and the NL work as platforms 
for heterochromatin anchoring (Bickmore and van Steensel, 2013; Padeken and Heun, 2014) ⁠.   
As already mentioned, DNA hypermethylation, particularly at CpG islands (frequently 
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occurring at promoters) is a distinctive, but not exclusive, feature of heterochromatin loci. In 
higher Eukaryotes, DNA methylation at promoters and at the body of genes varies during cell 
differentiation, developmental stage and in a tissue specific manner and does not always 
correlate with gene silencing (Suzuki and Bird, 2008). In heterochromatin, once DNA is 
methylated (usually a 5-methyl-cytosine or 5mC) it can be recognized by specific factors (such 
as the protein MeCP2 through its methyl-cytosine DNA binding domain – MBD) that can then 
block transcription by masking the sequences signaling the transcription start, lowering the 
affinity of transcription factors for their own target sequences or recruiting heterochromatin 
silencing factors, such as histone deacetylases (Adkins and Georgel, 2011). 5mC deposition is 
a highly conserved and stable epigenetic mark, found in mammals, plants, Drosophila and 
some yeast species. It is notably absent in both the budding yeast S. cerevisiae and the fission 
yeast S. pombe. In mammalian stem cells, where the genomic landscape is strongly 
euchromatic, DNA is generally hypo-methylated and a similar situation is often seen in several 
types of cancer, where cells undergo a vast de-differentiation reprogramming in which DNA 
methylation is partially lost,  also at repetitive sequences, giving rise to spurious recombination 
and genomic instability (Apostolou and Hochedlinger, 2013). 
In the plant model Arabidopsis thaliana, DNA methylation is coupled with histone H3K9 
methylation, in one of the best described heterochromatin formation pathways (Holoch and 
Moazed, 2015a). Similarly to what happens in the yeast Neurospora crassa (Tamaru and 
Selker, 2001), in A. thaliana deposition of H3K9 methylation by the KYP Su(var)3-9 
methyltransferase is necessary to recruit the DNA methyltransferase CMT3 to deposit the 5mC 
onto the DNA (Johnson et al., 2002). Like HP1 proteins, CMT3 is able to recognize specifically 
H3K9 methylation through its chromodomain and then modify the underlying DNA sequence 
(Du et al., 2012). In an analogous way, in human primary somatic and germline cells, H3K4 
dimethylation was found at hypo-methylated inactive CpG island promoters and it was 
hypothesized that the mark could act to prevent DNA methylation (Weber et al., 2007). These 
evidences indicate the presence of a hierarchy between epigenetic marks, with histone 
modifications being upstream of DNA methylation.  
The first genetic evidences for heterochromatin control of gene expression was the 
characterization of the Position Effect Variegation (PEV).  The first experiments performed by 
Muller in 1930 were showing that by irradiating Drosophila melanogaster flies with X-rays it 
was possible to mutate a gene responsible for eye pigmentation from a red to white phenotype, 
and that some of the mutant flies eyes were showing a distinct variegated pattern (or mottled), 
with some facets of the eye red and some white. In a subsequent irradiation step, it was possible 
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to revert the phenotype back. Since it was not likely that the gene responsible for the eye color 
had been mutated again, some other mutation occurring in a different gene was responsible for 
reverting the phenotype (Muller, 1930). It was later discovered that the initial mutation 
occurred because of an X-ray induced translocation that was placing the white gene close to a 
heterochromatic region, thereby seldom repressing its transcription. Subsequent mutagenesis 
steps could recover the white gene expression by impairing genes directly involved in 
heterochromatin formation and spreading, such as the suppressor of variegation Su(var)205 
gene encoding for the heterochromatin protein HP1a (Eissenberg et al., 1992). 
The evidences provided by these initial experiments indicated that the silencing could be spread 
across neighboring loci and that the heterochromatin formation was under the control of 
specific genes.  In particular, mutations on Suppressor of variegation Su(var) genes, prevents 
the silencing of a reporter gene nearby a heterochromatic region. Under these category of genes 
a wide variety of different functions can be found, such as the Su(var)3-9, a histone H3K9 
methyltransferase (homolog of the S. pombe Clr4), and several HP1 proteins. 
On the other hand mutation on Enhancers of variegation E(var) genes, increase the frequency 
of silencing of a reporter gene close to a heterochromatin region, indicating a spread beyond 
the chromatin boundaries as in the case of an H3K9 specific histone demethylase, an enzyme 
involved in preventing the spread of the heterochromatin H3K9me mark on transcriptionally 
active regions, like the S.pombe Epe1 (Braun et al., 2011; Ragunathan et al., 2014).  As can be 
deduced, heterochromatin boundaries have to be tightly controlled and there are several factors 
contributing to it. The presence of an actively transcribed gene, for instance, and all histone 
marks regulating its transcription, such as histone acetylation and H3K4me, are key players in 
preventing heterochromatin spreading. Moreover, the presence of NFR (Nucleosome Free 
Regions) impairs the deposition of new H3K9me and other repressive marks as well as a high 
nucleosome turn-over rate and chromatin remodeling (reviewed in (Wang et al., 2014). The 
process of organizing heterochromatin involves three main steps: the initial nucleation, the 
heterochromatin spreading from the initiation sites and the maintenance through the cell 
divisions. In different organisms, heterochromatin establishment involves different factors that 
allow the initial deposition of the histone H3K9me (or H3K27me) or the deacetylation of 
H4K16 (as occurs in S. cerevisiae). However, the initial signal that codes for heterochromatin 
formation passes through a histone post-translational modification deposition (in case of a 
repressive mark) or removal (in case of histone acetylation). The subsequent spreading occurs 
through amplification of the initial signal and several cycles of mark deposition or removal 
across the heterochromatic locus, with specific protein complexes involved in the process, such 
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as HMT –histone methyltransferases and HDAC- histone deacetylases. A boundary is set when 
an antagonizing histone post-translational mark is deposited on a nearby region, thus confining 
the heterochromatin formation at specific loci (Figure 1.2). The carefully controlled balance 
between nucleosome remodeling, histone PTMs deposition, nucleosome turn-over and 
transcription is what controls silencing and expression of single protein coding genes. This is 
therefore fundamental to allow timely and controlled expression of proteins and to prevent the 
rise of disease conditions, potentially fatal for the cell (Bhaumik et al., 2007; Garcia et al., 
2015). 
In the fission yeast S. pombe, the initial deposition of the H3K9me heterochromatin mark at 
centromeres is RNA interference (RNAi) dependent. RNAi factors recruit, in fact, a specific 
HMT (the Cul4-Rik1-Clr4 or CLRC complex) that deposits the H3K9me mark across the 
whole heterochromatin locus. The H3K9me mark is then recognized and bound by HP1 
proteins that cluster together nearby nucleosomes and silence the whole region (Bannister et 
al., 2001; Lachner et al., 2001; Nakayama et al., 2001). The H3K9me mark deposition and its 
readout are the key feature for heterochromatin formation, spreading and inheritance in 
S.pombe and in all the organisms, including mammals, in which similar mechanisms have been 
described. Since RNAi factors, H3K9me, HP1 and chromodomain proteins are well conserved 
from fission yeast to human, S.pombe represents one of the best organisms to study 
heterochromatin and silencing, given that its genome has been completely mapped, it grows 
rapidly under laboratory conditions and it is easy to genetically manipulate. 
 
Heterochromatin formation in Schizosaccharomyces pombe 
 
As described earlier, there are three main constitutive heterochromatin loci in S. pombe: 
centromeres, telomeres and the Mating type (MAT) locus (Allshire et al., 1995) (Figure 1.3). 
All three loci share homology between distinct non-coding DNA sequence repeats, named 
cenH like repeats or cenH elements, which have a central role in heterochromatin formation. 
These sequence elements are transcribed at low levels by RNA polymerase II and subsequently 
targeted by RNAi to induce transcriptional gene silencing (TGS) and H3K9me mark deposition 
(Djupedal et al., 2005; Noma et al., 2004; Verdel et al., 2004; Volpe et al., 2002).  
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Figure 1.3: Overview of the three main constitutive heterochromatin loci in S. pombe 
From (Mizuguchi et al., 2015): all three chromosome in fission yeast have extensive heterochromatin domains 
that are constitutively maintained throughout cell divisions: the telomeric ends, the centromeres and the Mating-
type (mat) locus on chromosome II. At centromeres, two classes of repeats, imr (innermost) and otr (outermost), 
surround the central core, cnt, where the kinetochore is assembled. Otr repeats can be further subdivided in dg 
and dh repeats, both transcribed and targeted by RNAi for heterochromatin formation. tRNA genes and IRC 
inverted repeats form boundary elements, limiting the spreading of heterochromatin from the centromere. At 
telomeres, multiple pathways are involved in heterochromatin formation, Taz1 and Swi6 dependent. RNAi plays a 
role in the initial establishment of heterochromatin from the sub-telomeric region, containing conserved dh-like 
repeats. Similarly a cenH element, homologous to dg and dh centromeric repeats is present at the mat locus, in 
between the IR-L and IR-R inverted repeats and the silenced mat2P and mat3M cassettes. In the blue boxes, the 
dg-dh repeats and their homologous sequence at the three heterochromatin loci.  
 
This process is fundamental in the establishment of heterochromatin formation. 
Heterochromatin is also found at rDNA repeats (Figure 1.3), even though its role has still not 
been elucidated in detail (Cam et al., 2005). In addition to constitutive heterochromatin, 
facultative heterochromatin can be assembled at other loci as well, targeting meiotic genes and 
other genomic locations in a euchromatic context (Hiriart et al., 2012; Zofall et al., 2012).  All 
these heterochromatin loci share the presence of high levels of H3K9 dimethylation, low level 
of histone acetylation (H3K4ac, H3K9ac, H3K14ac and H4K16ac) and binding of the two HP1 
proteins, Chp2 and Swi6, to the H3K9me2 histone mark. Moreover, reporter genes inserted in 
the vicinity or within any of these constitutive heterochromatin loci are transcriptionally 
silenced (Allshire et al., 1995). The H3K9 methylation mark deposition is carried out by the 
HMT Clr4, the only enzyme specific for the H3K9 residue, generating all three methylation 
states: mono-, di- and trimethylation (Al-Sady et al., 2013; Nakayama et al., 2001; Rea et al., 
2000). Clr4 is able to bind to the H3K9me mark through its chromodomain, thereby coupling 
the deposition of the H3K9me mark with its read-out, allowing the spreading of 
heterochromatin to nucleosomes directly nearby and maintain the H3K9me mark at constitutive 
loci upon cell division and mitotic growth throughout several generations (Al-Sady et al., 2013; 
Audergon et al., 2015; Nakayama et al., 2001; Ragunathan et al., 2014). While at centromeres 
RNAi is necessary for heterochromatin establishment and maintenance, at telomeres and at the 
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MAT locus other pathways are also involved as concurrent mechanisms (Jia, 2004; Kanoh et 
al., 2005).   
 
Heterochromatin at centromeres 
 
The three centromeres in S. pombe have variable size, ranging from 35 to 110 kb (Partridge et 
al., 2000; Steiner et al., 1993; Volpe et al., 2002; Wood et al., 2002). They are characterized by 
having a central core, called Cnt, the point of kinetochore assembly. In fact, the main function 
of centromere is ensuring an even chromosome segregation upon cell division in both mitosis 
and meiosis. To do so, a complex protein machinery called kinetochore has to assemble on the 
cnt/cc central region and then attach to the microtubules of the spindle fiber. The first 
component of the inner layer of the kinetochore is the histone H3 variant, Cnp1 (CENP-A 
homolog), that is found specifically in the cnt/cc region and additionally in the most internal 
part of the imr (innermost) repeats. The deposition of Cnp1 is dependent on heterochromatin 
only in the establishment of new kinetochores (Folco et al., 2008; Klutstein et al., 2015). 
Moreover, the central DNA sequence (around 2 kb- AT rich) in the cnt/cc is required for Cnp1 
deposition, and the process require specific stalling of RNA Pol II transcription over the 
centromeric locus. The centromeric sequence itself specifies for the low efficiency transcription 
and RNA Pol II stalling, which is required for CENP-A Cnp1 deposition (Catania et al., 2015), 
highlighting that centromere establishment is directed by both genetic and epigenetic 
mechanisms. Heterochromatin at centromeres has been shown to be facilitating the recruitment 
of the Rad21-cohesin to ensure sister centromere attachment and proper segregation. The 
deletion of Swi6 impairs the Rad21-cohesin recruitment causing segregation defects (Bernard 
et al., 2001). A similar role for Swi6-Psc3 cohesin has been shown at the MAT locus (Nonaka 
et al., 2002). 
Moreover, in a recent study, pericentromeric heterochromatin was found to be essential in 
recruiting cohesins to promote chromatin fiber compaction and inter-arm interactions within 
centromere proximal regions, forcing chromosomes in a rigid organization that limits extensive 
contacts between various chromatin domains. Loss of heterochromatin has the effect of 
increasing the inter- and intra- chromosomal arm associations, possibly enhancing the 
likelihood of aberrant recombination or impairing other nuclear processes (Mizuguchi et al., 
2014). 
The central core cnt/cc of the centromere is surrounded by two distinct classes of repeats: the 
closest to the kinetochore attachment site, the imr or innermost repeats, and the otr, or 
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outermost repeats (Partridge et al., 2000; Steiner et al., 1993; Volpe et al., 2002; Wood et al., 
2002). Both the imr and otr repeats are heterochromatic and any reporter gene inserted into 
these loci gets silenced (Allshire et al., 1995; Partridge et al., 2000). The external boundaries 
of centromeric heterochromatin are defined by the presence of actively transcribed tRNA genes 
(5 genes flanking three centromeric loci)(Noma et al., 2006; Scott et al., 2006), and localize 
anti-silencing factors such as the Epe1 H3K9 demethylase, the bromodomain protein Bdf1 and 
the histone acetyltransferase Mst2 (Cam and Grewal, 2004; Partridge et al., 2000; Wang et al., 
2013b, 2015). tRNA genes are also found in the inner core of the centromere (in chromosome 
3) and at the imr repeats (chromosomes 1-2-3), but are transcriptionally silenced (Volpe et al., 
2002). Functionally, the centromere in S.pombe can be divided into two main regions: 1) an 
inner core composed by the cnt/cc kinetochore attachment site and the imr repeats and 2) the 
outer repeats (otr) where pericentromeric heterochromatin is established. Otr repeats can be 
further sub-divided into two classes: dg and dh repeats. These blocks of sequences are present 
in multiple copies around each centromere and their copy number determines the variable size 
(35-110 kb) of the three centromeric loci in S.pombe (Partridge et al., 2000; Steiner et al., 1993; 
Volpe et al., 2002; Wood et al., 2002) (Figure 1.3). 
All centromeric locus is subject to low levels of transcriptional activity (Catania et al., 2015; 
Djupedal et al., 2005), which is essential for establishment of pericentromeric heterochromatin 
in a RNA interference mediated process (Kato, 2005; Verdel et al., 2004; Volpe et al., 2002). 
 
The RNA interference mediated heterochromatin formation 
 
Centromeric transcription generates both sense and antisense transcripts that are targeted by 
RNA interference in a co-transcriptional gene silencing process (Halic and Moazed, 2010; 
Kato, 2005; Moazed, 2009; Verdel et al., 2004; Volpe et al., 2002). The first evidences 
connecting RNAi to centromeric silencing came from the work of the Martienssen laboratory 
and others, showing that deletion of Argonaute (ago1+), Dicer (dcr1+) or the RNA dependent 
RNA polymerase (rdp1+) caused upregulation of centromeric transcripts and loss of H3K9 
methylation at the centromeric locus (Provost et al., 2002; Volpe et al., 2003, 2002). Further 
prove of RNA interference involvement in targeting centromeric transcripts was the isolation 
and characterization of siRNAs (short interfering RNAs) mapping to the pericentromeric dg 
and dh repeats (Reinhart and Bartel, 2002). The otr pericentromeric repeats are the initial 
nucleation site for centromeric heterochromatin and the process is dependent on the targeting 
of centromeric transcripts by RNA interference, directed by the Argonaute complex RITS 
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(RNAi- induced transcriptional silencing) (Bühler et al., 2006; Verdel et al., 2004). The RITS 
complex is composed by three protein: Argonaute (Ago1), binding short interfering RNAs 
(siRNAs) and targeting centromeric transcripts, the GW (glycine tryptophan) domain protein 
Tas3 and the chromodomain protein Chp1. The purification of Chp1 gave the first connection 
between the siRNA targeting of centromeric transcripts and heterochromatin (Verdel et al., 
2004). Chp1, in fact, binds H3K9me nucleosomes by direct recognition of the H3K9me mark 
through its chromodomain, and this interaction is fundamental for heterochromatin 
establishment and maintenance (Partridge et al., 2000; Schalch et al., 2009; Verdel et al., 2004). 
The specific targeting of pericentromeric transcripts occurs through base pair complementarity 
between an Argonaute bound siRNA and its target (Verdel et al., 2004). Argonaute is loaded 
with double stranded dsRNA in the ARC complex (Argonaute siRNA chaperone), containing 
Ago1 and two additional proteins, named Arb1 and Arb2, required as chaperones to facilitate 
the process (Buker et al., 2007; Holoch and Moazed, 2015b). The loaded Ago1 can be then 
incorporated into the RITS complex. The strand that is selected to be the targeting “guide” 
strand of the loaded dsRNA is the one more thermodynamically stable of the two, binding the 
MID domain with the 5´ end (Peek and Behlke, 2007). The other strand or “passenger” strand 
is usually cut, thanks to Ago1 slicer endonucleolytic activity, removed and targeted for 
degradation. An Argonaute slicer activity mutant fail to target pericentromeric transcripts, 
despite loading dsRNA, and has defects in heterochromatin formation (Buker et al., 2007; Halic 
and Moazed, 2010). The dsRNAs loaded by the ARC chaperone complex are in average double 
stranded 21-25 nt long with 2 nt overhangs at the 3´end, bound by the Ago1 PAZ domain, and 
a 5´ phosphate, bound by the Ago1 MID domain. These short dsRNA are the products of the 
degradation of self-associated sense and antisense dsRNA pericentromeric transcripts by the 
type III RNA endonuclease Dicer (Dcr1)(Holoch and Moazed, 2015a; Moazed, 2009; Provost 
et al., 2002). Once sense and antisense centromeric transcripts are generated they can pair 
together to generate dsRNA that is then targeted by Dcr1. The product are short dsRNA that 
can then be loaded into Ago1 through the ARC complex, which is not associating with 
chromatin, but serves as a platform to generate fully loaded Argonaute that can be then 
incorporated into the RITS complex (Holoch and Moazed, 2015b). RITS association through 
its chromodomain protein Chp1 to H3K9me chromatin, while targeting pericentromeric RNAs 
with Ago1 associated siRNAs, is fundamental to recruit two distinct machineries: one is the 
RNA dependent RNA polymerase complex or RDRC and the other is the Clr4-Rik1-Cul4 
(CLRC) complex. 
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Figure 1.4: The “nascent transcript” positive feedback loop model for heterochromatin formation at 
centromeres in S.pombe 
 
From (Holoch and Moazed, 2015a): Centromeric transcripts (lncRNA, transcribed by RNA PolII) are targeted by 
the RITS-Argonaute complex (formed by Chp1, Tas3 and Ago1) by complementary siRNAs loaded onto Argonaute 
(Ago1). The Chp1 protein, associates the Ago1 targeting the centromeric transcripts with the chromatin, though 
its binding to H3K9 methylated Nucleosomes (H3K9me2 or H3K9me3). Another component of the RITS, the GW 
protein Tas3, bridges Chp1 and Ago1 together and forms together with Chp1 and the transcribed centromeric 
lncRNA the recruiting platform for the siRNA loaded Ago1. The RITS once targeting the RNA, recruits two 
complexes: the RDRC and the CLRC. The RDRC (RNA dependent RNA polymerase complex) synthesizes a dsRNA 
starting from the targeted centromeric RNA and the Ago-bound siRNA as templates. dsRNAs can be then sliced 
by Dicer (Dcr1) to generate new siRNAs for centromeric RNA targeting, thus creating positive feedback loop. 
RDRC can be also recruited through Ers1 interaction with the HP1 protein Swi6. The second complex recruited 
by RITS, through Tas3-Chp1 interaction with Rik1 and Stc1, is the CLRC (Clr4-Rik1-Cul4 complex), containing 
the SET domain methyltransferase Clr4. Clr4 deposits the H3K9 methylation, which is then bound by the 
chromodomain of Chp1, and of the HP1 proteins, Swi6 and Chp2, for nucleosome compaction and 
heterochromatin formation. Both HP1s, Swi6 and Chp2, can recruit an additional silencing complex, the histone 
deacetylase SHREC complex (Snf2-histone deacetylase repressor complex), specific for H3K14 deacetylation. 
The TRAMP non-canonical poly(A) polymerase and the exosome contribute as well to the silencing of centromeric 
transcripts by direct degradation. The binding of the RITS complex to H3K9me Nucleosomes with Chp1 and to 
the centromeric RNA through Ago1 loaded siRNA, constitutes the core event for heterochromatin formation in the 
nascent transcript feedback loop model. 
 
 
Introduction 
20 
 
The RDRC complex is composed by Rdp1, the RNA dependent RNA polymerase, the Hrr1 
helicase and the Cid12 non-canonical poly-A polymerase (Motamedi et al., 2004; Sugiyama et 
al., 2005). The RNA dependent RNA polymerase complex associate with the RITS and 
catalyzes the synthesis of the complementary strand of the pericentromeric transcripts targeted 
by Ago1. This generates more substrates for the Dcr1 dependent 21-25nt dsRNA production 
(Colmenares et al., 2007; Motamedi et al., 2004), thus amplifying the initial input siRNA in a 
feedback positive loop. A novel protein, Dsh1, recently characterized, helps the activity of Dcr1 
in generating siRNA and recruits RDRC complex to perinuclear foci to generate siRNA 
generating factories (Kawakami et al., 2012). The CLRC complex, on the other hand,  
interacting with the RITS through the subunit Rik1 (Gerace et al., 2010) and the bridging LIM 
domain protein Stc1 (Bayne et al., 2010), is involved in depositing the H3K9 methylation mark 
through its methyltransferase subunit Clr4 (Zhang et al., 2008). Clr4 is a H3K9 specific 
methyltransferase, able to deposit the H3K9me mark and bind to it through its chromodomain, 
enabling a dual function of both “writer” and “reader” of the histone modification (Al-Sady et 
al., 2013; Audergon et al., 2015; Nakayama et al., 2001; Ragunathan et al., 2014; Zhang et al., 
2008). The other major components of the CLRC complex are the proteins Rik1 (that associates 
with both the RDRC and the RITS complex), Raf1, Raf2 and the E3 ubiquitin ligase Cul4. Cul4 
target for ubiquitination is still unknown but its activity is required for heterochromatin 
formation (Jia et al., 2005).  
The deposition of the H3K9 methylation, as previously described, creates a binding platform 
for the other S. pombe chromodomain protein: Chp1 and the two HP1 proteins, Swi6 and Chp2. 
HP1 protein binding contributes to centromeric silencing by bridging together nearby 
nucleosomes through recognition of the H3K9me mark and self-oligomerization through the 
chromo-shadow domain, and by recruiting HDAC complexes such as the SHREC and Sir2 
deacetylases (Buscaino et al., 2013; Motamedi et al., 2008; Sugiyama et al., 2007). Histone de-
acetylation contributes to erasing the acetylation mark to probe chromatin for H3K9me 
deposition. The SHREC complex, formed by the Clr1, Clr2, Clr3 and Mit1 proteins, de-
acetylates specifically the histone H3K14 residue (through the activity of the H3K14 
deacetylase Clr3), and is required for dictating proper nucleosome positioning in 
heterochromatin and silence the transcriptional activity of RNA Polymerase II (Motamedi et 
al., 2008; Sugiyama et al., 2007; Wirén et al., 2005). Sir2 specifically de-acetylates the histone 
H3K9 residue, making it accessible for methylation mark deposition (Wirén et al., 2005). It has 
been proposed that H3K4 acetylation mediated by the acetyltransferase Mst1, might work as a 
switch mark to recruit HP1 (Swi6/Chp2) proteins to H3K9me chromatin during 
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heterochromatin reassembly (Xhemalce and Kouzarides, 2010). Recruitment of the SHREC 
effector complex by HP1 (Swi6) proteins to H3K9me chromatin is also regulated by post-
translational modifications at HP1 N-terminus by the Casein-kinase 2 (CK2). Loss of CK2 
dependent phosphorylation at the N-terminus of Swi6 reduces the localization of SHREC to 
heterochromatin with a concomitant increase of the demethylase Epe1 localization and 
impairment of the transcriptional gene silencing (TGS) (Shimada et al., 2009). A recent study 
highlights the evolutionary importance of CK2 phosphorylation to HP1 binding to nucleosome, 
which is increasing the specificity for the H3K9me mark, by impairing non-specific binding to 
nucleosomal DNA (Nishibuchi et al., 2014). Chromatin bound Swi6 can also recruit additional 
RNAi complexes (RITS, RDRC) and Dcr1 through the interaction with the silencing factor 
Ers1, linking directly heterochromatin to RNA interference (Hayashi et al., 2012; Rougemaille 
et al., 2008, 2012). Ers1 strongly interacts with the RDRC subunit Hrr1, and loss of Ers1 
impairs RDRC centromeric localization. This process of recruitment of the RDRC complex is 
RNA interference independent and explains the importance of having the Swi6 
heterochromatin platform properly assembled to anchor the RDRC complexes to chromatin 
(Hayashi et al., 2012). Moreover, HP1 protein help recruiting the HIRA/Asf1 histone 
chaperone complex, which, in concert with the histone deacetylase Clr6 and the SHREC 
complex, suppresses antisense transcription by promoting histone de-acetylation and 
promoting nucleosome occupancy at the heterochromatin repeats. TFIIIC factor (RNA 
polymerase III specific initiation factor – tRNA gene specific) act as a boundary element, 
limiting the spreading of SHREC and Clr6 de-acetylase activity to tRNA bordering genes 
(Yamane et al., 2011). 
One of the biggest questions in the latest years was to find out what is the triggering factor for 
this positive feedback loop mechanism that establish heterochromatin in S. pombe. Halic and 
Moazed discovered a new class of small RNA, called primal RNAs (priRNAs), which are 
generated independently of Dicer activity and are able to establish small level of H3K9 
methylation by associating with the RNAi machinery. priRNAs are product of general sense 
and antisense transcript degradation and stochastically associate with Argonaute to initiate 
RNAi. Because of naturally occurring high level of antisense transcription at heterochromatic 
loci in S.pombe, many repetitive elements and retrotransposons, priRNA can be generated and 
target their complementary sense transcripts, thus probing for RNAi dependent 
heterochromatin establishment (Halic and Moazed, 2010). priRNA are thought to be an RNAi 
dependent surveillance mechanisms against transposons and other mobile elements, which are 
known to be transcribed bi-directionally. Antisense transcription would drive the generation of 
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priRNA and target RNAi to form heterochromatin at these loci. Deletion of the exosome 
subunit Rrp6 causes an increase in antisense transcription and spurious heterochromatin 
establishment in those loci in which antisense transcripts are usually degraded (Marasovic et 
al., 2013). The deletion of the enzyme Triman, responsible for priRNAs biogenesis, 
counterbalances the lack of Rrp6 and prevents the non-regulated establishment of H3K9 
methylation. Moreover, Triman is required for establishment of heterochromatin at centromeres 
in cells in which Dcr1 and Clr4 have been re-introduced after deletion. This indicates a 
fundamental role for priRNAs in inoculating the initial H3K9 methylation and RNAi targeting 
of centromeric transcripts (Halic and Moazed, 2010; Marasovic et al., 2013).  
Another class of siRNA has been recently classified and called primary RNAs. These small 
RNAs are both Rdp1 independent and Dicer dependent, and helped defining a model for RNAi 
heterochromatin formation in which convergent transcription, Dcr1 concentration and low 
transcription efficiency define the loci in which heterochromatin is going to be more likely 
established (Yu et al., 2014). This is very well supported by the fact that centromeric 
transcription lacks strong termination and poly-adenylating signals and that generation of low 
levels of siRNAs is independent of H3K9 methylation (Halic and Moazed, 2010; Yu et al., 
2014). It seems therefore that the initiating signal for heterochromatin establishment is 
determined by the generation of two distinct classes of small RNAs, primal and primary RNAs, 
which recruit RNAi machinery to convergently transcribed loci. 
 
Heterochromatin at the Mating type (MAT) locus  
 
The silent Mating type (MAT) locus is located on the right arm of Chromosome 2 and space a 
region of roughly 30 kb, distant from both centromeric and telomeric loci.  Within these region 
there are three linked loci: mat1, mat2-P and mat3-M (Figure 1.3). mat1 is the only locus 
expressed and determines the actual Mating type of the cell, either P or M. mat2-P and mat3-
M are silenced by heterochromatin and are separated between each other from a 11 kb K-region, 
containing the 4.3 kb cenH repeats, that share 96% homology with the centromeric dg and dh 
repeats (Grewal and Klar, 1997). In homothallic h90 strains, a gene recombination event 
converts the gene cassette in mat1 into one of the two cassettes, mat2-P or mat3-M, in a 
preferential fashion: if mat1-P, it will recombine with mat3-M, if mat1-M it will recombine 
with mat2-P (Grewal and Klar, 1997). A specific protein complex, the Recombination 
Promoting Complex (RPC), containing the proteins Swi5 and Swi2, is responsible for 
mediating the conversion between mating cassettes in a directional way (Jia et al., 2004). In 
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homothallic strains this interconversion event happens every second cell division, and it is 
driven by an unrepaired single strand break during DNA replication that becomes an 
intermediate for DNA recombination (Holmes et al., 2005; Kaykov et al., 2004). At the MAT 
locus, two distinct pathway are redundant to establish heterochromatin at the mat2-P and mat3-
M cassettes.  
Loss of heterochromatin at the Mating type locus fosters spurious recombination events 
between cassettes, impairing the normal Switching (Swi) phenotype in homothallic h90 strains 
and inducing meiotic recombination in the K-region (Lorentz et al., 1992). One of the genes 
isolated to be responsible for defective MAT type switching is Swi6, encoding for the HP1 
homolog. Swi6 is binding through the H3K9me mark and recruiting the SHREC deacetylase 
complex to establish and spread heterochromatin at the MAT locus (Hall et al., 2002). 
Establishment of heterochromatin at the MAT locus is dependent on the cenH element, which 
is transcribed and targeted by RNA interference that in turns recruits the CLRC complex to 
deposit the H3K9me mark (Hall et al., 2002). Replacement of the cenH element with an ura4+ 
reporter gene resulted in cells having a variegated mating phenotype and epigenetic silencing 
(Grewal and Klar, 1996). These results indicated that any epigenetic mechanism established 
for gene control at the MAT locus is heritably transmitted through various cell generations, 
independently of the DNA sequence. On the other hand, cenH genomic integration in other 
genomic loci is able to establish heterochromatin in a RNAi dependent fashion (Hall et al., 
2002). However, RNA interference is dispensable for heterochromatin maintenance and 
inheritance which is guaranteed by another pathway, dependent on the ATF/CREB transcription 
factors Atf1/Pcr1 (Hall et al., 2002; Jia, 2004). These DNA binding proteins can recognize two 
heptameric sequence (called REIII element), between the cenH repeats and mat3-M cassette, 
and then form complexes with the histone deacetylase Clr3, Clr6 and the HP1 protein Swi6 to 
limit RNA polymerase II transcription and silence the entire locus (Kim et al., 2004; Sugiyama 
et al., 2007; Yamada et al., 2005).  
 
Heterochromatin at telomeres 
 
Heterochromatin at telomeres and telomeric associated sequences (TAS, also known as sub-
telomeres) is essential to protect chromosome ends from inter- and intra-chromosomal 
recombination, to maintain genomic stability (Bisht et al., 2008; Schoeftner and Blasco, 2009). 
Like in the case of MAT locus, RNA interference is involved in heterochromatin formation at 
sub-telomeric regions (that harbor cenH like repeats, Figure 1.3) but it is not the main pathway 
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directing it. In fact, RNAi mutants do not have heterochromatin defects at telomeres, as the 
HP1 protein Swi6 maintain its localization and there are no drops in H3K9me levels (Kanoh et 
al., 2005). Mutations in Swi6, Clr4, the DNA binding protein Taz1 and Rap1 all affect telomeric 
silencing (Cooper et al., 1997; Kanoh and Ishikawa, 2001; Nimmo et al., 1998; Schoeftner and 
Blasco, 2009). In the absence of Swi6 in particular, H3K9me is restricted at the cenH-like 
repeats, overlapping with the cenH siRNA distribution, indicating a role for RNAi in the 
establishment of sub-telomeric heterochromatin starting from centromeric dg and dh like 
homologous loci. Deletion of the cenH like homology region causes an effect similar to the 
deletion of any RNAi factor, indicating that targeting of sub-telomeric transcripts is required 
for heterochromatin establishment at sub-telomeres (Kanoh et al., 2005). RNAi components 
and H3K9 methylation are in fact distributed all over the 40 kb sub-telomeric region (Cam et 
al., 2005). Taz1 and Rap1 are part of a conserved protein complex called Shelterin, involved in 
chromosome end protection, to prevent end-to-end inter- and intra-chromosome fusion and to 
establish silencing across the telomeric locus (Bisht et al., 2008; de Lange, 2009). The telomeric 
Taz1, homolog of the mammalian Shelterin TRF2, is responsible for recruiting Swi6 through 
Clr4 activity, to establish de novo H3K9me and induce heterochromatin silencing (Kanoh et 
al., 2005). Deletion of Taz1 causes an increase in telomeric repeats length (Shelterin is involved 
in inhibiting telomerase activity once assembled on the chromosome end (de Lange, 2009)) 
and loss of silencing for telomeric transcripts (Kanoh et al., 2005). Deletion of Taz1 and RNAi 
factors releases Swi6 from the sub-telomeres, indicating two redundant pathways involved in 
establishing and spreading heterochromatin at telomeres (Kanoh et al., 2005; Schoeftner and 
Blasco, 2009). Moreover, Taz1, together with the Shelterin Ccq1 and RNA interference, are 
fundamental to recruit the SHREC deacetylase complex to telomeres, which deacetylates and 
adjust nucleosome occupancy to induce silencing (thanks to its subunits Clr3 and the chromatin 
remodeler Mit1)(Sugiyama et al., 2007). Telomeric repeats in S.pombe are transcribed, even 
though the role of transcription for telomere length regulation, chromosome end protection or 
silencing is still obscure (Bah et al., 2012). Recent studies reveal novel roles for telomeres in 
regulating centromeric heterochromatin assembly. The rate limiting distribution of 
heterochromatin factors through the different heterochromatin domains makes cells lacking 
normal Shelterin assembly able to bypass RNAi for pericentromeric heterochromatin 
formation. This would be caused by an altered recruitment of silencing factors to telomeres and 
their re-distribution to centromeres (Tadeo et al., 2013), indicating a cross-talk between 
different chromatin domains and explaining also the reason for clustering in similar nuclear 
compartments. Further confirmation of this co-regulation is found in the need for proper 
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telomere localization (through the Bouquet complex anchoring to the nuclear membrane) to re-
assemble pericentromeric heterochromatin in meiosis, which is required for CENP-A 
deposition and Spindle Pole Body attachment (Klutstein et al., 2015). 
 
Heterochromatin formation main players: HP1 and chromodomain proteins 
 
Silencing is mediated by the coordinated action of different proteins and chromodomain 
containing proteins play a fundamental role in many Eukaryotic organisms to ensure the 
establishment and propagation of heterochromatin. The first evidences of chromodomain 
proteins having a fundamental role for heterochromatin stability were from studies done in 
Drosophila melanogaster, as previously mentioned.  
 
Figure 1.5: HP1 proteins and their domains 
From (Maison and Almouzni, 2004): (a) alignment between the three mammalian HP1 isoforms: HP1α , HP1β 
and HP1γ. While the three Chromodomains (CD, in red) and Chromoshadow domains (CSD, in blue) share a high 
degree of conservation, the Hinge region is characterized by being not conserved and positively charged with 
many basic residues. (b) Domain organization of the mammalian HP1α  protein with its interaction partners. In 
red, the CD, in green the Hinge domain and in blue the CSD. This organization is shared among HP1 proteins. 
 
In 1986, James and Elgin discovered and characterized through a screening for PEV (Position 
Effect Variegation) suppressors, the HP1a (Heterochromatin Protein 1a, encoded by the 
Su(var)2-5 gene, reviewed in (Eissenberg and Elgin, 2014)), a non-histone protein associated 
with heterochromatin  (James and Elgin, 1986). Later, more evidences showed that the HP1a 
gene was associated with the control of PEV: a G to A transition mutation causing a splicing 
defect of the gene was responsible for a strong dominant PEV suppressor phenotype 
(Eissenberg et al., 1990) and PEV increase could be observed when over-expressing the HP1a 
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(under the Hsp70 heat inducible promoter) after transduction of a P-element, carrying the HP1a 
gene, transformed into fruit-fly germline cells (Eissenberg et al., 1992). This initial studies 
were highlighting the role of HP1 chromodomain proteins in establishing and maintaining 
heterochromatin domains and tightly defining their borders. Many HP1 homologs are found in 
different organisms, from fission yeast to humans, with isoforms having distinct functions and 
interacting with different complexes (Lomberk et al., 2006a).  
In the budding yeast S. cerevisiae silencing does not occur through deposition of the H3K9 
methyl mark and its own read out (there is no H3K9 methylation or HP1 homologs), but 
through coupling of SIR mediated histone H4K16 de-acetylation and SIR complex binding. 
The SIR complex, formed by the deacetylase Sir2, the Sir3 and Sir4 proteins, recognize 
specifically de-acetylated nucleosomes, binds to them through the Sir3 BAH domain and 
oligomerize through its Sir3 and Sir4 subunits, thereby spreading the silencing from the 
recruiting locus (recruitment occurs through protein-protein interaction with DNA binding 
factors such as ORC complex, Abf1 and Rap1. The sequence elements required for the 
recruitment are called E –essential- or I –important- silencers). The H3K79 histone globular 
domain modification antagonizes the SIR complex binding to chromatin, thus marking actively 
transcribed genes (Oppikofer et al., 2013).  
In a similar way as the SIR complex in S. cerevisiae, HP1 recognition of the H3K9 histone 
post-translational modification is essential for establishing a silencing platform, necessary for 
the recruitment of different complexes to repress transcription. This recognition occurs through 
the chromodomain, first discovered by studying the Drosophila Polycomb gene, which is 
showing an N- terminal region having high homology with the HP1 N- terminal region (Paro 
and Hogness, 1991) (Figure 1.5). The Polycomb-group proteins chromodomain (there are at 
least 5 different variants of CBX proteins in the canonical mammalian PRC1 complex, with 
different affinities for the H3K27, some of them showing dual affinity for H3K9 methylation 
(Bernstein et al., 2006; Di Croce and Helin, 2013)) recognizes specifically H3K27 methylation, 
a mark of facultative heterochromatin, while sharing structural and sequence similarity with 
the HP1 chromodomain (Min et al., 2003). However, swapping of the Polycomb 
chromodomain with HP1 chromodomain alters the localization and function of these factors to 
chromatin, indicating specialized roles for these domains in dictating the distribution of 
heterochromatin proteins (Fischle et al., 2003).  The chromo- (Chromatin Organization 
Modifier) domain is found in all HP1 proteins and in many chromatin specific factors, with a 
broad range of affinity for different target histone methylation marks as reviewed in 
(Eissenberg, 2012).  Mutations in the chromodomain, that alter its specificity or affinity for its 
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target H3K9 methylation mark, impair the silencing activity of HP1 proteins, revealing the 
importance of H3K9 recognition to mediate heterochromatin establishment (Eissenberg, 2012; 
Platero et al., 1995). Moreover, post-translational modifications such as Ser-83 
phosphorylation of the fruit-fly HP1 gamma, can alter the localization of HP1 proteins from 
heterochromatin to euchromatin, indicating the existence of a HP1 sub-code beside the 
recognition of the H3K9 heterochromatin mark (Lomberk et al., 2006b). Protein of the HP1 
family share other common features beside the chromodomain, such as the presence of a widely 
unstructured part called Hinge domain and the Chromo-Shadow (CSD) domain (Figure 1.5). 
The Chromo-Shadow domain was first identified through its similarity with the 
Chromodomain (Assland and Stewart, 1995). Structure and sequence analysis revealed the 
presence of a conserved pentameric motif, the PXVXL motif, necessary for CSD dimerization 
(Smothers and Henikoff, 2000). The ability of the CSD to dimerize is required to recruit more 
HP1 proteins to chromatin and establish heterochromatin silencing, coupled with H3K9me 
recognition from the chromodomain (Thiru et al., 2004).  
The Hinge domain separates the Chromodomain from the Chromo-Shadow domain and 
represents the most flexible part of the protein, with the least conserved sequence (Munari et 
al., 2013; Nishibuchi and Nakayama, 2014). Several studies (Keller et al., 2012; Mishima et 
al., 2013; Muchardt et al., 2002) showed that the Hinge region binding to RNA and DNA was 
essential to coordinate HP1 localization to chromatin, along with H3K9 methyl mark 
recognition. Particularly, the Hinge of the S. pombe HP1 Swi6 was shown to specifically bind 
to centromeric RNAs and a model of coordinated eviction of Swi6 from chromatin was 
proposed: Swi6 binds centromeric RNAs to prompt them for degradation. To do so, Swi6 would 
dissociate from heterochromatin and interact with transcribed RNAs with its Hinge domain 
(Keller et al., 2012). 
Other proteins of fundamental importance for heterochromatin formation are the Su(var)3-9 
methyltransferases (such as the S.pombe Clr4). First characterized in Drosophila (Tschiersch et 
al., 1994), this class of enzymes has also a chromodomain. The chromodomain allows them to 
couple directly the deposition of H3K9 methylation with its read-out, facilitating the spreading 
of the histone mark, independently of the underlying DNA sequence (Audergon et al., 2015; 
Ragunathan et al., 2014). 
 
The chromodomain: structure and function in heterochromatin regulation 
 
The Chromatin Organization Modifier domain or Chromodomain (CD) is a small domain of 
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roughly 10 kDa, formed by a three antiparallel β-strand and a C-terminal α-helix. It is one of 
the first nucleosome binding domains characterized in details, as first studies performed 
showed it had a high specificity for the histone tail H3 methylated at the Lysine 9 residue 
(Bannister et al., 2001; Lachner et al., 2001). Confirmation for this binding specificity came 
from additional in vivo and in vitro experiments, showing a strict dependence between 
chromodomain interaction with nucleosomes and the presence of the H3K9 methylation mark. 
In fact loss of the H3K9me causes HP1 proteins delocalization from chromatin, in yeast, 
Drosophila and mammalian cells (Eissenberg, 2012; Jacobs et al., 2001; Lachner et al., 2001; 
Nakayama et al., 2001; Schotta et al., 2004). The first structure with the specifically recognized 
target (Jacobs and Khorasanizadeh, 2002), the H3K9 methylated histone tail, highlighted that 
the residues interacting with the modified Lysine 9 form an aromatic cage around it, with 
affinity extremely sensitive to the degree of methylation (either mono- di or tri- methyl state). 
The three residues of the aromatic pocket (in Chp1CD: Tyrosine Y22, Tryptophan W44 and 
Tyrosine Y47) interact with the positively charge methyl-lysine residue through the interaction 
of the cationic charge of the ε-amine group with the delocalized electron cloud of the 
Tryptophan aromatic ring (cation-π interaction)(Hughes et al., 2007). The degree of 
methylation changes the cationic strength of the ε-amine, with the tri-methyl state being more 
positively charged and having the strongest binding affinity in vitro (Figure 1.6). While 
chromodomains are structurally conserved among the HP1 and Polycomb family of proteins, 
they are able to distinguish with high specificity between H3K9 methylation and H3K27 
methylation (Fischle et al., 2003; Min et al., 2003). As already mentioned, swapping of the 
HP1 CD with the Polycomb CD causes a mis-localization of the HP1 protein, with consequent 
loss of heterochromatin (Platero et al., 1995). This indicates that CDs not only are able to read 
the Lysine residue that is methylated but also the surrounding residues along the histone tail, 
conferring further specificity to the binding. The deposition of different methyl- marks 
therefore influences the distribution of chromodomain proteins with different specificities, as 
in case of the HP1 with the H3K9me and Polycomb with H3K27me histone marks. However, 
some CDs, such as the mammalian Polycomb isoforms Cbx2 and Cbx7, share similar affinities 
for H3K9 and H3K27 methylation (Bernstein et al., 2006). This hints on the possibility that 
different Polycomb isoforms contribute to the recognition of the H3K27 or H3K9 methylation 
mark in different ways, thus modifying the efficiency of recruitment or the nuclear distribution 
of the Polycomb complex in a regulated way.  
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Figure 1.6: The chromodomain (CD) specifically recognizes H3K9 methylation  
From (Blus et al., 2011): X-ray crystal structure of the canonical chromodomain (in green) of the HP1 protein, 
bound to the H3K9me3 peptide (in grey). The cation-π interaction is mediated by three aromatic residues (two 
conserved Tyrosine and a Tryptophan, Y22, W44 and Y47 in the S.pombe Chp1) with their aromatic rings 
delocalized electrons stabilizing the positive charge of the methylated lysine residue (H3K9me) of the histone tail. 
Different methylation states alter the charge on the lysine, thereby changing the affinity of binding. As shown in 
the alignment, the three residues (in the red boxes) are conserved throughout evolution, from fission yeast (Chp1 
and Clr4) and Drosophila (Pc and HP1) to mammals (Cbx7, CDYL2).  
 
CD recognition of its target can be regulated in two ways: 1) by modifying the substrate 
recognition sequence or 2) by post-translationally modifying the chromodomain itself. 
Growing evidences show that the histone tail can be modified to prevent binding of HP1 
proteins in vivo. Histone H3S10 is phosphorylated by the Aurora B kinase/Ilp1 upon entry in 
S phase (Hsu et al., 2000).  A study by Hirota and colleagues in 2005 showed that such a 
modification occurs on histone tails harboring already the H3K9 methyl mark, and that the dual 
marking exists in vivo. The binding affinity of HP1 proteins for the H3K9me in the presence 
of Serine 10 phosphorylation is severely impaired, and deposition of the H3S10phospho mark 
causes the delocalization of HP1 proteins from chromatin (Hirota et al., 2005). Both histone 
H3K9 methylation and H3S10 phosphorylation can be reversible (PP1 phosphatase reverts 
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H3S10 phosphorylation (Hsu et al., 2000)), showing that HP1 recruitment to chromatin is 
subjected to a complex layer of regulation involving substrate modification. Different H3 
Lysine residue that have been shown to be methylated in vivo are adjacent to Threonine or 
Serine residues that can be phosphorylated. It is the case for Lysine 4 (H3K4), close to 
Threonine 3 (H3T3) and Lysine 79 (H3K79) close to Threonine 80 (H3T80). Both mark of 
actively transcribed regions, H3T3 has been shown to be phosphorylated in vivo by the Haspin 
kinase and to lower the binding affinity of the CHD1 CD, regulating its binding in a similar 
manner as HP1/H3S10phospho (Dai et al., 2005; Flanagan et al., 2005).  
Moreover, phosphorylation by the DYRK1A kinase at residues H3T45 and H3S57 affects the 
binding of the three mammalian HP1 isoforms, HP1α, HP1β and HP1γ (Jang et al., 2014). 
It is still unclear the effect of direct post-translational modifications on the CD on its binding 
activity in vivo. It is well known that HP1 proteins are heavily phosphorylated by Casein kinase 
(CKII) in Drosophila and fission yeast (Shimada et al., 2009; Zhao and Eissenberg, 1999; Zhao 
et al., 2001) and that this is required for proper silencing and heterochromatin formation. There 
is still little evidence of regulated CD modifications that alter the binding affinity in vivo: a 
study from Ayoub et al. showed that HP1β CD is phosphorylated on residue T51 in response 
to DNA damage, lowering the CD binding affinity for H3K9me and therefore dissociating 
HP1β from chromatin (Ayoub et al., 2008). Interestingly, phosphorylation of Serine 42 of the 
chromodomain of the mouse Polycomb Cbx2 protein lowers its affinity for the H3K9 
methylated peptides while increasing  the binding for H3K27 methylated peptides (Hatano et 
al., 2010). Post-translational modifications could therefore regulate not only the binding 
affinity of the chromodomains but also their specificity.  
Another striking feature of CDs is their ability to interact with the nucleic acids. The fist 
example of such interaction was discovered in Drosophila, with the chromodomain of the MOF 
protein, member of the MSL (Male Sex Lethal) complex, responsible for X inactivation and 
dosage compensation (Akhtar et al., 2000). MSL is a riboprotein complex with two structural 
RNAs, roX1 and roX2 and two chromodomain proteins MOF and MSL3. Both chromodomains 
were found to interact with the roX2 RNA, and MOF dependent acetylation of MSL3 is 
required to stabilize the binding (Buscaino et al., 2003). The interaction with the roX2 RNA is 
essential for the stability and function of the MSL complex.  
MSL3 CD recognizes specifically H4K20 mono-methylation but DNA binding is essential to 
mediate the association, forming a stable ternary complex (DNA, MSL3, H4K20 tail) (Kim et 
al., 2010). Association of chromodomains with both DNA and RNA has been shown now in 
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several organisms to be likely relevant in vivo. The chromodomain of the mouse Polycomb 
Cbx7 requires RNA binding to mediate its recruitment to the inactive X chromosome 
(Bernstein et al., 2006). The human CBX7 is able to bind both the H3K27me histone tail and 
the ANRIL non-coding RNA and this contributes to control the expression of the tumor 
suppressor locus INK4b/ARF/INK4a (Yap et al., 2010).  
Similarly, the CD of Chp1, member of the RITS complex of S. pombe, has been shown to have 
nucleic acids binding in vivo, with the binding interface restricted to the C-terminal positively 
charged α-helix (Ishida et al., 2012). Swapping of the C-terminal residues of Chp1 CD with 
the homologous residues from Swi6 CD (which does not bind RNA or DNA in vitro) causes 
transcripts up-regulation and diminished levels of H3K9me at centromeres, hinting on the 
importance of nucleic acids binding for heterochromatin formation (Ishida et al., 2012). 
Similarly, Clr4CD binds the RNA in vitro (Ishida et al., 2012) even though the importance of 
this interaction related to H3K9me deposition is still to be explored.   
  
The chromodomain proteins of Schizosaccharomyces pombe in heterochromatin 
formation 
 
There are four chromodomain proteins involved in heterochromatin formation in S.pombe: two 
of them belonging to the HP1 family, namely Chp2 and Swi6, the histone methyltransferase 
Clr4, homologous to the Su(var)3-9 and the member of RITS complex, Chp1 (Figure 1.7). 
Swi6 is the HP1 homolog, involved in heterochromatin assembly at centromeres, telomeres 
and at the MAT locus (Ekwall et al., 1995). Chp2 is its functional isoform, as well localizing 
at all three heterochromatin loci. Both Swi6 and Chp2 are required for the assembly of 
repressive heterochromatin, but Chp2 is less abundant and has a more defined role in recruiting 
the SHREC (Chp2 has higher affinity than Swi6 for SHREC deacetylase Clr3) and Epe1 to 
chromatin (Motamedi et al., 2008; Sadaie et al., 2008). Cellular fractionation experiments 
showed that the interaction of Chp2 with chromatin is more dynamic than that of Swi6 (Sadaie 
et al., 2008), with more protein concentrated in the nuclear soluble fraction rather than the 
chromatin bound.  
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Figure 1.7: Chromodomain proteins in fission yeast 
From (Sadaie et al., 2004): Schematic representation of three of the four heterochromatin protein in S.pombe: 
Chp1, Swi6 and Chp2. The fourth one is the methyltransferase Clr4, responsible for the H3K9me mark deposition 
(not shown in the cartoon, it harbors a CD and a methyltransferase SET domain). Chp1 is member of the RITS-
Argonaute complex, whereas Swi6 and Chp2 are fission yeast HP1 homologs. The Chromodomain is highlighted 
in red (CD), the Chromoshadow domain (CSD) in blue. In the panel below, GFP tagged version of Chp1, Swi6 
and Chp2 localize as nuclear foci in clr4+ cells. In the absence of H3K9me (dependent on Clr4) the proteins are 
not anymore localized in distinct foci. DNA was stained with Hoechst33342 as cellular control. 
 
Moreover, Swi6 interacts with centromeric RNAs in vivo and this has been proposed to be a 
mechanisms to facilitate RNAi targeting of centromeric transcripts (Motamedi et al., 2008) or 
their degradation (Keller et al., 2012). Chp2, on the other hand, recruits the SHREC to 
deacetylate H3K14 (through its Clr3 subunit) and, in cooperation with Swi6, limits the access 
of RNA Polymerase II to centromeric loci (Fischer et al., 2009; Motamedi et al., 2008). Single 
Swi6 or Chp2 deletion mutants have similar effect on centromeric transcripts up-regulation, 
while swi6∆chp2∆ double mutant shows a cumulative defect and an increased loss of silencing. 
This indicates that Swi6 and Chp2 have different non-overlapping roles in heterochromatin 
formation and that they are involved in distinct silencing pathways (Motamedi et al., 2008). In 
both cases, however, CSD dimerization mutants (Swi6 L315E and Chp2 I370E) that are unable 
to associate through CSD interaction, show a strong impairment in heterochromatin 
maintenance, highlighting that the two HP1 need self-association to promote silencing (Sadaie 
et al., 2008).  Despite sharing similar overall organization, Swi6 and Chp2 domains are not 
equivalent in terms of function. Swapping of Swi6 and Chp2 CD, Hinge or CSD domains 
causes a loss of heterochromatin silencing (Sadaie et al., 2008). When swapping the N-terminal 
part of the proteins, however, Chp2 did not have a visible loss of silencing, whereas Swi6 had 
a huge Kint2::ura4+ reporter transcript upregulation. This is consistent with the role of the N-
terminal domain of Swi6 (and similarly the one of the human homolog HP1α), which is heavily 
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phosphorylated by CKII in vivo, in regulating its function (Nishibuchi et al., 2014). 
Localization of both HP1 proteins to heterochromatin loci is dependent on Clr4, as shown by 
Swi6 and Chp2 ChIP sequencing data and immunofluorescence experiments (Sadaie et al., 
2004, 2008). As already mentioned, the methyltransferase Clr4 is depositing the H3K9 
methylation mark, which is necessary for the recruitment of HP1 proteins to heterochromatin 
(Nakayama et al., 2001) (Figure 1.7). The catalysis of H3K9me is mediated by the SET domain 
of Clr4, the sole H3K9 methyltransferase identified in fission yeast (Rea et al., 2000). The 
name SET domain derived from the Su(var)3-9 and Enhancer of Zeste proteins, where it was 
first characterized. Clr4 has its own CD, with which it can recognize H3K9 methylation and 
methylate nearby nucleosomes, in a read-write mechanism (Al-Sady et al., 2013). This is 
particularly important to epigenetically maintain the epigenetic mark, even in the absence of 
RNAi or other heterochromatin initiating stimuli (Audergon et al., 2015; Ragunathan et al., 
2014). The CD of Clr4 binds with higher affinity H3K9 trimethylation (H3K9me3) rather than 
the H3K9 dimethylation (H3K9me2), and its SET domain catalyzes with more efficiency 
H3K9me2 deposition (which is the most abundant form of H3K9 methylation in S.pombe). 
This has a huge functional importance, as reported in (Al-Sady et al., 2013), since the HP1 
protein Swi6 CD has higher affinity than Clr4CD for H3K9me2 but not for H3K9me3. In the 
competition between the two proteins at heterochromatin, Swi6 will outcompete Clr4 for 
H3K9me2 binding, given the abundance of this methylation state. On the other hand, Clr4 may 
use the fewer H3K9me3 spots as anchor site for H3K9me deposition. Swapping of Clr4CD 
with a Chp1CD mutant showing higher affinity for H3K9me2, while maintaining the same 
affinity for H3K9me3 (Chp1CDF61A as shown in (Schalch et al., 2009)), causes a huge defect 
in spreading the H3K9 methylation mark beyond the initiation point at the MAT locus (Al-
Sady et al., 2013). This indicates that the selective recognition from Clr4CD between different 
H3K9 methylation states is necessary to coordinate its function with HP1 proteins. To sum up, 
this is an example of how the localization of different chromatin readers, recognizing the same 
histone mark, is organized by the individual CD affinities for H3K9me and different 
methylation states. 
The fourth CD protein involved in heterochromatin formation and focus of the present thesis 
work, is Chp1. Chp1 is a member of the RNA induced transcriptional silencing complex 
(RITS), necessary to anchor Argonaute to centromeric heterochromatin, as previously 
discussed (Verdel et al., 2004) . It is a relatively big protein, with a size of 108.73 kDa, 
interacting with the N-terminal part of the GW protein Tas3 with its C-terminal domain 
(Schalch et al., 2011). Together, Chp1 and Tas3 form a functional sub-complex of the RITS 
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that binds H3K9me marked nucleosomes and form a platform for recruiting Argonaute (loaded 
with mature siRNAs) to centromeric transcripts. A Tas3 mutant no longer able to bind to Chp1 
had a severe loss of centromeric heterochromatin ((Tas3∆(10-24)), indicating the importance 
of Chp1-Tas3 integrity for RITS formation and RDRC complex recruitment (Debeauchamp et 
al., 2008).  Chp1 and Tas3 were shown to interact also independently of Argonaute in ago1∆ 
cells, though not recruited to heterochromatin loci (that are depleted in H3K9me in the absence 
of RNAi) (Petrie et al., 2005).   
Chp1 is essential for heterochromatin establishment and maintenance at centromeres, whereas 
at telomeres and at the mating type loci chp1∆ cells do not show evident defects in silencing 
(Sadaie et al., 2004). This is explained by the presence of additional pathways, which act in 
redundancy with RNAi to maintain heterochromatin at telomeres and the MAT locus, as 
discussed previously.  
However, establishment of heterochromatin is dependent on Chp1 at all three heterochromatin 
loci (Sadaie et al., 2004). As shown by Cam and colleagues, RNA interference components 
recruitment to all three heterochromatin loci is dependent on Clr4 deposition of H3K9 
methylation (Cam et al., 2005). The H3K9 methylation serves as anchoring point not only for 
HP1 proteins, but also for Chp1-RITS, and high affinity of Chp1 CD for H3K9me is necessary 
to establish heterochromatin (Schalch et al., 2009).  
The specific interaction of Chp1 with its target histone modification is therefore a key feature 
to establish and maintain heterochromatin in S. pombe and the focus of the work presented in 
this thesis.   
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Aim of the thesis 
 
Heterochromatin formation is fundamental for the regulation of Eukaryotic genome expression 
and spatial organization inside the Nucleus. Heterochromatin is characterized by the presence 
of a specific histone post-translational modification, the H3K9 methylation, which signals for 
the establishment and maintenance of gene silencing. The binding of this histone mark is 
operated by specific chromatin readers called chromodomain proteins, which mediate the 
initial interaction with H3K9me and then recruit additional complexes responsible for H3K9me 
deposition and chromatin compaction (Eissenberg, 2012; Eissenberg and Elgin, 2014; 
Nakayama et al., 2001; Nishibuchi and Nakayama, 2014). Many structures of chromodomains 
were published to date, but mostly either CDs alone or binding to H3K9me peptides, 
mimicking the methylated histone H3 tail (Fischle et al., 2003; Horita et al., 2001; Ishida et al., 
2012; Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002; Schalch et al., 2009). No 
structural information is available on the binding of chromodomains with the H3K9me3 
Nucleosome, their natural interactor. How chromodomain proteins interact with the H3K9me 
Nucleosome? Chromodomain containing proteins have been shown to have different functions: 
among them are HP1 proteins (Nishibuchi and Nakayama, 2014), structural components of 
heterochromatin, H3K9 methyltransferases, such as the Su(var)3-9 family (Tschiersch et al., 
1994) and chromatin remodelers. How all these functions are regulated at the same genomic 
loci, despite the recruiting signal being the same H3K9 methylation? Moreover, different 
chromodomains have been shown to be able to bind to nucleic acids (Akhtar et al., 2000; 
Bernstein et al., 2006; Buscaino et al., 2003; Ishida et al., 2012). How does this interaction 
regulate their physiological function? 
The aim of the work presented in this thesis was to understand the mechanism of binding of 
chromodomain proteins to chromatin and to shed light on how this interaction might be 
regulated in the context of heterochromatin formation. Extensive studies have been performed 
on heterochromatin and silencing in the model organism S. pombe. The attention of this Thesis 
work was focused on nuclear S. pombe chromodomain proteins, and in particular on Chp1, 
member of the RITS-Argonaute complex (Verdel et al., 2004), to investigate how its interaction 
with the H3K9me Nucleosome influences heterochromatin establishment and maintenance. 
Biochemical and in vivo experiments were employed to give an answer to all these important 
questions in the chromatin field. 
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RESULTS 
 
In vitro reconstitution of the Chp1CD-H3K9me3 Nucleosome complex  
 
In order to gain insights on how chromodomains interact with nucleosomal particles, the 
Chp1CD-H3K9me3 Nucleosome complex was reconstituted in vitro, starting from the single 
components. The chromodomain of Chp1 was expressed and purified from the bacterial E.coli 
BL21(DE3)pLysS strain from the pET28a expression vector as an His6-Thrombin digestion 
site-SUMO tag fusion construct (Schalch et al., 2009). The expressed SUMO-Chp1CD was 
purified by Ni-NTA chromatography and run at around 25 kDa on a 15% SDS-PAGE gel 
(Figure 2.1 A). Single Xenopus laevis histones (H2A,H2B,H3,H4) were purified as well from 
the bacterial E.coli BL21(DE3)pLysS expression strain from the pET3 expression vector as 
previously described (Dyer et al., 2004). Histones were DMSO extracted from isolated 
inclusion bodies and purified by gel filtration under denaturing conditions (Dyer et al., 2004). 
After gel filtration, histones were dialyzed in 3 mM β-mercaptoethanol before being 
lyophilized for long term storage. Lyophilized histone H3 was then re-suspended in Alkylation 
buffer and chemically modified by addition of (2-bromoethyl) trimethylammonium bromide to 
generate the Methyl-lysine analog (MLA) mimicking the H3K9 tri-methylation. The procedure 
installing MLA on histone H3 was done strictly following a previously published protocol 
(Simon et al., 2007). The modifications obtained are exactly equivalent to H3K9 methylation 
and have been reported to be recognized by HP1 and Polycomb proteins with the same affinity 
as their native counterpart (Simon et al., 2007). To check for proper installation of the MLA 
mark we performed mass-spectrometry (data analysis by Dr. Thomas Fröhlich – Gene Center 
– Munich) and western blot on the modified H3 histones. The mass spectrometry profile gives 
one clear peak at the expected mass of 15297 Da (Figure 2.1 D). The additional peak seen at 
around 15340 Da has been described as an artifact, present in the original batch of histone H3 
before alkylation, not reflecting a true contaminating specie (Simon et al., 2007). The western 
blot (Figure 2.1 E) confirmed that not only the MLA modification was installed correctly on 
histone H3, but also that an antibody elicited against the natural H3K9me3 mark could 
recognize it as well. This indicates the biochemical and functional equivalence between the 
MLA system and the in vivo H3K9 methylation. From this point onwards the MLA H3K9me3 
Nucleosomes will be referred as H3K9me3 Nucleosomes. 
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Figure 2.1:  In vitro assembly of the Chp1CD-H3K9me3 Nucleosome complex 
 
A) Coomassie staining of a 15% SDS-PAGE gel showing the Chp1 Chromodomain (Chp1CD) purification. 
Chp1CD runs above 25 kDa (7 kDa Chp1CD + SUMO tag). (B) In vitro reconstitution of the nucleosome octamer 
run on a 15% SDS-PAGE gel: all Xenopus laevis histone bands are visible. H2A and H2B cannot be separated 
and run as duplet. (C) Nucleosome reconstitution: nucleosomes were run on a 5% TBE-Native acrylamide gel 
and stained with SyBr GOLD and Coomassie. (D) Mass spec analysis performed on H3K9cme3 histones (data 
provided by Thomas Fröhlich – Gene Center). A main peak at the mass of 15297.4 Da indicates that the alkylation 
reaction was successful. The +45 Da extra peak was already described as uninfluential for the purity of the 
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preparation (Simon et al., 2007). (E) Western blot on the H3 MLA histones. The anti-H3K9me3 antibody (ab8898 
Abcam) is specific to the alkylated histones and does not react with the untreated histone H3. F) Experimental 
scheme for the Chp1CD-H3Kc9me Nucleosome complex assembly. G) Coomassie stained 15% SDS-PAGE gel 
showing the assembly of Chp1CD-H3K9me3 Nucleosome complex and its elution from the Ni-NTA resin by 
Thrombin digestion. H) Nucleosome pull down/western blot experiments using the His6-SUMO tag alone bound 
to the Ni-NTA resin. As expected, the SUMO tag cannot interact with H3K9me3 Nucleosomes. I) Negative stain 
EM micrograph showing the Chp1CD-H3K9me3 Nucleosome complex.  
 
 
The reconstitution of the Nucleosome core particles (NCP) was performed starting from lyoph-
ilized histones and strictly according to the Luger lab procedure (Dyer et al., 2004; Luger et 
al., 1999). Histones were re-suspended in denaturing Guanidium-HCl unfolding buffer (see 
Materials and Methods Table 4) and mixed with the following molar ratio (H2A:H2B:H3:H4 
1.1 : 1.1 : 1 : 1) for Nucleosome octamer reconstitution. The assembled histone octamer was 
then purified by gel filtration and its purity and integrity was checked on SDS-PAGE (Figure 
2.1 B). The NCP was completely reconstituted by mixing the 601 Widom 147 bp DNA 
(Lowary and Widom, 1998) and the assembled octamer (DNA:Octamer 1.1 : 1 ratio) and by 
performing a step gradient dialysis with decreasing salt concentration. Nucleosome reconstitu-
tion was assessed by Native-TBE PAGE (Figure 2.1 C): the NCPs can be stained both with 
SyBr GOLD, specific for nucleic acids, and with Coomassie Blue. Moreover, EMSA assays 
on the same Native PAGE-TBE gels showed that NCP particles run slower than the free 601 
147bp DNA sequence, indicating that the octamer was stably assembled onto the DNA. To 
assemble the NCP, the 601 Widom sequence was preferred over other possible DNA sequences 
(such as the 5S RNA gene of Lytechinus variegatus (Dyer et al., 2004) due to its reported high 
stability (Lowary and Widom, 1998): this prevented the need of subsequent steps of heat shift-
ing of the NCP particle to center the octamer onto the 147 bp DNA sequence and the risk of 
having a non-homogenous population of Nucleosome particles with different octamer-DNA 
orientations. Moreover, NCP particles assembled with the 601 Widom sequence have been 
previously crystallized, showing that they can be obtained with high purity and are stable for 
structural studies (Vasudevan et al., 2010). The Chp1CD-H3K9me3 Nucleosome complex was 
assembled with a pull down strategy, using the His6-SUMO tag to bind the Chp1CD on the Ni-
NTA resin. After anchoring the Chp1CD onto the Ni-NTA resin, we added the H3K9me3 Nu-
cleosomes and incubated on ice. Elution was performed by adding Thrombin, which digested 
between the His6 tag and the SUMO tag. Thrombin addition caused a shift in size of the 
Chp1CD protein (fourth lane from the left, Figure 2.1 G), due to the release of the His6 tag, 
with consequent elution of the SUMO-Chp1CD-H3K9me3 Nucleosome complex. Without ad-
dition of Thrombin the complex stayed bound to the resin (fifth lane from the left, Figure 2.1 
G). The Ni-NTA resin alone incubated with H3K9me3 Nucleosomes did not show any non-
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specific NCP particle binding (ninth lane from the left, Figure 2.1 G): this indicated that the 
complex was indeed formed due to the specific recognition by the Chp1CD of H3K9me3 Nu-
cleosomes. To further investigate the interaction, the SUMO tag was tested for the binding with 
H3K9me3 Nucleosomes. The Nucleosome pull down assay was performed using only the 
SUMO tag, with the same experimental procedure applied for the entire SUMO-Chp1CD con-
struct. Given the higher sensitivity compared to the classical Coomassie Blue staining, Western 
blot using an anti-H3 specific antibody was used to test the interaction. SUMO was not able to 
affinity purify H3K9me3 Nucleosomes (second lane from the left, Figure 2.1 H). It could be 
therefore excluded that the SUMO-Chp1CD-H3K9me3 Nucleosome interaction was influ-
enced by the presence of the SUMO tag in addition to the Chp1 chromodomain. Once assem-
bled and eluted, the SUMO-Chp1CD-H3K9me3 Nucleosome was checked under the Morgagni 
(FEI Company) transmission electron microscope by Negative staining Electron Microscopy 
(EM). The eluted complex (fourth lane from the left, Figure 2.1 G), appears to be homogenous 
in shape and concentrated enough to cover large part of the carbon coated EM grid uniformly 
(Figure 2.1 I). This prompted us to further continue with the study, aiming to solve the structure 
of the Chp1CD-H3K9me3 Nucleosome complex by using cryo-EM. 
 
Chp1CD binding to the H3K9me3 Nucleosome depends on the stability of its 
interacting loops 
 
A preliminary cryo-EM analysis performed in our laboratory (data not shown), showed the 
Chp1CD-H3K9me3 Nucleosome complex at a sub-nanometer resolution. The fitting of the 
crystal structure of the Chp1CD in one of the best resolved cryo-EM density maps showed that 
the Chp1CD assumed a distinct orientation, with the first loop of the three stranded antiparallel 
β-sheet making a strong contact with the histone H3 loop (residues 77-81), as well as other 
minor contacts between the second loop and the C-terminal α-helix and histones H2B and H4. 
Therefore, the preliminary structural analysis showed that Chp1CD interacts with the 
Nucleosome core, mainly at histone H3, through the first two loops of its β-sheet, while the C-
terminal α-helix protrudes outwards from the Nucleosome surface. In order to prove the 
described structural model, mutations were done by substituting those residues in the first loop 
(LOOP1, residues 31-38aa) and in the second loop (LOOP2, residues 48-52aa) of Chp1CD 
which were close to the Chp1CD contact points with the Nucleosome core in the cryo-EM 
maps (data not shown). LOOP1 mutant harbors three different mutations: R31S, N33A and 
N35A (Figure 2.3 A). LOOP1 mutants can be divided in two classes, namely LOOP1A (having 
Results 
40 
 
all three mutations, R31S, N33A and N35A) and LOOP1B (having only N33A and N35A 
mutations). LOOP2 mutants on the other hand can be divided into LOOP2A (harboring an 
N52A mutation) and LOOP2B (harboring W49A, Y50A and D51A mutations). The mutated 
residues are conserved in a number of other chromodomains (Figure 2.2 A). In particular 
residues R31, D51 and N52 are conserved in different chromodomain proteins in S.pombe as 
well as other Eukaryotes, whereas LOOP1 N33 and N35 are found only in a subset of other 
CDs (N35 is conserved in Clr4, not shown in the alignment in Figure 2.2 A). All the residues 
in LOOP1 that were mutated are actually aligning with the S. cerevisiae Sir3 protein BAH 
(Bromo Associated Homology) domain loop 3. The BAH domain interacts with the 
Nucleosome core (Armache et al., 2011; Wang et al., 2013a) and BAH domain loop3, which 
showed structural and primary sequence conservation with Chp1CD LOOP1 (Figure 2.2 B), 
interacts with the Nucleosome core at the interface between histone H3, H2B and H4. The 
BAH domain Nucleosome binding mode is similar to what we observed for Chp1CD in our 
preliminary cryo-EM maps (data not shown). All mutants were expressed and purified in high 
amounts from the E.coli BL21 (DE3) pLysS expression strain (Figure 2.5 A). As illustrated in 
Figure 2.3 D and in Figure 2.4 D, in Nucleosome pull down assays, mutations in the Chp1CD 
loops already destabilized the binding with H3K9me3 Nucleosomes. The efficiency of 
Nucleosome pull down already diminished in the LOOP2B mutant and it was further impaired 
in the LOOP1A mutant and in the LOOP1A/LOOP2B and LOOP1B/2B combinations.  A 
similar trend was observed for wild-type Nucleosome pull downs (Figure 2.4 E): in this case 
almost no Nucleosome was bound in LOOP1A/2B and LOOP1A/2A mutants, while LOOP1A 
and LOOP2B mutants were already showing a defective pull down efficiency. 
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Figure 2.2: Sequence alignment of Chp1 chromodomain 
(A) Sequence alignment of Chp1CD with chromodomains from fission yeast, Drosophila melanogaster and several 
mammals. The LOOP1/LOOP2 residues mutated show some conservation: R31, D51 and N52 are present in most 
chromodomains analyzed, whereas N33 is conserved only in a small group. The different shades of green 
correspond to a different degree of conservation (darker green is higher conservation). (B) Sequence alignment 
of the Sir3 protein BAH domain (from S.cerevisiae) with the Chp1CD. The residues in Chp1CD LOOP1 interacting 
with the Nucleosome core are conserved also in Sir3BAH. 
 
 
Nucleosome without histone tails were generated (Tailless Nucleosomes, Figure 2.4 A) by 
Trypsin digestion, to determine whether the Chp1CD-H3K9me3 Nucleosome complex 
instability observed was determined by a decreased H3 tail binding affinity or by Nucleosome 
core interaction loss. The wild-type Chp1CD was able to bind to Nucleosomes in the absence 
of histone tails (Figures 2.3 C and 2.4 C). This evidence proved biochemically what previously 
observed in the preliminary cryo-EM structures: Chp1CD could bind to the Nucleosome core 
independently of the histone tails. However, given the amount of Nucleosome input applied in 
the pull down assays and comparing the various Nucleosome species, it could be concluded 
that the highest affinity is always determined by the presence of a methylated histone H3 tail, 
in accordance to the published literature (Schalch et al., 2009). In the cryo-EM density maps 
(data not shown) Chp1CD was contacting the Nucleosome core through protein-protein 
interactions, with the main contact between the Chp1CD LOOP1 and the histone H3 loop 
(residues 77-81). 
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Figure 2.3: Mutations in Chp1CD LOOP1 and LOOP2 destabilize the interaction with the Nucleosome 
 
A) Schematic representation of the mutations introduced on the Chp1CD loops (model produced by Prof. Dr. 
Mario Halic). Highlighted in yellow the three mutations on LOOP1 (R31S, N33A and N35A). In blue, the 
mutations introduced on LOOP2: in light blue the LOOP2A mutation (N52A) and in dark blue the LOOP2B 
mutations (W49A, Y50A and D51A). In blue on a side, the nucleosome is shown, with the side chain of the H3K79 
residue protruding, close to the Chp1CD. (B) Microscale thermophoresis assay (MST) showing the binding affinity 
of the Chp1CD for an H3K9me3 peptide after introducing the LOOP1B/2B mutations, compared to the wild-type 
protein. (C) Tailless Nucleosome pull down assay showing that the interaction with the core of the Nucleosome is 
lost in the LOOP1B/2B mutant. (D) H3K9me3 Nucleosome pull down assay showing that the stability of the 
Chp1CD-H3K9me3 Nucleosome complex is diminished in the LOOP1B/2B mutant. (E) MST assay showing the 
binding affinity of the Chp1CD for an H3K9me3 Nucleosome after introducing the LOOP1B/2B mutations, 
compared to the wild-type protein. 
 
To investigate the importance of this interaction for Chp1CD core binding, Chp1CD LOOP1 
and LOOP2 mutants were tested for the ability to pull down Tailless Nucleosomes. In LOOP2B 
and LOOP1A mutants a several time reduction in the pulled-down Tailless Nucleosome signal 
was observed (Figure 2.4 C). This indicated that destabilizing one of the two Nucleosome core 
interacting loops was already sufficient to impair the affinity for Tailless Nucleosomes. A 
complete loss of binding was observed when destabilizing both interacting loops 
(LOOP1A/2B, LOOP1A/2A, LOOP1B/2B combinations (Figures 2.3 C and 2.4 C). The 
cumulative experimental evidence prompted us to conclude that the Nucleosome core 
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interaction is dependent on the Chp1CD LOOP1 and LOOP2 integrity. As already mentioned 
a decreased affinity was observed in LOOP1/2 mutants for the H3K9me3 Nucleosome, which 
is the natural binding partner of the Chp1CD in vivo (Figures 2.3 D and 2.4 D). To determine 
the contribution of the Nucleosome core binding to the stability of the Chp1CD-H3K9me3 
Nucleosome complex, the affinity of the LOOP1 and LOOP2 mutants for the H3K9me3 tail 
was measured. This allowed to discriminate between the histone H3 tail and the Nucleosome 
core contributions to the stability of the Chp1CD-H3K9me3 Nucleosome complex.  
Therefore, H3K9me3 peptide pull down and equilibrium-in solution H3K9me3 peptide binding 
assays (Microscale Thermophoresis) with LOOP1 and LOOP2 mutants were set up to quantify 
the binding affinity for the H3 methylated tail. 
 
 
F 
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Figure 2.4: Chp1CD-Nucleosome interaction is destabilized in LOOP1/2 mutants (in the previous page) 
A) Coomassie Blue stained 15% acrylamide gel showing the Nucleosome digestion by Trypsin, with a shift in 
molecular weight for each histone band in the treated sample. (B) Native-TBE acrylamide gel run of Nucleosome 
and Nucleosome trypsinized (Tailless) stained with Coomassie Blue and SyBrGOLD. Tailless Nucleosomes are 
stable after Trypsin digestion. (C) Tailless Nucleosome pull down assay showing that the interaction with the core 
of the Nucleosome is lost in the LOOP1A/2A and LOOP1A/2B mutants.(D) H3K9me3 Nucleosome pull down 
assay showing that the interaction with the Nucleosome is impaired in the LOOP1/2 mutants. (E) Unmodified 
Nucleosome pull down assay showing that the interaction with the core of the Nucleosome is lost in the 
LOOP1A/2A and LOOP1A/2B mutants. (F) Coomassie Blue stained 15% acrylamide gel of an H3K9me3 
Nucleosome pull down assay.  Chp1CD was bound to a Ni-NTA resin and incubated with two types of H3K9me3 
Nucleosomes: the wild-type H3K9me3 Nucleosome and a mutated version, harboring the H3K79A/T80A/D81A 
mutations of the Chp1CD interacting H3 loop. As shown, Chp1CD binding to H3K9me3 Nucleosomes is not 
destabilized by the presence of additional mutations on the histone H3 globular domain, most likely because the 
interaction interface with the Nucleosome core is degenerated, with multiple contact points. A similar result was 
obtained with the Sir3 BAH domain, unaffected by single mutations on the Nucleosome interacting interface 
(Wang et al., 2013a).   
 
In the H3K9me3 peptide pull down assays, all Chp1CD mutants retained the ability of binding 
the H3K9me3 histone peptide as the wild-type protein (Figure 2.5 B and C). As comparison 
for complete loss of binding, the previously characterized W44A mutant, affecting the stability 
of the Chp1CD aromatic cage (Ishida et al., 2012), was used as negative control.  Mutating 
residues N33A and N35A in LOOP1 did not affect histone H3 peptide-Chp1CD binding. The 
same occurred in LOOP2B (three mutations: W49A/Y50A/D51A) and LOOP2A (one mutation 
in the conserved N52 residue: N52A) mutants. One residue revealed to be important for the 
H3K9me3 peptide binding stability, namely Chp1CD R31. In all the mutants harboring the 
R31S mutation (R31S single mutant, LOOP1A, LOOP1A/2A and LOOP1A/2B), the Chp1CD 
binding affinity dropped to roughly 50% of the wild-type protein in the pull down experiments 
(Figure 2.5 C). Therefore, in this set of mutants (LOOP1A, LOOP1A/2A, LOOP1A/2B) it was 
not possible to discriminate if the lack of H3K9me3 Nucleosome binding stability observed 
(Figure 2.4 D) was due to a loss of affinity for the H3K9me3 histone tail (Figure 2.5 C), for the 
lack of binding to the Nucleosome core (Figure 2.4 C) or the cumulative effect of the two. On 
the other hand, mutants LOOP1B (N33A and N35A mutated) and LOOP1B/2B (N33A, N35A 
and W49A/Y50A/D51A mutated) were generated by excluding the R31A mutation from 
LOOP1A and LOOP1A/2B mutants. These mutants showed wild-type levels of binding for the 
H3K9me3 peptide in the pull down assays (Figure 2.5 B and C). To confirm the pull down 
experiments on LOOP1B and LOOP2B mutants another method was used in parallel, the 
Microscale Thermophoresis (MST).  
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Figure 2.5: LOOP1B/2B mutations do not affect the binding affinity for the H3K9me3 peptide or the RNA 
(in the previous page)  
 
A) Coomassie stained SDS-PAGE showing the purified Chp1CD wild-type and mutant proteins. (B) Peptide pull 
down assay with various Chp1CD mutants. The binding affinity is normalized to the wild-type Chp1CD in each 
assay. (C) Quantification of the H3K9me3 peptide pull down shown in (B). 3 independent repetitions were 
averaged. The Chp1CD mutants bearing the R31S mutation in LOOP1 showed a prominent defect in H3K9me 
peptide binding. LOOP2A, LOOP2B, N33A, N35A and LOOP1B/2B mutants show no significant difference 
compared to the wild-type protein. W44A mutant was used as a control for no binding (Ishida et al., 2012). (D) 
Microscale thermophoresis H3K9me3 peptide binding assay on the wild-type Chp1CD and the LOOP1B, 
LOOP2B, LOOP1B/2B mutants. Calculated Kd is shown below each binding curve. (E) RNA shift assay on a 
TBE-Native gel showing that LOOP1 and LOOP2 mutants bind centromeric RNAs as the wild-type Chp1CD 
(performed by Dr. Mirela Marasovic).     
 
 
MST is commonly used to measure the binding affinity of proteins for their interaction partners 
in solution, by estimating their ability to move under infrared beam heat: if a protein is 
interacting in a complex, its thermal motion in solution would be slower compared to the 
protein alone. This can be measured by fluorescently labeling the protein of interest and 
measuring the local decrease in fluorescence over the time while the infrared stimulus is 
applied.  By increasing the amount of one of the interacting proteins while keeping constant 
the concentration of the fluorescently labeled one, it is possible to obtain a binding affinity 
curve and estimate the dissociation constant (Kd). Therefore, the Chp1CD wild-type protein, 
the LOOP1B, LOOP2B and LOOP1B/2B mutants were fluorescently labeled and two binding 
experiments were set up: one with a crescent concentration of H3K9me3 peptide and one with 
a crescent concentration of H3K9me3 Nucleosome. We measured the dissociation constants 
for each H3K9me3 peptide binding assay and we did not observe substantial differences in 
affinity for the Chp1CD wild-type (Kd=345 nM) and the LOOP1B (Kd=260 nM), the LOOP2B 
(Kd=365 nM) and the LOOP1B/2B (Kd=292 nM) mutants (Figure 2.3 B and 2.5 D). These 
results confirmed what previously emerged from the H3K9me3 peptide pull down assays, 
showing that mutations in LOOP1 and LOOP2 had no effect on H3K9me3 tail affinity unless 
residue LOOP1 R31 was modified. On the other hand, LOOP1B/2B mutations had huge impact 
on the stability of the Chp1CD-H3K9me3 Nucleosome complex, with a drop of about five fold 
in the affinity for H3K9me3 Nucleosomes from the wild-type protein (Kd=180 nM) to the 
LOOP1B/2B mutant (Kd=972 nM) (Figure 2.3 E). Despite the binding affinity for the 
H3K9me3 tail remained unchanged (Figure 2.3 B and  2.5 D), both the pull down assays 
(Figure 2.3 D) and the MST (Figure 2.3 E) showed that LOOP1B/2B mutations cause a drop 
in affinity for the H3K9me3 Nucleosome which is independent from the presence of the H3K9 
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methylation mark. The loss of interaction with the Nucleosome core observed for all LOOP1/2 
mutant combinations (particularly in LOOP1A, LOOP1A/2A, LOOP1A/2B, LOOP1B/2B - 
Figures 2.3 C and 2.4 C) explains the importance of the integrity of Chp1CD LOOP1 and 
LOOP2 for the Nucleosome core binding and the stability of the Chp1CD-H3K9me3 
Nucleosome complex. In particular, the specific protein-protein interaction occurring between 
the Chp1CD loops (LOOP1 and LOOP2) and histone globular domains of the Nucleosome 
core seems necessary to maintain the stability of the Chp1CD-H3K9me3 Nucleosome 
complex. However, comparing the strength of pull down of the wild-type Chp1CD for the 
H3K9me3 Nucleosomes, Unmodified Nucleosomes and Tailless Nucleosomes, it remained 
clear that the main recruitment of Chp1CD occurred only through the deposition of the H3K9 
methylation mark (compare intensities of input and Pulled-down Nucleosomes for the wild-
type Chp1CD in Figure 2.3 C-D and Figure 2.4 C-D-E). The binding to the Nucleosome core 
could contribute to give to Chp1 higher affinity for the Nucleosome target (only after H3K9me3 
tail is bound) and a less dynamic behavior, to allow for timely recruitment of the RITS-
Argonaute to establish heterochromatin. These biochemical evidences correlated very well 
with the structural model proposed and induced us to better investigate the importance of the 
Chp1CD-Nucleosome core interaction in heterochromatin maintenance and establishment.  
 
Chp1CD binding to the Nucleosome core is required for heterochromatin formation 
 
To understand the importance of core interaction in Chp1 function, the ability of our Chp1 
mutants to rescue defective heterochromatin in vivo was tested. The chp1+ wild-type gene and 
the chp1 LOOP1/2 mutated versions (the entire chp1+ transcriptional unit) were cloned on a 
pREP1 plasmid under the chp1+ gene endogenous promoter (replacing the original pREP1 
nmt1+ promoter) and transformed in a chp1∆ strain. Growth assays under selective FOA 
medium showed that when transforming the chp1∆ strain with the wild-type chp1+ gene a full 
silencing rescue was obtained (Figure 2.6, chp1∆ + chp1, compared to wild type). Similarly, 
all those chromodomain mutants that in the in vitro assays (pull downs and MST) did not show 
any affinity defects for the H3K9me3 peptide or the H3K9me3 Nucleosome (Figure 2.3, 2.4 
and 2.5), did not have any growth defect under selective FOA medium and were able to fully 
restore heterochromatin, rescuing the chp1∆ strain phenotype (Figure 2.6 A and B, LOOP2A, 
LOOP2B, LOOP1B). 
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By contrary, transformation of LOOP1A, LOOP1A/2A, LOOP1A/2B, LOOP1B/2B mutants 
did not lead to the rescue of the chp1∆ strain centromeric silencing defect (Figure 2.6). These 
mutants were previously observed having a defect in binding H3K9me3 Nucleosomes (Figures 
2.3 D and 2.4 D) and Tailless Nucleosomes (Figures 2.3 C and 2.4 C) in pull down assays.  
 
 
Figure 2.6: Chp1CD interaction with the Nucleosome core is required for heterochromatin formation  
 
(A-B) Silencing assays showing the effect of LOOP1/2 mutations on centromeric heterochromatin. 10-fold serial 
dilutions were spotted on YES (non-selective), YES+FOA, EMMc+FOA, EMMc-Ura media.   
 
 
These evidences highlight the importance of the stability of the Nucleosome core interaction 
for heterochromatin silencing. The partial defective phenotype of the LOOP1A mutants (Figure 
2.6 A-B) could be derived from a combination of loss of affinity for both the H3K9me3 histone 
tail (Figure 2.5 C) and the Nucleosome core (Figure 2.4 C). By combining LOOP1 and LOOP2 
mutations, the centromeric silencing was further impaired (Figure 2.6 A-B, LOOP1A/2A, 
LOOP1A/2B, LOOP1B/2B mutants) correlating with the need for both LOOP1 and LOOP2 in 
Chp1CD interaction with the Nucleosomal core interface.   
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Figure 2.7: Relative expression of dg and dh centromeric transcripts in wild-type and Chp1CD mutants 
RT-qPCR experiments quantifying the centromeric RNA levels in wild-type and Chp1CD mutant cells. LOOP1/2 
mutants showed the highest enrichment over wild-type both at dg (above) and dh repeats (bottom), correlating 
with the silencing defect observed in the growth assays. dh repeats showed a more prominent defect in silencing, 
with LOOP1/2 mutants having a dh RNA upregulation comparable to the chp1 deletion strain.  Error bars indicate 
the Standard Error Mean (SEM) of three independent experiments.  
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Figure 2.8: Centromeric H3K9me2 levels are decreased in Chp1CD LOOP1/2 mutants 
 
ChIP-qPCR experiments measuring the levels of H3K9me2 at centromeric dg and dh repeats. LOOP1/2 mutants 
showed a prominent H3K9me2 level drop at both centromeric dg and dh repeats. Error bars represent the 
Standard Error Mean (SEM) of three independent experiments. 
 
 
To understand more in detail the contribution of Nucleosome core binding to the described 
phenotype, the attention was focused on the LOOP1B/2B mutant, which did not present any 
affinity change for the H3K9me3 histone tail compared to the wild type Chp1CD (Figure 2.3 
B). As shown previously, the affinity for the H3K9me3 Nucleosome in vitro sensibly drops 
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(almost 5 fold, MST, Figure 2.3 E), despite LOOP1B/2B still retained the ability to bind the 
H3 methylated tail. This was due to a lack of interaction with the Nucleosome core (Figure 2.3 
C) and likely explained why the phenotype observed in vivo for LOOP1B/2B was not as severe 
as for LOOP1A/2A and LOOP1A/2B mutants, which had, on top of impaired core binding, 
also a lower affinity for H3K9me3 tail (Figure 2.5 C). To further confirm the phenotype 
screening, the centromeric RNA expression levels were measured by using RT-qPCR. 
LOOP1/2 mutant combinations had the strongest silencing defects, both at centromeric dg and 
dh repeats (Figure 2.7). Already an N35A single mutations in LOOP1 caused a slight 
upregulation in the centromeric dg transcripts. LOOP1A had a fivefold increase in dg RNA 
levels whereas the combination of LOOP1A with LOOP2 mutations had almost 10 fold 
increase.  
Together with centromeric RNA silencing, the levels of H3K9me2 deposition at centromeres 
were monitored, to verify whether LOOP1/2 Chp1CD mutants had lower levels of the histone 
mark compared to wild-type cells.  
As envisioned, the LOOP1/2 mutants (LOOP1A/2A, LOOP1A/2B and LOOP1B/2B) had the 
strongest loss of H3K9me2 at centromeres, further confirming the results obtained with the 
silencing assays and the RT-qPCR experiments for the centromeric RNA expression (Figure 
2.8). Moreover, ChIP experiments with an antibody specific for the Chp1 protein showed that 
the defect in silencing at centromeres is accompanied by a loss of Chp1 protein localization 
both at dg and dh repeats (Figure 2.9). In fact, LOOP1A/2A and LOOP1A/2B had a full defect 
in localizing Chp1 at the centromeric region (Figure 2.9). LOOP1B did not present any major 
impairments, while LOOP1B/2B had also a prominently impaired Chp1 localization (Figure 
2.9). The loss of localization indicated that the Nucleosome core interaction is indeed affecting 
the stability of Chp1 on chromatin. Since the LOOP1B/2B mutant binds the histone H3 tail as 
the wild-type Chp1CD, the recruitment disability could arise only from a defective core 
binding. Moreover, published results (Schalch et al., 2009) underlined that a drop in affinity of  
the Chp1CD for the H3K9me3 histone tail in the range of the one we observed for the 
Nucleosome (5-fold for the H3K9me3 Nucleosome, Figure 2.3 E) did not have any major 
repercussions in vivo on heterochromatin maintenance. This further proves that Chp1CD 
Nucleosome core interaction is indeed required for a specialized function which is beyond 
histone H3 tail recognition. Since the observed phenotypes could have been caused by a 
difference in expression of the mutant Chp1 proteins, the expression levels of the Chp1 protein 
in our heterochromatin rescue mutants were quantified by Western blot  and compared to the 
wild-type rescue. All the Chp1 mutant proteins are expressed at similar levels as the wild-type 
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protein, further validating the results obtained (Figure 2.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Chp1 localization at centromeres is compromised in LOOP1/2 mutants 
 
Chp1 ChIP experiments showing the loss of localization of the Chp1 protein when LOOP1/2 mutations are present. 
Error bars represent the Standard Error Mean (SEM) of three independent experiments. 
 
 
Previously published results (Ishida et al., 2012) showed the importance of the positively 
charged residues in the C-terminal α-helix of the Chp1CD in binding either DNA or RNA in 
vitro and centromeric RNAs in vivo. Chp1CD α-helix mutants that were not able to bind nucleic 
acids in vitro had also a defect in heterochromatin formation. 
Therefore Chp1CD mutants were tested for centromeric RNA binding affinity. In fact, LOOP 
mutations could possibly have an indirect effect on RNA binding that would explain the 
observed in vivo loss of silencing. Our Chp1CD mutants however bind the centromeric RNA 
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(30 nt centromeric RNA) as the wild-type protein in in vitro RNA native EMSA assays (Figure 
2.5 E). 
 
Figure 2.10: The Chp1 proteins (wild-type and Chp1CD mutants) are expressed at the same levels in vivo 
Western-blot experiment on whole cell lysates with a Chp1 specific antibody. As loading controls, we used either 
an anti-Tubulin antibody or the Amido-black stained membrane. * (on the left panel) marks a non-specific band 
present in all the tested cell extracts. 
 
This directed to the conclusion that the observed heterochromatin loss was due to an impaired 
Chp1CD-Nucleosome core interaction. In conclusion, the overall in vivo evidences presented 
in this sub-chapter highlighted the importance of Chp1CD Nucleosome core interaction for 
Chp1 proper localization and function in heterochromatin formation. 
 
Genomic integration of the LOOP1B/2B mutant causes loss of heterochromatin 
silencing at centromeres 
 
The Chp1 heterochromatin rescue experiments showed that mutations in LOOP1/2 are 
effective in determining centromeric loss of silencing. It was still under question whether the 
phenotype observed might have been induced from the slight over-expression of the rescuing 
Chp1 protein (expressed under its endogenous promoter on a pREP1 plasmid modified to 
remove the nmt1+ promoter), derived from the ectopic plasmid being in multiple copies in the 
cell. The wild-type Chp1 protein was completely rescuing the chp1∆ strain heterochromatin 
defect, bringing the silencing back to the chp1+ wild-type strain (Figure 2.6, 2.7 and 2.8- 
compare the rescue chp1∆+chp1 with the wild-type strain). Therefore, the minimal over-
expression of Chp1 was not toxic for cell growth or heterochromatin assembly. Moreover, all 
the Chp1 proteins were expressed (wild-type and mutants) at similar levels in the rescue strains  
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Figure 2.11: The genomic integration of LOOP1B/2B mutations causes a heterochromatin defective 
phenotype 
 
Silencing assays showing that the genomic insertion of LOOP1B/2B mutations in a wild-type (SPY28) background 
–panel above- or in a chp1∆ (SPY28) background –panel below- causes a defect in heterochromatin maintenance 
comparable to the one previously observed with the plasmid rescue experiments. 10-fold serial dilutions were 
spotted on YES and YES+FOA. Results are shown for two colonies of the LOOP1B/2B integration for both 
backgrounds, named LOOP1B/2B (1) and (2).  
 
 
(Figure 2.10), indicating not only their stability, but also that the differences observed in the 
growth and molecular assays were arising from their intrinsic properties.  
Nonetheless, as additional control, the Chp1LOOP1B/2B mutations were integrated in the 
genome, creating the following molecular construct:  
(SphI) Region at the 5´ of Chp1 gene (Chromosome I, 2215500 – 2215055)  (AscI) – HphMX6 
resistance cassette –(SphI) Chp1 endogenous promoter (Chromosome I, 2214829 – 2214664) 
– Chp1 coding sequence – (BamHI) Chp1 terminator (Chromosome I, 2210976 – 2210582) 
(BamHI). 
The wild type Chp1 and the Chp1LOOP1B/2B constructs were generated from the initial 
pREP1 plasmid by traditional cloning, amplified by PCR and transformed into both the wild-
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type and chp1∆  background strains (SP28 and SP170, genotypes reported in Materials and 
Methods, Table 3). The wild-type construct transformation was an important control to verify 
that the integration upstream of the chp1+ gene of the hygromycin antibiotic resistance cassette 
(hphmx6) into the wild-type or the chp1∆  strain would not cause a heterochromatin defect by 
itself. The genomic integration of the wild-type Chp1 did not have any phenotypic effect under 
selective medium (YES+FOA), indicating that the protein is functional in both the wild-type 
and the chp1∆  backgrounds (Figure 2.11). However, Chp1LOOP1B/2B genomic introduction 
caused a heterochromatin defective phenotype, totally similar to what observed in the plasmid 
rescue assays (Figure 2.6, compare with the Chp1LOOP1B/2B in Figure 2.11). The result was 
confirmed by checking the expression levels at dg and dh centromeric repeats (Figure 2.12). In 
both backgrounds, an upregulation of centromeric transcripts (> 20 fold) at dg and dh repeats 
for the Chp1LOOP1B/2B mutant was observed, with a slightly higher defect at dh repeats and 
overall higher defect than the one observed in the plasmid rescue experiments (Figure 2.7). 
 
Figure 2.12: Centromeric RNA expression levels in wild-type and Chp1LOOP1B/2B genomic integration 
strains 
 
Relative expression of centromeric dg (on the left) and dh transcripts (on the right) for the wild-type and 
Chp1LOOP1B/2B genomic integration strain. As controls, the wild-type and chp1∆ background strains were 
compared to the integration strains. Error bars represent the SEM on three independent RNA sets 
 
There was not substantial difference regarding the two backgrounds tested: Chp1LOOP1B/2B 
integrated in both wild-type and the chp1Δ deletion strain caused similar silencing impairment 
at centromeres with upregulation of centromeric transcripts to similar values (Figures 2.11 and 
2.12). The integrated wild-type Chp1 construct, on the other hand, was able to maintain 
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heterochromatin to wild-type levels with no difference if compared to the wild-type 
background strain. The genomic integration of the LOOP1B/2B mutations gave us an important 
confirmation on how Nucleosome core binding is important for heterochromatin maintenance 
in vivo. Moreover, this added additional proof that no artifact phenotype was introduced by 
using the pREP1 modified Chp1 plasmid to rescue the chp1Δ defect (Figure 2.6, 2.7, 2.8 and 
2.9), since the slight over-expression of Chp1 did not cause any heterochromatin defect. 
 
Chp1CD-RNA binding stability is influenced by the Nucleosome core interaction 
 
As already shown (Ishida et al., 2012), Chp1CD was able to bind nucleic acids and Chp1CD 
mutants in the residues responsible for this interaction had a defective heterochromatin 
maintenance. In this study, the observed Chp1CD mutant phenotypes could have been 
originated from a defect in RNA binding rather than in the Nucleosome core interaction. To 
address this question, Native RNA EMSA assays with two different length of centromeric dg 
RNA, namely 30 nt (Figure 2.5 E) and 100 nt (Figure 2.13) were performed.  
 
Figure 2.13: Chp1CDLOOP1B/2B binds to RNA with a slightly higher affinity than the wild-type Chp1CD 
 
Gel shift assay with crescent amounts of Chp1CD (LOOP1B/2B and wild-type) incubated with 32P radiolabeled 
100 nt dg centromeric RNA and H3K9me3 peptide (1:1 Chp1CD:H3K9me3 peptide ratio). LOOP1B/2B binds to 
RNA with a slightly higher affinity compared to wild-type Chp1CD. 
 
All the LOOP1/2 Chp1CD mutants analyzed for RNA binding still maintained the interaction 
(Figure 2.5 E). Particularly, the LOOP1B/2B mutant was interacting with the RNA with a 
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slightly stronger affinity compared to the wild-type Chp1CD (Figure 2.13). All the binding 
assays were performed in the presence of H3K9me3 peptide, since LOOP2 mutations were 
already shown to have a defect when binding the RNA without the presence of the methylated 
H3 histone tail (Ishida et al., 2012). 
It seemed therefore that the defect determined in vivo was not originating from a lack of affinity 
of our Chp1CD mutants for the RNA. Nonetheless, an RNA pull down assay was performed to 
test whether the lack of Nucleosome core interaction in the LOOP1B/2B mutant could indeed 
impair the efficiency of binding for centromeric RNA (Figure 2.14). 32P radiolabeled 100nt dg 
centromeric RNA was incubated with Ni-NTA bound Chp1CD chromodomain (wild-type and 
LOOP1B/2B mutant) in the presence of H3K9me3 Nucleosomes (in a 1:1 Chp1CD: H3K9me3 
Nucleosome ratio). Chp1CD LOOP1B/2B, despite binding the RNA with higher affinity when 
saturated with H3K9me3 peptide (Figure 2.13), is less able compared to the wild-type Chp1CD 
to pull down the RNA in the presence of H3K9me3 Nucleosomes (Figure 2.14). 
 
Figure 2.14: RNA pulldowns with Chp1CD (wild-type and LOOP1B/2B mutant) in the presence of 
H3K9me3 Nucleosomes  
 
32P radiolabeled 100nt dg centromeric RNA pull down experiment showing that the LOOP1B/2B mutants is 
defective in binding in the presence of H3K9me3 Nucleosomes, compared to the wild-type Chp1CD. The resin 
control show no non-specific background RNA (bound fraction).   
 
It can be speculated that the impaired binding to the Nucleosome core might interfere with the 
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ability of Chp1CD LOOP1B/2B to stably interact with the RNA. A potential scenario, in fact, 
is that both wild-type and LOOP1B/2B mutant Chp1CD pulled-down the same levels of RNA 
(since the binding of the H3K9me3 tail was still at saturating levels) but that the difference in 
the overall stability, determined by the Nucleosome core binding, increased the binding 
interaction strength of the wild-type compared to the LOOP1B/2B mutant. One possibility is 
that RNA interaction is destabilized in the Chp1CD-Nucleosome core mutants, explaining how 
the in vivo phenotypes obtained are similar to the ones previously described (Ishida et al., 2012) 
for the DNA/RNA binding mutants (αmut1 and αmut2), with a clear defect in heterochromatin 
maintenance. This led us to propose a model (Figure 3.1) in which the Chp1CD-Nucleosome 
core interaction is fundamental for stable anchoring of centromeric RNAs to chromatin, to 
facilitate their siRNA mediated downstream targeting by the RITS-Argonaute for siRNA 
amplification, H3K9me2 deposition and heterochromatin formation.
 
Over-expression of Chp1, Swi6, Chp2 and Clr4 in S. pombe cells destabilizes 
centromeric heterochromatin  
 
The dynamic of interaction between chromodomain proteins in S. pombe and heterochromatin 
is very complex and has to be tightly regulated.  
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Figure 2.15: over-expression of Chp1, Swi6, Chp2 and Clr4 chromodomain proteins destabilizes 
centromeric silencing 
 
A) Silencing assay showing that the over-expression of Chp1 under a strong nmt1+ promoter (pREP1 plasmid) 
cannot rescue the silencing defect of a chp1Δ strain. We have previously showed that a complete plasmid rescue 
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occurs when Chp1 is expressed under its endogenous promoter (Figure 2.6).  10- fold serial dilutions were 
spotted on YES (non-selective) and YES+FOA media. Results are shown for two colonies of the Chp1 rescue 
transformation, for both the FLAG tag and untagged Chp1, indicated as (1) and (2). (B) Silencing assay 
showing that the over-expression of Chp2 under a strong nmt1+ promoter (pREP1 plasmid) only partially 
rescues the silencing defect of a chp2Δ strain. 10- fold serial dilutions were spotted on YES (non-selective) and 
YES+FOA media. Results are shown for two colonies of the Chp2 rescue transformation, for both the FLAG tag 
and untagged Chp2, indicated as (1) and (2). (C) Silencing assay showing that the over-expression of Swi6 
under a strong nmt1+ promoter (pREP1 plasmid) cannot rescue the silencing defect of a swi6Δ strain. 10- fold 
serial dilutions were spotted on YES (non-selective) and YES+FOA media. Results are shown for two colonies of 
the Swi6 rescue transformation, for both the FLAG tag and untagged Swi6, indicated as (1) and (2). (D) 
Silencing assay showing that the over-expression of Clr4 under a strong nmt1+ promoter (pREP1 plasmid) 
cannot rescue the silencing defect of a clr4Δ strain. 10- fold serial dilutions were spotted on YES (non-selective) 
and YES+FOA media. Results are shown for two colonies of the Clr4 rescue transformation for the FLAG tag 
and one colony for the untagged Clr4, indicated as (1) and (2). 
 
It was previously showed that a plasmid carrying the Chp1 protein expressed under its 
endogenous promoter was able to completely rescue the chp1Δ strain silencing defect (Figure 
2.6). Therefore, the slight over-expression of Chp1 due to the pREP1 plasmid copy number 
was not affecting the function of the protein in heterochromatin silencing at centromeres. 
However, over-expression of Chp1 under an nmt1+ strong promoter in a chp1Δ strain, despite 
not causing a growth defect, was definitely impairing centromeric heterochromatin formation, 
and was not rescuing the background chp1Δ strain defect (Figure 2.15 A). Similar results were 
obtained for the HP1 Swi6 (Figure 2.15 C) and for H3K9 methyltransferase Clr4 (Figure 2.15 
D). In the case of Chp2, less abundant HP1 isoform of Swi6, over-expression caused a partial 
rescue of the chp2Δ strain centromeric defect (Figure 2.15 B). This finding probably reflects 
the more specialized function of Chp2 in heterochromatin regulation. Over-expression of Clr4 
likely interferes with proper H3K9me mark deposition, thereby altering the equilibrium of HP1 
and RITS recruitment across the entire genome. Purification of the over-expressed FLAG 
tagged version of the proteins, with sufficient yields for structural studies, was successful only 
for Chp2 (Figure 2.17 A). The in vivo purified Chp2 retains its post-translational modifications, 
which could provide clues on how HP1 chromatin binding is regulated.   
To further understand the dynamic of interaction between fission yeast chromodomain proteins 
and chromatin, additional Nucleosomal complexes were assembled following a similar 
experimental procedure adopted for Chp1CD, with the aim of solving their structure by using 
cryo-EM. In the next subchapters, the in vitro assembly of H3K9me3 Nucleosomes in a 
complex with Swi6, Chp2 and Clr4 is discussed.  
 
In vitro reconstitution of the Swi6-H3K9me3 Nucleosome complex  
 
The S. pombe fission yeast HP1 homolog Swi6 was expressed and purified from E.coli 
BL21(DE3)pLysS bacterial strain from a pETDuet (Novagen) vector as an His6-Swi6-FLAG 
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double tag construct. The purification protocol followed was the same as in the case of the 
His6-SUMO-Chp1CD: we purified His6-Swi6-FLAG through Ni-NTA affinity purification, as 
described for Chp1CD. As showed in Figure 2.16 A, the His6-Swi6-FLAG runs between 50 
and 60 kDa, higher than the calculated molecular weight of 37.29 kDa. After Ni-NTA 
purification, His6-Swi6-FLAG was bound to the FLAG M2 affinity gel in Nucleosome binding 
buffer. With the FLAG resin binding step, we were able to further purify Swi6 from 
contaminants and degradation products. Once Swi6 was bound to the FLAG resin, we 
assembled the Swi6-H3K9me3 Nucleosome complex by adding H3K9me3 Nucleosomes, 
following the experimental scheme shown in Figure 2.16 B. We then eluted the complex from 
the resin by adding FLAG peptide. The addition of FLAG peptide was able to competitively 
elute the Swi6-H3K9me3 Nucleosome complex (Figure 2.16 C - fourth lane from the left). If 
no FLAG peptide was added, the Swi6 Nucleosome complex remained stably anchored to the 
resin (Figure 2.16 C - fifth lane from the left). Moreover, no H3K9me3 Nucleosome was 
detected when no Swi6 was bound to the FLAG resin, indicating that the complex formation 
observed was specific (Figure 2.16 C - second lane from the right). We then performed 
Negative stain EM on the eluted Swi6-H3K9me3 Nucleosome complex to verify its quality 
and homogeneity (Figure 2.16 D), as previously done for the Chp1CD-H3K9me3 Nucleosome 
complex (the procedure is described in Materials and Methods).  Particles were homogeneous 
and concentrated enough to cover the majority of the carbon coated EM grid holes. Differently 
from what observed for Chp1CD-H3K9me3 Nucleosome, the Swi6-H3K9me3 Nucleosome 
complexes seemed to have outwards protrusions and connections with each other, which might 
reflect the way Swi6 binds to Nucleosomes and oligomerizes. On the contrary, negative stain 
EM can give rise to artifacts, derived from the addition of the heavy metal Uranyl acetate stain, 
causing protein flattening and non-specific aggregation. It would be therefore premature to 
make any interpretations. Further structural studies using cryo-EM and new generation electron 
detectors will be needed to achieve high resolution and to understand how Swi6 interacts with 
H3K9me3 Nucleosomes under physiological conditions.  Nonetheless, the preparation of the 
Swi6-H3K9me3 Nucleosome complex for EM studies represents an important step toward the 
structural characterization of the HP1- Nucleosome interaction. 
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Figure 2.16: in vitro assembly of the Swi6-H3K9me3 Nucleosome complex 
 
A) Coomassie stained gel showing the purified His-Swi6-FLAG protein from E.coli BL21(DE3)pLys expression 
strain. The protein runs at around 55 kDa. (B) Experimental scheme for the Swi6-H3K9me Nucleosome complex 
assembly. (C)  Coomassie stained 15% SDS-PAGE gel showing the assembly of Swi6-H3K9me3 Nucleosome 
complex and its elution from the FLAG resin (Sigma) upon FLAG peptide (Sigma) addition. (D) Negative stain 
EM micrograph showing the Swi6-H3K9me3 Nucleosome complex.  
 
 
In vitro reconstitution of the Chp2-H3K9me3 Nucleosome complex  
 
The S. pombe Chp2 was purified from fission yeast chp2Δ cells transformed with a pREP1 
plasmid overexpressing an N-terminal FLAG tagged Chp2 under the nmt1+ promoter (Figure 
2.15 B). As discussed in the Introduction, Chp2 is the HP1 Swi6 isoform, with similar 
heterochromatin localization and almost overlapping functions. The advantage of the in vivo 
purification approach used is that Chp2 maintains its post-translational modifications (PTMs) 
and this could give more insights on how the binding to chromatin is regulated. However, over-
expression might change not only the cellular localization of Chp2 but also affect the type of 
PTMs deposited on its residues. The structural characterization of the in vivo purified Chp2 in 
complex with Nucleosomes has therefore to be coupled with proper identification of Chp2 
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PTMs, in the wild-type and overexpression strain, to better understand the regulation of its 
binding. FLAG-Chp2 was immuno-precipitated by using the FLAG M2 affinity gel. Like in 
the case of Swi6, Chp2 runs at roughly 65 kDa, a higher molecular weight than the one 
calculated from the primary sequence: 42.95 kDa (Figure 2.17 A). The resin was washed to 
remove the unbound fraction and the Chp2-H3K9me3 Nucleosome complex was assembled 
by incubating the resin bound FLAG-Chp2 with H3K9me3 Nucleosomes. The experimental 
scheme is shown in Figure 2.17 B. After washing the unbound H3K9me3 Nucleosomes from 
the FLAG resin, the Chp2-H3K9me3 Nucleosome complex was eluted by addition of the 
Prescission protease. The FLAG-Chp2 construct has in fact a Prescission protease digestion 
site between the FLAG tag sequence and the N-terminal start of the protein. Addition of the 
Prescission protease, removed the tag anchoring Chp2 to the resin, thereby eluting the Chp2-
H3K9me3 Nucleosome complex (Figure 2.17 C- fourth lane from the left). The advantage of 
the Prescission lies in its high specificity and in the low optimal temperature of 4 °C, which 
allowed to complete the elution on ice, without destabilizing the Chp2-H3K9me3 Nucleosome 
complex. Moreover, specificity was required since many impurities were still present on the 
resin after FLAG-Chp2 immuno-precipitation, which would have been carried over on the EM 
grid if we would have performed a general FLAG peptide elution. Controls on the complex 
assembly, showed that elution happened only when adding the Prescission protease (Figure 
2.17 C- fifth lane from the left) and that no H3K9me3 Nucleosome was non-specifically 
sticking to the FLAG resin (Figure 2.17 C- second lane from the right). Negative stain EM of 
the eluted complex showed the presence of particles with similar shape and size, even though 
less concentrated if compared to what previously achieved with the Swi6-
H3K9me3Nucleosome complex (Figure 2.17 D). A similar Swi6 dual tag approach should be 
used in the future also for the Chp2-H3K9me3 Nucleosome complex, moving to a bacterial 
expression system, which generally gave better protein yields for Chp1CD and Swi6 proteins. 
Biochemical and structural characterization of the in vivo Chp2-H3K9me3 Nucleosome 
complex might be continued in parallel, since maintaining post-translational modifications on 
the protein could give further insights on the regulation of HP1 binding to chromatin. However, 
the elution strategy has to be optimized to give a more concentrated EM sample.  
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Figure 2.17: in vitro assembly of the Chp2-H3K9me3 Nucleosome complex 
 
A) Coomassie stained gel showing the purified FLAG-Chp2 protein from a wild-type S.pombe strain. The strain 
was transformed with a pREP1 plasmid over-expressing FLAG- Chp2 under the nmt1+ promoter. The protein 
runs at around 65 kDa. (B) Experimental scheme for the Chp2-H3K9me Nucleosome complex assembly. (C)  
Coomassie stained 15% SDS-PAGE gel showing the assembly of Chp2-H3K9me3 Nucleosome complex and its 
elution from the FLAG resin (Sigma) upon addition of the Prescission protease. A Prescission cut site is present 
between the FLAG tag and the Chp2 protein N-terminal end. (D) Negative stain EM micrograph showing the 
Chp2-H3K9me3 Nucleosome complex.  
 
 
In vitro reconstitution of the Clr4-H3K9me3 Nucleosome complex  
 
The S. pombe H3K9 methyltransferase Clr4 was purified from the E. coli BL21(DE3)pLysS 
expression strain as a double tag construct His6-Clr4-FLAG (we thank Bassem Al-Sady for the 
construct, published in (Al-Sady et al., 2013). The purified protein run at around 80 kDa, higher 
than the 55.92 kDa calculated based on its primary sequence (Figure 2.18 A). As described 
previously for Swi6, the assembly of the Clr4-H3K9me3 Nucleosome complex followed the 
procedure described in Figure 2.18 B. After the initial Ni-NTA purification, Clr4 was rebound 
to the FLAG M2 affinity resin. Then H3K9me3 Nucleosomes were added to assemble the Clr4-
H3K9me3 Nucleosome complex. The binding occurred in the same buffer conditions described 
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for Chp1CD, Swi6 and Chp2. After washing the unbound H3K9me3 Nucleosomes, the Clr4-
H3K9me3 Nucleosome complex was eluted by addition of the FLAG peptide (Figure 2.18 C - 
fourth lane from the left). Complex elution was dependent on addition of the FLAG peptide, 
and no Nucleosome was spontaneously dissociating from the resin (Figure 2.18 C - fifth lane 
from the left). As in the case of Swi6, Clr4-H3K9me3 Nucleosome complex assembly was 
specific and no Nucleosome was observed sticking on the FLAG resin in the absence of bound 
Clr4 (Figure 2.18 C - second lane from the right). The eluted complex was later spotted on a 
carbon coated EM grid for Negative staining. We observed homogenous and well distributed 
Clr4-H3K9me3 Nucleosome particles, with a round shape and similar size (Figure 2.18 D). As 
for the other Nucleosome complexes purified and assembled, cryo-EM data on the assembled 
Clr4-H3K9me3 Nucleosome complex will be collected in order to better understand how the 
Clr4 H3K9 methyltransferase interacts with the Nucleosome and exerts its own enzymatic 
function. This could potentially give precious informations on how the H3K9me mark is 
deposited and how the chromodomain of Clr4, which shares striking primary sequence 
similarity with Chp1CD, binds to the H3 histone tail. Clr4 is of particular interest since, among 
the four fission yeast heterochromatin proteins with a chromodomain, it is the only one 
coupling the “chromatin reader” and the “chromatin writer” functions. A high resolution 
structure of this complex will be therefore beneficial to the chromatin field, given also the 
conservation of the Su(var)3-9 family of H3K9 methyltransferases and their fundamental role 
in heterochromatin formation. 
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Figure 2.18: in vitro assembly of the Clr4-H3K9me3 Nucleosome complex 
 
A) Coomassie stained gel showing the purified His-Clr4-FLAG protein from E.coli BL21(DE3)pLys expression 
strain. The protein runs at around 80 kDa. (B) Experimental scheme for the Clr4-H3K9me Nucleosome complex 
assembly. (C)  Coomassie stained 15% SDS-PAGE gel showing the assembly of Clr4-H3K9me3 Nucleosome 
complex and its elution from the FLAG resin (Sigma) upon FLAG peptide (Sigma) addition. (D) Negative stain 
EM micrograph showing the Clr4-H3K9me3 Nucleosome complex.  
 
Cross-linking of the Swi6-H3K9me3 Nucleosome complex 
 
In order to better stabilize the Swi6-H3K9me3 Nucleosome interaction for structural studies 
and Mass Spectroscopy, cross-linking was performed on the assembled complex by using 
bis(sulfosuccinimidyl)suberate or BS3. BS3 is a homobifunctional amine-amine cross-linker 
that reacts with two primary amine residues, such as lysines, covalently linking them together 
with a spacer distance of 11.4 Å. In order to assess the optimal BS3 concentration for cross-
linking, avoiding over reaction, titration experiments were set up, using Swi6 and Nucleosomes 
alone and the Swi6-H3K9me3 Nucleosome complex (Figure 2.19). Together with Swi6, the 
SwiL315D protein (Canzio et al., 2011), carrying a mutation in the Chromo shadow domain 
preventing dimerization in solution, was analyzed.   
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Figure 2.19: BS3 cross-linking titration experiments for the Swi6-H3K9me3 Nucleosome complex 
A) Coomassie stained 12% acrylamide gel of a BS3 titration experiment on the Swi6 protein and the Swi6L315D 
dimerization mutant. As can be noticed, at higher concentration of cross-linker (1 and 2 mM) Swi6 but not 
Swi6L315D, shifts upwards, indicating the formation of oligomers. (B) Coomassie stained 15% acrylamide gel of 
a BS3 titration experiment on the H3K9me3 Nucleosome. Histone bands are visible up 1 mM BS3 concentration. 
(C) Coomassie stained 15% acrylamide gel of a BS3 titration experiment on the Swi6-H3K9me3 Nucleosome 
complex, assembled in solution. (D) Coomassie stained 15% acrylamide gel of a BS3 titration experiment on the 
Swi6L315D-H3K9me3 Nucleosome complex, assembled in solution.   
 
The analysis on the Swi6L315D mutant is fundamental to understand the contribution of Swi6 
oligomerization for Nucleosome interaction. The cross-linking reaction was carried out at 30°C 
for 30 minutes and quenched by the addition of 50 mM Ammonium Carbonate for 10 minutes, 
for a total protein concentration of 0.5 mg/ml.  
As shown in Figure 2.19 A, a concentration of BS3 of 0.5 mM or higher caused a shift upwards 
of the Swi6 protein in SDS-PAGE, indicating a covalent bond formation between Swi6 dimers. 
As expected, the Swi6L315D mutant, unable to dimerize, did not show the same shifting 
(Figure 2.19 A).  H3K9me3 Nucleosomes started showing higher molecular weight histone 
bands starting from a BS3 concentration of 0.5 mM (Figure 2.19 B). In conclusion the minimal 
BS3 concentration for cross-linking the Swi6-H3K9me3 Nucleosome complex, without over 
reaction, was around 0.5 mM. We assembled the Swi6-H3K9me3 Nucleosome and the 
Swi6L315D-H3K9me3 Nucleosome complexes in solution and performed low concentration 
BS3 titration experiments, starting from 0.05 mM to 0.5 mM BS3 (Figure 2.19 C and D). The 
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appearance of cross-linked molecular species occurred at a concentration of BS3 comprised 
between 0.1 mM and 0.5 mM. For cross-linking Mass Spectrometry, the minimal concentration 
of cross-linker able to efficiently cross-link H3K9me3 Nucleosomes and the Swi6-H3K9me3 
Nucleosome complex was used, namely 0.5 mM. The Swi6 protein alone, but not 
Nucleosomes, shifted at lower BS3 concentrations.  
 
Figure 2.20: cross-linking of the Swi6-H3K9me3 Nucleosome complex 
Native -TBE acrylamide gel showing the cross-linked Swi6-H3K9me3 Nucleosome and the Swi6L315D-H3K9me3 
Nucleosome complex with and without BS3 cross-linking (0.5 mM). Note the upper shifted Nucleosome band 
corresponding to the assembled Swi6-Nucleosome complex. 0.5 mM BS3 cross-linking does not change the 
migration of the Swi6-Nucleosome complex on Native PAGE. 
 
As shown in Figure 2.20, cross-linking with a concentration of 0.5 mM BS3 did not change the 
migration properties of the Swi6-H3K9me3 Nucleosome complex in Native PAGE.  
 
Figure 2.21: Negative stain EM of the cross-linked Swi6-H3K9me3 Nucleosome and the Swi6L315D-
H3K9me3 Nucleosome complexes 
. 
In fact, in EMSA with or without 0.5 mM BS3, there was a clear upward shifting Nucleosomal 
band, corresponding to the assembled Swi6-H3K9me3 Nucleosome complex. The cross-linked 
Swi6 and Swi6L315D Nucleosomal complexes were also subjected to Negative stain EM 
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(Figure 2.21), to assess the quality of the particles. On the EM grids, cross-linked complexes 
looked similar in size and in shape, with an optimal concentration to cover homogenously the 
carbon surface. The sample seemed, therefore, to be optimal to proceed further with the cryo-
EM structural analysis.  
Cross-linking Mass Spectrometry data will allow us to pin-point the residues in both Swi6 and 
the Swi6L315D dimerization mutant directly interacting with the histone H3K9me3 tail and 
the Nucleosome core. This powerful method, coupled with cryo-EM, will give us an idea on 
how Swi6 structurally interacts with Nucleosomes to form heterochromatin.  
 
Reconstitution of H3K9me3 di-Nucleosomes  
 
 
 
 
 
 
Figure 2.22: in vitro reconstitution of H3K9me3 di-Nucleosomes 
 
H3K9me di-Nucleosome reconstitution: nucleosomes were run on a 5% TBE-Native acrylamide gel and stained 
with SyBr GOLD and Coomassie Blue. Mono H3K9me3 Nucleosomes (NCP) were loaded as a control. Two 
different quantities (5 µg and 2 µg) of di-H3K9me3 Nucleosomes were run. Note the shifting of the 2x146bp 601 
DNA in the di-Nucleosome samples and the double staining with SyBr GOLD and Coomassie Blue. 
 
To further expand the analysis on chromodomain proteins chromatin interaction, H3K9me3 di-
Nucleosomes were reconstituted for cryo-EM studies. As substrate for reconstitution we used 
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the 2 x 146 bp 601 DNA sequence, containing two copies of the 601 146 bp Widom sequence 
previously used to assemble single Nucleosome core particles (Lowary and Widom, 1998). The 
di-H3K9me3 Nucleosomes were reconstituted following the same procedure described 
previously for the mono H3K9me3 Nucleosomes. Histone Octamer was mixed with the 2x 146 
bp 601 DNA sequence in a DNA : Octamer ratio of 1.1:1, in a Step gradient dialysis lowering 
the salt concentration.  As shown in Figure 2.22, the reconstituted di-H3K9me3 Nucleosomes 
run higher compared to the 2 x 146 bp 601 DNA and the mono- H3K9me3 Nucleosomes alone 
and were stained with both SyBr GOLD and Coomassie Blue. To understand whether 
assembled di-H3K9me3 Nucleosomes were functional for Swi6 binding an EMSA was 
performed with Swi6 - di-H3K9me3 Nucleosomes in a 5 : 1 ratio, in both cross-linked (0.5 mM 
BS3) and native conditions (Figure 2.23).  
 
Figure 2.23: Swi6-H3K9me3 di-Nucleosome complex assembly  
 
Native -TBE acrylamide gel showing the cross-linked and native Swi6-H3K9me3 mono-Nucleosome and the Swi6-
H3K9me3 di- Nucleosome complex with and without BS3 cross-linking (0.5 mM).  
 
 
The addition of Swi6 to H3K9me3 di-Nucleosomes caused a shifting in the Nucleosomal band, 
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indicating Swi6 binding. Addition of 0.5 mM BS3 stabilized the Swi6 - H3K9me3 di-
Nucleosome complex, with the appearance of a more defined shifted Nucleosomal band 
(Figure 2.23 – compare the last two lanes). Since it was possible to assess the binding of Swi6 
to H3K9me3 di-Nucleosomes, we next wanted to assess the quality of the assembled di-
Nucleosome particles by Negative stain EM.  
 
 
 
 
Figure 2.24: Negative stain EM micrograph of reconstituted H3K9me3 di-Nucleosomes  
 
H3K9me3 di-Nucleosomes showed the presence of many protein aggregates compared to 
mono- H3K9me3 Nucleosomes in the same buffer, with many debris and irregular shaped 
particles. The addition of 1 mM EDTA to the Nucleosome binding buffer, did not resolve the 
H3K9me3 di-Nucleosome aggregation on the Negative stain EM grid (Figure 2.24). It is 
fundamental in order to use di-Nucleosomes for cryo-EM studies, to understand how to prevent 
aggregation, which might be derived from sensitivity to the Uranyl Acetate low pH, from 
carbon interaction that causes di-Nucleosome disassembly or general biochemical instability.  
Future optimization of di-Nucleosome chromodomain protein complexes will shed more light 
on how heterochromatin is assembled and regulated in complex chromatin substrates.  
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DISCUSSION 
 
The organization of the chromatin into euchromatin and heterochromatin is fundamental to 
regulate a wide variety of nuclear processes, such as transcription, DNA replication and 
chromosome segregation, DNA repair, genome organization in the nucleus and its expression.   
In S. pombe as well as in many other Eukaryotes, the recognition of H3K9 methylation from 
chromodomain proteins is essential to establish and maintain constitutive heterochromatin, and 
to recruit protein complexes involved in the regulation of various nuclear processes. However, 
there is still no sufficient insights on how heterochromatin chromodomain proteins interact 
with their natural binding partners: the H3K9me2/3 Nucleosomes. There are still many open 
questions on how the different chromodomain proteins involved in heterochromatin formation 
recognize the H3K9 methylation mark and cross-talk with each other to coordinate their 
functions at the same genomic locus. 
In the present work of thesis the attention was mainly focused on the chromodomain of Chp1, 
a protein involved in the recruitment of Argonaute to chromatin, to trigger the RNA interference 
mediated heterochromatin formation in the fission yeast S. pombe. Among the four 
chromodomain proteins involved in heterochromatin formation in fission yeast (Chp1, Chp2, 
Swi6 and Clr4), the chromodomain of Chp1 is the one with the highest affinity for the H3K9 
methylation mark. This was already shown previously by various in vitro H3K9me peptide 
binding experiments (pull downs, fluorescence anisotropy and isothermal calorimetry-ITC), 
which, even despite showing differences in the affinity constants (Kd) measured, they 
consistently underlined that Chp1CD binds the H3K9me3 tail with the highest affinity (Al-
Sady et al., 2013; Ishida et al., 2012; Schalch et al., 2009). Ishida and colleagues (Ishida et al., 
2012), measured by ITC that the affinity of the Chp1CD for the H3K9me3 peptide was around 
37.5 nM, whereas Swi6CD affinity was roughly 160 nM. Schalch and colleagues (Schalch et 
al., 2009) measured an H3K9me3 peptide affinity by fluorescence anisotropy of roughly 190 
nM for Chp1CD, 600 nM for Clr4CD and 3.34 µM for the Swi6CD. However, isothermal 
calorimetry experiments gave slightly less difference in the binding affinity between Chp1CD 
and Swi6, with Chp1CD binding the H3K9me3 peptide with a Kd = 0.3 µM and Swi6 with a 
Kd = 1.69 (Schalch et al., 2009). For Zhang and colleagues, the measured affinity by 
fluorescence polarization of the Clr4CD for the H3K9me3 peptide was 6 µM (Zhang et al., 
2008). In a recent study (Al-Sady et al., 2013), the Clr4 protein with the Clr4CD swapped with 
a F61A Chp1CD (Schalch et al., 2009), was still able to recognize the H3K9me3 mark with the 
same affinity of the Clr4CD, but had tighter binding to H3K9me2. This was done to prevent 
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the swapped chimeric F61AChp1CD-Clr4 protein to discriminate between H3K9me3 and 
H3K9me2 marks. It was highlighted however that the wild-type Chp1CD had higher affinity 
compared to the Clr4CD for the H3K9me mark, independently of the methylation state, as 
previously measured (Schalch et al., 2009).  In this study, the H3K9me3 peptide affinities 
measured by Microscale Thermophoresis (MST) of Chp1CD chromodomain wild-type (Kd= 
345 nM) and the LOOP1B (Kd= 260 nM), LOOP2B (Kd= 292 nM) and LOOP1B/2B (Kd= 
365 nM) mutants, are all in a comparable range to what previously shown in ITC measurements 
for the Chp1CD construct (Schalch et al., 2009). 
However, no experiments have been done so far to compare the binding affinity of all the 
chromodomains mentioned with H3K9me3 Nucleosomes in vitro. In this study, MST 
measurements of the wild-type Chp1CD affinity in complex with the H3K9me3 Nucleosome 
gave a dissociation constant of Kd= 180 nM, a value lower than the one measured with the 
H3K9me3 peptide (Kd= 345 nM). This can be due to the presence of additional Nucleosomal 
surface that can increase the affinity of binding, even though these values are difficult to 
compare since the binding buffer used in the Nucleosome binding assay had to be supplemented 
(+10% glycerol compared to the buffer used in H3K9me3 peptide assays, see Materials and 
Methods)) to prevent sample aggregation on the thermophoresis capillaries.  
What was already shown, on the other hand, is that a heterochromatin defective phenotype is 
obtained when swapping chromodomains between Chp1, Swi6, Chp2 and Clr4.  
Swapping of Swi6CD with its HP1 isoform Chp2CD caused a major defect in silencing at the 
MAT locus (Sadaie et al., 2008). On the other hand, swapping of Chp2CD with Swi6CD had a 
less impactful heterochromatin defect. The swapping of Chp1CD with Swi6CD resulted in 
defective heterochromatin establishment at centromeres, with no effects on heterochromatin 
maintenance (Schalch et al., 2009). The swapping previously described (Al-Sady et al., 2013) 
of the Clr4CD with a less H3K9me2/3 specific F61AChp1CD, caused impaired chromatin 
spreading at the MAT type locus. Moreover, the swapping of the Swi6CD with either Chp1CD 
or Clr4CD caused a slight defect of silencing at centromeres (Ishida et al., 2012). No defect 
was observed when swapping Swi6CD with Chp2CD at centromeres, in contrast to what 
previously seen at the MAT type locus (Sadaie et al., 2008). This might hint on the fact that 
Swi6 and Chp2 have equivalent functions at centromeres but not at the MAT locus, despite 
chromatin fractionation experiments (Sadaie et al., 2008) showed that Swi6 is mainly localized 
in the soluble fraction (Nucleoplasm), whereas Chp2 is more in the chromatin pellet fraction 
(Chromatin bound), and that the localization of the two proteins is largely determined by their 
Chromo-Shadow domains (CSD). The cited references provided useful insights in 
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understanding how affinity regulates the different roles of chromodomain proteins at the same 
loci. Particularly interesting is the model proposed by Al-Sadi and colleagues in which the 
stronger affinity of Clr4 for H3K9me3 mark compared to the H3K9me2 mark allows Clr4 to 
outcompete HP1 proteins for the H3K9me3 mark. On the other hand, HP1 proteins have a 
stronger affinity for the H3K9me2 mark than Clr4, which is the most abundant H3K9 
methylation variant present in vivo in fission yeast. The model presented (Al-Sady et al., 2013) 
explains how the careful balance between H3K9me deposition by Clr4 and the differential 
affinities for the H3K9me variants contribute to regulate the function of the chromodomain 
proteins in heterochromatin formation.  
The different affinities of the four S. pombe heterochromatin chromodomain proteins for H3K9 
methylation are definitely dependent on the CDs primary amino acid sequences, rather than 
their fold (which is the conserved canonical chromodomain fold, with a three stranded anti-
parallel β-sheet and C-terminal α-helix (Horita et al., 2001; Ishida et al., 2012; Schalch et al., 
2009). The mentioned CD swapping experiments indicated that each chromodomain has 
peculiar characteristics that determine the specific functions of each heterochromatin protein 
and that they are therefore not interchangeable, despite recognizing the same target, the 
H3K9me histone tail.  
A preliminary cryo-EM structure of the Chp1CD-Nucleosome complex obtained in our 
laboratory (data not shown) revealed that Chp1CD is actually interacting not only with the 
H3K9me tail but also with the Nucleosome core, through protein-protein direct interaction 
mediated by the two loops of its three stranded antiparallel β-sheet. The mutagenesis study 
highlighted that destabilization of either loops (LOOP1, LOOP2 mutants or LOOP1/2 mutants) 
causes partial or total loss of the Nucleosome core interaction with consequent destabilization 
of the Chp1CD-H3K9me3 Nucleosome complex, resulting in an affinity drop of roughly 5 fold 
compared to the wild-type Chp1CD (see Figure 2.3 E, LOOP1B/2B mutant). As published 
previously (Schalch et al., 2009), genomically integrated Chp1CD mutants with similar affinity 
defects for H3K9me3 peptide binding did not have a visible phenotype in heterochromatin 
maintenance, but they were defective in heterochromatin establishment. In establishment 
assays, the sole H3K9me methyltransferase Clr4 is re-introduced in a Clr4 deletion strain. The 
mutants of the protein of interest are generated in the Clr4 deletion strain and, if 
heterochromatin cannot be re-established after Clr4 re-introduction, the mutant protein causes 
a defective heterochromatin establishment. With the re-introduction of Clr4 and background 
levels of H3K9me mark, the high affinity of Chp1CD for the H3K9me mark is required for the 
Discussion 
75 
 
recruitment of the RITS-Argonaute complex to give the initial signal for heterochromatin 
formation and generate high levels of siRNAs (Halic and Moazed, 2010). In maintenance, the 
presence of other back-up mechanisms, including the Clr4 read-write maintenance function 
(Audergon et al., 2015; Ragunathan et al., 2014), makes the affinity of Chp1CD for the 
H3K9me mark less critical to feed-in the heterochromatin signaling. In our case, the general 
loss of affinity in vitro for the H3K9me3 Nucleosome in our LOOP1/2 mutants reflected 
immediately in a defective silencing in heterochromatin maintenance, both in Chp1 deletion 
strains transformed with plasmids carrying wild-type and mutant LOOP1/2 Chp1CD proteins 
(heterochromatin rescue assays) and in genomically integrated LOOP1/2 Chp1CD mutants. 
Consequently, a defect in heterochromatin maintenance reflects a defect in heterochromatin 
formation on a general level, since cells cannot keep optimal H3K9me levels and constitutive 
heterochromatin silencing throughout the generations. Comparison between the 
heterochromatin defects obtained in our genomically integrated versus the plasmid rescued 
strains highlights that the slight over-expression of the Chp1 protein in the plasmid rescue 
strains in vivo is not responsible for the phenotypes observed. Moreover, the mutant Chp1CD 
proteins have been showed to be stably expressed (Figure 2.10), and the LOOP1B/2B Chp1CD 
mutant, showing a strong heterochromatin defect in vivo, is functional (therefore LOOP1B/2B 
has to be properly folded) in binding the H3K9me3 histone peptide with an affinity comparable 
to the wild-type Chp1CD. LOOP1B/2B Chp1CD mutant showed the importance of the 
Chp1CD-Nucleosome core interaction in heterochromatin formation. Despite having only a 5-
fold drop in affinity for the H3K9me3 Nucleosome (considered not sufficient to cause a 
heterochromatin maintenance impairment (Schalch et al., 2009)), LOOP1B/2B has a 
heterochromatin defect in vivo, indicating that the Chp1CD-Nucleosome core interaction, 
mediated by LOOP1 and LOOP2, has a broad significance in heterochromatin formation that 
goes beyond the sole recognition of the H3K9me3 histone tail.  
The Nucleosome core interaction positions the Chp1CD in a defined orientation with the 
positively charged C-terminal α-helix protruding outwards from the Nucleosome surface (data 
not shown). A previous study (Ishida et al., 2012), showed that Chp1CD is able to interact with 
nucleic acids. This interaction is mediated by the positively charged lysine residues of the C-
terminal α-helix as shown by NMR spectroscopy experiments (Ishida et al., 2012) Figure S4 
(C-D)). Mutations aimed at swapping C-terminal α-helix residues between Swi6CD, which 
does not bind nucleic acids in vitro, and Chp1CD (αmut1 and αmut2 mutants) caused not only 
loss of binding for RNA and DNA in vitro but also a severe heterochromatin maintenance defect 
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in vivo. Notably, both αmut1 and αmut2 mutants bind the H3K9me3 peptide with the same 
affinity as the wild-type Chp1CD, since none of the residues previously shown to be involved 
in the histone tail binding affinity was modified. The heterochromatin defect therefore 
originated by the incapacity of the αmut1 and αmut2 Chp1CD to bind the RNA, as shown also 
in the in vivo centromeric RNA-IP assays (Ishida et al., 2012). The Chp1CD W49Y50/DPS, 
which substituted the DPS residues found in Swi6 as alignment homologous, with the W49 and 
Y50 residues, showed a defective centromeric RNA binding in vitro, immediately rescued by 
the addition of H3K9me3 peptide in solution (Ishida et al., 2012). The authors concluded that 
this differential behavior in the presence or absence of H3K9me histone tail was due to a 
flexibility change of the W49Y50/DPS when free in solution. When bound to the H3K9me3 
peptide the Chp1CD W49Y50/DPS is assuming a conformation that allows it to bind with 
higher affinity with the RNA. LOOP2B mutant (W49AY50AD51A) has two mutations in 
common to the mentioned W49Y50/DPS, albeit Alanine residues substitutions. Our peptide 
binding assays (pull downs and MST, Figure 2.5) indicated that LOOP2B is able to bind the 
H3K9me3 peptide with comparable affinity to the wild-type protein. Moreover, our RNA 
EMSA assays indicated that, in the presence of the H3K9me3 peptide in solution, Chp1CD 
LOOP2B is able to bind to the centromeric RNA with no defects observed (Figure 2.5 E). The 
Chp1CD LOOP2B mutant was also able to completely rescue the heterochromatin defect in a 
chp1∆ strain, restoring the levels of H3K9me2 at centromeres and completely silencing the 
centromeric RNAs to wild-type levels. This confirmed the results previously obtained (Ishida 
et al., 2012). The observation of Chp1CD mutants having impaired silencing at centromeres, 
despite being able to bind the H3K9 methylated histone tail (LOOP1B/2B and αmut1), 
indicates that stability of the Chp1CD on the Nucleosome core and centromeric RNA binding 
might play a common role in heterochromatin formation.  
The in vitro RNA pulldowns in the presence of H3K9me3 Nucleosomes showed that 
LOOP1B/2B, defective in Nucleosome core interaction, is not able to strongly bind to the 
centromeric dg RNA as the wild-type protein (Figure 2.14). The same RNA shift assays, in the 
presence of only the histone H3K9me3 peptide, showed that Chp1CD wild-type and 
LOOP1B/2B have no significant difference in terms of RNA binding affinity (Figure 2.5 E and 
Figure 2.13). If no H3K9me3 peptide or Nucleosome is present, LOOP2B mutations alone are 
sufficient to cause an RNA/DNA binding loss (Ishida et al., 2012). This clearly points toward 
the importance of the histone H3K9me3 tail to recruit the Chp1CD for Nucleosome core 
interaction and RNA/DNA binding.  Chp1CD can bind to RNA and dsDNA with a similar 
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affinity in the presence of H3K9me2 peptide (Kd=0.3 µM) (Ishida et al., 2012). This points out 
that Chp1CD might also interact with lesser extent with the Nucleosomal DNA, even though 
our preliminary structural data and the biochemical data highlight that the main interaction is 
a direct protein-protein contact with the histone globular domain.  
Given the orientation of the Chp1CD in our preliminary cryo-EM maps (data not shown), the 
C-terminal α-helix, which is facing away from the Nucleosome surface, might indeed form a 
binding interface for RNA stabilization onto chromatin. The binding surface of Chp1CD on the 
Nucleosome core is variegated, with one main contact for Chp1CDLOOP1 at the H3 histone 
globular domain and two minor contacts for Chp1CDLOOP2 and the tip of the C-terminal α-
helix, spotted at lower contour level close to histone H2B and H4. Point mutations on the 
Nucleosome core, histone H3 K79AT80AD81A, did not have any effects on the stability of the 
Chp1CD-H3K9me3 Nucleosome core interaction (Figure 2.4 F). This can be explained from 
the fact that multiple contact points of Chp1CD with the Nucleosome core were detected (data 
not shown), and the resolution of our preliminary cryo-EM structure did not allow to pinpoint 
exactly the histone residues interacting, but only the approximate regions. 
A similar result was obtained when mutating the Nucleosome interface of the Sir3BAH domain 
Nucleosome core complex. An H3K79A mutant did not have any effects on the ability of the 
Sir3BAH domain to bind the Nucleosome (Wang et al., 2013a). In order to obtain a completely 
defective Nucleosome core binding, all histone residues interacting should be mutated 
simultaneously, which could also impair the stability of the Nucleosome particle itself.  
Moreover, destabilization of only one of the two interacting Chp1CD LOOPs resulted either in 
a partial or no heterochromatin formation defect. The indication that to have a silencing 
impaired phenotype we needed to mutate two different LOOPs in Chp1CD argues that the 
Nucleosome core interaction requires multiple contact points. In this case, improvement in the 
cryo-EM maps resolution will prove to be fundamental to better understand which residues are 
involved in the Chp1CD-Nucleosome core interaction, on the side of the Nucleosome. This 
suggests multiple possibilities regarding the regulation of the stability of Chp1 on the H3K9me 
chromatin and could highlight the ability of Chp1CD to read multiple histone marks at the same 
time, adding more complexity on the mechanism of recruitment of the RITS-Argonaute 
complex to heterochromatin.  
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The model of interaction between the chromodomain of Chp1 and the Nucleosome 
core 
 
The structure of the Chp1CD-H3K9me3 Nucleosome complex gave us the initial evidence that 
chromodomain interaction with the Nucleosome is not only restricted to the H3K9 methylated 
histone tail but might interest also several parts of the Nucleosome core surface. Questions still 
remain on how common this binding mechanism is in other chromodomain or chromatin 
proteins and how regulated it is. The in vitro and in vivo experiments showed that the Chp1CD- 
Nucleosome core interaction has a deep impact on heterochromatin stability and it is therefore 
necessary for Chp1 to exert its function, at least at centromeres. According to the model we 
propose (Figure 3.1), Chp1 is recruited through H3K9 methylation to chromatin by direct 
interaction with the histone tail mediated by the aromatic cage (Y22, W44, Y47 residues) of its 
chromodomain. The high affinity of this interaction, determined not only by the aromatic cage, 
but also spatially neighboring residues (E23, V24, N59 and F61), is necessary for initial 
recognition of the H3K9me mark in heterochromatin formation, but not for maintaining the 
heterochromatic silencing after its establishment (Schalch et al., 2009). The biochemical data 
suggested that the main recruitment of Chp1CD occurs through the recognition of the H3K9me 
histone tail, but that the overall stability of the Chp1-Nucleosome complex is dependent on the 
Nucleosomal core interaction.  
The interaction with the Nucleosome core positions the Chp1CD in a defined orientation (data 
not shown), with the LOOP1/2 in contact with histone H3, H2B and H4 globular domains 
(mainly with the H3 loop) and the C-terminal lysine rich α-helix protruding outwards. This 
helix is therefore exposed for interaction with nucleic acids, particularly centromeric RNAs, 
already shown to be binding Chp1CD helix in in vivo RNA-IP and biochemical experiments 
(Ishida et al., 2012). As already shown by Ishida and colleagues, the RNA binding of Chp1CD 
is a necessary feature for heterochromatin maintenance, and in vivo experiments showed that 
mutants unable to bind either DNA or RNA in vitro, were incapable to maintain centromeric 
silencing (Ishida et al., 2012). The phenotype we observe is a defective heterochromatin 
maintenance, which could similarly reflect the Chp1CD inability of properly binding 
centromeric RNA. In vitro binding assays showed that the LOOP1B/2B mutant is less able to 
interact with H3K9me3 Nucleosomes and efficiently pull down centromeric dg RNAs, 
compared to the wild-type Chp1 (Figure 2.14). 
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Figure 3.1: Model of interaction of Chp1 - RITS complex with the H3K9 methylated Nucleosome (described 
in this section) 
 
Therefore, the Nucleosome core binding could determine not only the orientation but also the 
stability of the Chp1CD for RNA interaction. As shown in Figure 3.1, the binding of RNA on 
the Chp1CD α-helix gives a stabilized interface for Argonaute siRNA targeting. Chp1 interacts 
with its C-terminal domain with the GW protein Tas3, forming a platform for Argonaute 
recruitment (Debeauchamp et al., 2008; Schalch et al., 2011; Verdel et al., 2004). Our model 
implies that Chp1 stability on the H3K9me3 Nucleosome is dependent on the Nucleosome core 
interaction. In LOOP1B/2B mutants, where core binding is lost, there might be a defective 
anchoring of centromeric RNAs onto chromatin, impairing Argonaute siRNA mediated 
targeting. This would explain why the in vivo phenotypes observed previously (Ishida et al., 
2012) and in the present study are very similar to each other, with loss of heterochromatin 
maintenance that might indeed be correlated with a destabilized RNA binding, not related with 
H3K9me histone tail recruitment (the affinity mutants did not have a phenotype in maintenance 
(Schalch et al., 2009)). In this case, Argonaute would be less efficiently targeting centromeric 
RNAs for siRNA amplification and H3K9me mark deposition, which in turn results in 
H3K9me levels drop (Figure 2.8, LOOP1/2 mutants).  
A similar RNA/DNA binding role might be envisioned also for Clr4CD, possessing a similarly 
lysine-arginine rich C-terminal α-helix and able to bind nucleic acids in vitro (Ishida et al., 
2012). The chromodomain swapping experiments nonetheless demonstrated that CDs are not 
equivalent in terms of function: in fact, their primary sequences might have been finely tuned 
from evolution to adjust their affinities (for both histone tails and the Nucleosomal core) and 
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coordinate their respective functions at the same heterochromatin loci. Further studies will be 
needed to see if Nucleosome core binding is a shared feature among fission yeast 
chromodomain proteins or if it is specific for Chp1.  
 
Conclusions and perspectives 
 
The results of the work presented in this thesis contributed to answer some questions regarding 
how the affinity of chromodomains for chromatin might be further increased and regulated by 
their interaction with the Nucleosome core. The advantage of using cryo- electron microscopy 
to solve the structure of the Chp1CD-H3K9me3 Nucleosome complex is that we would be able 
to isolate different conformations of binding, as well as different contact points on the 
Nucleosome surface, allowing us to build a comprehensive model of the interaction, further 
confirming the biochemical analysis. The model discussed, however, needs to be further 
implemented and would benefit from the addition of new data regarding the regulation of 
Chp1CD binding to chromatin. In fact, it is of paramount interest to understand whether post-
translational modifications on the so far characterized contact points (data not shown) between 
Chp1CD and histone globular domains on the Nucleosome core are, in fact, deposited and how 
they could regulate the binding. This would create a double-switch mechanism of regulation 
different from the ones previously characterized (Eissenberg, 2012), with the recruiting 
H3K9me counteracted by a histone globular domain PTM, rather than a modification on a close 
histone residue (it is the case for double switch modifications such as H3K9me and H3S10 
phosphorylation or H3K4me and H3T3 phosphorylation, immediately close to each other). The 
proposed type of interaction between distant histone marks is similar to what observed for the 
regulation of the Sir3 protein binding to the Nucleosome in S. cerevisiae, with histone H4K16 
acetylation and H3K79 methylation acting against Sir3BAH domain Nucleosome core binding 
and competing with H4K16 deacetylation, operated by Sir2.  
Further structural and biochemical studies are needed on Swi6, Chp2 and Clr4 proteins to 
understand whether the Nucleosome core interaction is specific for Chp1CD or is a conserved 
feature of chromodomain proteins involved in heterochromatin formation in S. pombe. 
Particularly interesting is the RNA binding role of Clr4CD in heterochromatin formation, not 
explored in (Ishida et al., 2012). What would be the function of the Clr4 methyltransferase in 
stabilizing RNA binding onto chromatin? Is Nucleosome core binding a conserved feature 
between Clr4 and Chp1? How would Nucleosome core binding be affecting the 
methyltransferase activity of Clr4?  
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Chp1CD binding of RNA has been characterized but the chromodomain is also able to bind the 
DNA in vitro with similar affinity (Ishida et al., 2012). Our study showed that Chp1CD is 
autonomously able in vitro to contact through direct protein-protein interaction the Nucleosome 
core, even though it is possible that Chp1CD-Nucleosome conformations in which Chp1CD 
contacts the Nucleosomal DNA exist. There is still therefore the possibility of Chp1CD binding 
to H3K9me3 tail and contacting not only the transcribed centromeric RNA for Argonaute 
targeting, but the Nucleosomal DNA of a neighboring Nucleosome. In the case of Clr4CD this 
would be particularly useful for clustering together the recruiting H3K9me3 Nucleosome and 
the Nucleosome connected to it, which has to be targeted for H3K9 methylation (Al-Sady et 
al., 2013). The work presented further discusses how chromodomains evolved in specialized 
roles and are not interchangeable. RNA/DNA and Nucleosome core binding give additional 
complexity in our understanding of how chromatin readers´ affinity for chromatin is regulated. 
It has been shown that nucleic acids interaction is not conserved among fission yeast 
heterochromatin proteins (Ishida et al., 2012). Similarly, Nucleosome core interaction might 
not be a common feature for heterochromatin proteins in Eukaryotes.  Additional structural and 
biochemical studies are needed to understand the regulation of the diverse functions of 
chromatin readers in heterochromatin, using both single Nucleosomes and chromatin arrays.  
These studies will be of fundamental importance to understand how the genetic program of 
silencing is regulated in different organisms, taking into account the growing complexity, the 
developmental program, the spatial and time organization of genome expression, in cells and 
tissues, in health condition and disease. 
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MATERIALS AND METHODS 
 
MATERIALS 
 
Table 1. Oligonucleotides 
DNA oligonucleotides were ordered and purchased from Metabion (Martinsried, Germany).  
  
OLIGONUCLEOTIDES SEQUENCE 
SphI-BamHI chp1+ ORF + 
endogenous promoter cloning 
 
346F  CACGCATGCGCAATTATCAAAAGAGGTCGTG 
174R CACGGATCCCTATTTTAAACCAATAGCTCTCATAA
AAGT 
Chp1 Chromodomain mutants   
349F.R31S  CTGACTCGGTAAATAAAAATGGC 
349R(common to R31S, N33A, 
N35A, LOOP1) 
CAAGGATATCTTCCACCTC 
351F.N33A CTGACCGCGTAGCTAAAAATGGC 
358F.N35A  CTGACCGCGTAAATAAAGCTGGCATAAAC 
359F.E39S  AAACTCGTATTATATAAAATGGGCTGGCTAT 
359R.E39S  ATGCCATTTTTATTTACGCGGTC 
354F.LOOP1A(R31S,N33A,N35
A)  
CTGACTCGGTAGCTAAAGCTGGCATAAACGAATA
T  
356F.LOOP2B(W49Y50D51/AA
A)  
GGCTATGATGCTGCTGCTAATACTTGGGAACCTG
AACAAA 
356R.LOOP2A/2B  AGCCCATTTTATATAATATTCGTTTATG 
357F.LOOP2A(N52A)  GGCTATGATTGGTATGATGCTACTTGGGAACCT 
442F.LOOP1B(N33A,N35A) CTGACCGCGTAGCTAAAGCTGGCATAAACGAATA
T 
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RT-qPCR and ChIP 
oligonucleotides 
 
110A.TDH1_F  CCAAGCCTACCAACTACG 
110A.TDH1_R  AGAGACGAGCTTGACGAA 
110F.DGF_F  CTGCGGTTCACCCTTAACAT 
110F.DGF_R  CAACTGCGGATGGAAAAAGT 
110E.DHE_F GCCCATTCATCAAACGAGTC 
110E.DHE_R GATTCGGCACCTTTGTCATT 
 
Table 2. Plasmids 
 
Plasmid 
number 
 Name 
p463 pET28a - 6His SUMO Chp1 Chromo-Domain (residues 15-75) 
p515 pREP1 -   chp1 promoter_chp1_nmt1 terminator 
p522 pREP1 -   chp1 promoter_chp1 R31S_nmt1 terminator 
p523 pREP1 -   chp1 promoter_chp1 N33A_nmt1 terminator 
p524 pREP1 -   chp1 promoter_chp1 E39S_nmt1 terminator 
p525 pREP1 -   chp1 promoter_chp1 R31SN33AN35A_nmt1 terminator 
p526 pREP1 -   chp1 promoter_chp1 N52A_nmt1 terminator 
p527 pREP1 -   chp1 promoter_chp1 W49AY50AD51A_nmt1 terminator 
p545 pREP1 -   chp1 promoter_chp1 N52A/ R31SN33AN35A _nmt1 terminator 
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p546 pREP1 -   chp1 promoter_chp1 W49AY50AD51A/ R31SN33AN35A_nmt1 
terminator 
p557 pET28a - 6His SUMO Chp1 Chromo-Domain N52A 
p558 pET28a - 6His SUMO Chp1 Chromo-Domain  W49AY50AD51A 
p564 pREP1  -  chp1 promoter_chp1 N35A_nmt1 terminator 
p569 pET28a - 6His SUMO Chp1 Chromo-Domain W49AY50AD51A/ 
R31SN33AN35A 
p571 pET28a - 6His SUMO Chp1 Chromo-Domain R31SN33AN35A 
p576 pET28a - 6His SUMO Chp1 Chromo-Domain R31SN33AN35A/N52A 
p597 pET28a - 6His SUMO Chp1 Chromo-Domain R31S 
p599 pET28a - 6His SUMO Chp1 Chromo-Domain N35A 
p601 pET28a - 6His SUMO Chp1 Chromo-Domain E39S 
p606 pET28a - 6His SUMO Chp1 Chromo-Domain N33A 
p638 pREP1  -  chp1 promoter_chp1 N33AN35A_nmt1 terminator 
p639 pREP1  -  chp1 promoter_chp1 N33AN35A/W49AY50AD51A_nmt1 
terminator 
p646 pETDuet - 10His SUMO Chp1 Chromo-Domain  N33AN35A 
p647 pETDuet - 10His SUMO Chp1 Chromo-Domain  
N33AN35A/W49AY50AD51A 
p406 pET3- Xenopus laevis histone H2A (same as in (Dyer et al., 2004)) 
p407 pET3- Xenopus laevis histone H2B (same as in (Dyer et al., 2004)) 
p408 pET3- Xenopus laevis histone H3 (same as in (Dyer et al., 2004)) 
p409 pET3- Xenopus laevis histone H4 (same as in (Dyer et al., 2004)) 
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p420 pUC57 – 8 X 145bp 601 sequence     (plasmid construct received from Davey 
CA and published in (Vasudevan et al., 2010)) 
 
p794 pREP1-(SphI) Region at the 5´ of Chp1 gene (Chromosome I, 2215500 – 
2215055)  (AscI) – HphMX6 resistance cassette –(SphI) Chp1 endogenous 
promoter (Chromosome I, 2214829 – 2214664) – chp1+ ORF– (BamHI) 
Chp1 terminator (Chromosome I, 2210976 – 2210582) (BamHI). 
p795 pREP1-(SphI) Region at the 5´ of Chp1 gene (Chromosome I, 2215500 – 
2215055)  (AscI) – HphMX6 resistance cassette –(SphI) Chp1 endogenous 
promoter (Chromosome I, 2214829 – 2214664) – chp1LOOP1B/2B ORF– 
(BamHI) Chp1 terminator (Chromosome I, 2210976 – 2210582) (BamHI). 
 
Table 3. Strains 
 
Strain 
number 
Name 
SP28 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 
SP170 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 
SP170 + p515 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1+ 
SP170 + p522 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1R31S 
SP170 + p523 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1N33A 
SP170 + p524 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1E39S 
SP170 + p525 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6+ chp1R31SN33AN35A 
SP170 + p526 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6+ chp1N52A 
SP170 + p527 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6+ chp1 W49AY50AD51A 
SP170 + p545 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6+ chp1N52A/ R31SN33AN35A 
SP170 + p546 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1 W49AY50AD51A/ R31SN33AN35A 
SP170 + p564 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6+ chp1N35A 
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SP170 + p638 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1 N33AN35A 
SP170 + p639 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1::TAP-
KanMX6 + chp1 N33AN35A/W49AY50AD51A 
SP101 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 
SP64 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δclr4::KanMX6 
SP967 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 chp1+:: 
HphMX6- chp1+(ChrI- 2214829- 2210582) 
SP968 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 chp1+:: 
HphMX6- chp1LOOP1B/2B (ChrI- 2214829- 2210582) 
SP970 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1:: 
HphMX6- chp1+(ChrI- 2214829- 2210582) 
SP972 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 Δchp1:: 
HphMX6- chp1LOOP1B/2B(ChrI- 2214829- 2210582) 
SP974 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 chp1+:: 
HphMX6- chp1+(ChrI- 2214829- 2210582) Δclr4::KanMX6 
SP975 h+ leu1-32 ura4-D18 imr1R(NCol)::ura4+ oriI ade6-216 chp1+:: 
HphMX6- chp1LOOP1B/2B (ChrI- 2214829- 2210582) Δclr4::KanMX6 
Bacterial 
strains 
(Escherichia 
coli) 
 
Xl1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIq Z∆M15 
Tn10 (Tetr )] 
BL21(DE3)pL
ysS 
F- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) pLysS(cmR) 
 
 
Table 4. Buffers and solutions 
 
Name Composition 
YES medium 
(S.pombe) 
5g/l Yeast Extract, 30g/l glucose, 0.225 g/l amino acids (leucine, 
histidine, lysine), 0.225 g/l adenine  (+ 20g/l agar for solid plates, 
+1% FOA for selection under ura4+ expression) 
EMMc-leu minimal 
medium (S.pombe) 
12.4 g/l EMM without dextrose (Formedium), 0.225 g/l adenine, 
0.225 g/l leucine, 0.056 g/l uracil (+ 20g/l agar for solid plates, +1% 
FOA for selection under ura4+ expression)  
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EMMc-ura minimal 
medium (S.pombe) 
12.4 g/l EMM without dextrose (Formedium), 0.225 g/l adenine, 
0.225 g/l leucine, (+ 20g/l agar for solid plates, +1% FOA for 
selection under ura4+ expression)  
LB medium (E.coli) 10g/l NaCl, 5g/l Yeast Extract, 10g/l Tryptone 
Ampicillin 100mg/ml 1000X stock 
Kanamycin 50 mg/ml 1000X stock 
Chloramphenicol 34mg/ml 1000X stock in 100% Ethanol 
IPTG for bacterial 
induction 
1M IPTG stock, used at 0.2-0.5 mM final concentration 
RNA purification  
Lysis buffer 300mM NaOAc pH 5.2, 10mM EDTA, 1% SDS 
Chromatin 
immunoprecipitation 
(ChIP)  
 
Lysis buffer 50mM Hepes pH 7.5, 1.5M NaOAc, 5mM MgCl2, 1mM EDTA, 
1mM EGTA, 0.1% NP-40 and 1X Protease Inhibitors (Complete 
EDTA- Roche) 
Elution buffer 50 mM Tris-HCl pH 8, 10 mM EDTA, 1% SDS  
Protein purifications 
(E.coli BL21 pLys 
expression)  
 
Lysis buffer 20 mM Hepes pH 7.5, 150 mM NaCl, 20 mM Imidazole pH 8, 0.5 
mM DTT, 1 mM PMSF 
Binding and Wash 
buffer 
20 mM Hepes pH 7.5, 500 mM NaCl, 20 mM Imidazole pH 8, 0.5 
mM DTT, 1 mM PMSF (in the Wash buffer 40 mM Imidazole 
instead) 
Elution buffer 20 mM Hepes pH 7.5, 150 mM NaCl, 300 mM Imidazole pH 8, 0.5 
mM DTT, 1 mM PMSF 
Dyalisis buffer 20 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM DTT 
Nucleosome 
reconstitution (Dyer 
et al., 2004; Luger et 
al., 1999)  
 
Wash buffer 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM PMSF, 1 mM β-
mercaptoethanol 
Guanidinium 
unfolding buffer 
6M Guanidinium HCl, 20 mM Tris-HCl pH 7.5, 5 mM DTT 
Octamer 
reconstitution buffer 
2 M NaCl, 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 5 mM β-
mercaptoethanol 
RB-high 10 mM Tris-HCl pH 7.5, 250 mM KCl, 1 mM DTT, 1 mM EDTA 
RB-low 10 mM Tris-HCl pH 7.5, 2 M KCl, 1 mM DTT, 1 mM EDTA 
MLA alkylation   
Alkylation buffer 1 M HEPES pH 7.8, 4 M Guanidinium HCL, 10 mM D/L-
methionine 
Agarose gel 
Electrophoresis 
 
50X TAE 2M Tris acetate pH 8.2-8.4, 50mM EDTA 
SDS PAGE  
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10X Tris-glycine 
running buffer 
 250 mM Tris-Cl, 2.5 M glycine, 1% SDS 
Western Blot  
Amido-black solution 7.5% Acetic acid, 20% Ethanol, 0.1% Amido black 
De-staining solution 50% Ethanol, 5% Acetic acid 
Blotting buffer 20% Ethanol, 39 mM Glycine, 48 mM Tris base, 0.037% SDS 
1X TBS-T 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20 
Milk solution 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20 + 2.5% 
(m/v) Skimmed Milk powder 
MST (Microscale 
Thermophoresis) 
 
Binding buffer 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM DTT, 0.05% 
Tween 20 (+10% Glycerol for Nucleosome binding assays)  
Nucleosome Binding   
Binding buffer 20 mM Tris-HCl pH 7.5, 75 mM KCl, 0.5 mM DTT (+20 mM 
Imidazole for Ni-NTA resin Chp1CD-H3K9me3 NCP complex 
assembly) – used for all Nucleosome complexes 
RNA EMSA Binding  
Binding buffer 20 mM Tris-HCl pH 7.5, 100 mM KCl, 0.5 mM DTT and 3% 
Glycerol 
 
Table 5. Antibodies 
 
Name Producer Source Dilution 
Chromatin 
immunoprecipitation 
(ChIP) 
   
Anti-H3K9me2  (ab1220) Abcam  0.8 µg per 20 µg of 
Dynabeads Protein A 
coupled (Invitrogen) 
Anti- Chp1 (ab18191) Abcam Rabbit polyclonal 0.8 µg per 20 µg of 
Dynabeads Protein A 
coupled (Invitrogen) 
Western blot (primary 
antibodies) 
   
Anti-H3K9me3 (ab8898) Abcam Rabbit polyclonal 1:1000 in 2.5% Skimmed 
Milk in TBS-T 
Anti-H3 (ab12079) Abcam Goat polyclonal 1:1000 in 2.5% Skimmed 
Milk in TBS-T 
Anti- Chp1 (ab18191) Abcam Rabbit polyclonal 1:1000 in 2.5% Skimmed 
Milk in TBS-T 
Anti-Tubulin (B-7) Santa Cruz Mouse 
monoclonal 
1:1000 in 2.5% Skimmed 
Milk in TBS-T 
Western blot (secondary 
antibodies) 
   
Rabbit anti-Goat IgG 
(H+L)-HRP Conjugate 
(#1721034) 
BioRAD Rabbit  1:3000 in 2.5% Skimmed 
Milk in TBS-T 
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Goat anti-Rabbit IgG 
(H+L)-HRP Conjugate 
(#1706515) 
BioRAD Goat 1:3000 in 2.5% Skimmed 
Milk in TBS-T 
Goat anti-Mouse IgG 
(H+L)-HRP Conjugate 
(#1721011) 
BioRAD Goat 1:3000 in 2.5% Skimmed 
Milk in TBS-T 
 
METHODS 
 
Strains and plasmids construction  
 
All the plasmids used for the in vivo assays in this study were generated by modifying the 
pREP1 plasmid through insertion of the chp1+ gene with its endogenous promoter (-949 bp 
from the start of chp1+ coding sequence, replacing the original nmt1+ promoter), using SphI-
BamHI restriction sites. For the biochemical analysis of Chp1CD function, Chp1CD was 
expressed from the pET28a expression vector as previously described (Schalch et al., 2009). 
Chp1CD mutants for the in vivo and biochemical experiments were then generated through 
inverse PCR (iPCR), using the primers listed in Table 1. The PCR products obtained were then 
purified and treated with T4 PNK (Roche) for 1h at room temperature, ligated with T4 DNA 
Ligase (NEB) for 1h at 22°C, and subsequently treated with the DpnI endonuclease at 37°C for 
1h. The obtained plasmids were then transformed with the standard heat-shock protocol into 
E.coli Xl1-Blue for sequencing validation and long-term storage, and in BL21(DE3)pLysS for 
protein expression and purification.  
For the in vivo heterochromatin rescue assays, the obtained pREP1- chp1+ derivative and 
pREP1- chp1+ CD mutants were transformed into the SP170 chp1Δ strain (Table 3). SP170 
cells were grown in YES (25 ml) at OD600 1 at 32 °C. Cells were then harvested and washed in 
1.2 M Sorbitol (Roth) twice. Pellets were then re-suspended with 1 ml 1.2 M Sorbitol and 500 
ng of plasmid DNA were added and mixed. Transformation was performed through 
electroporation using the Bio-RAD MicroPulser electroporator (Yeast Sph5 settings) and 
standard electroporation cuvettes (0.2cm gap- green cap - BioRAD). Cells were then plated 
and selected on EMMc-leu plates.  
For genomic integration, the pREP1 plasmid was modified to replace the nmt1+ promoter with 
the following integration cassette: (SphI) Region at the 5´ of Chp1 gene (Chromosome I, 
2215500 – 2215055)  (AscI) – HphMX6 resistance cassette –(SphI) Chp1 endogenous promoter 
(Chromosome I, 2214829 – 2214664) – Chp1 coding sequence – (BamHI) Chp1 terminator 
(Chromosome I, 2210976 – 2210582) (BamHI). 
The integration cassette (both the chp1+ cassette and the chp1LOOP1B/2B cassette) was then 
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PCR amplified and transformed by electroporation, (following the transformation procedure 
mentioned above), into SP101, SP170 and SP64 strains. Cells were initially plated on YES 
after transformation and replicated the day after on selective YES+ Hygromycin (50 mg/ml 
Hygromycin) plates. Single colonies were isolated, PCR screened and sequenced for the 
genomic insertion of the HphMX6 resistance cassette and the LOOP1B/2B mutations. All 
bacterial and yeast strains and the plasmids used in this study are listed in Table 2 and Table 3. 
 
Silencing assays 
 
For silencing assays, cells were grown to OD600 0.7-1 and normalized to a final concentration 
of 107 cells/ml of culture. For the spotting, 5X 1:10 serial dilutions were made so that the 
densest spot corresponds to 105 cells and the least dense spot corresponds to 101 cells. 3 µl of 
each dilution was spotted onto non-selective (N/S) (either YES or EMMc-leu), 5-fluorootic 
acid (FOA) and EMMc-ura plates. Cells were then incubated at 32°C for three to four days and 
imaged.  The SP170 chp1∆ strains has a ura4+ reported gene inserted at the centromeric imr 
repeats. When heterochromatin is defective at centromeres, the ura4+ gene is expressed and 
becomes toxic in the presence of 5-FOA. Therefore, cells having defective centromeric 
heterochromatin assembly are counter-selected on 5-FOA plates. Similarly, expression of the 
ura4+ reporter can be detected on EMMc-ura auxotrophic selection.  
 
Total RNA purification and Reverse Transcription (RT) 
 
10 ml of yeast cells were harvested at OD600 0.7-1 and the pellets re-suspended in 500 µl of 
Lysis buffer (300mM NaOAc pH 5.2, 10mM EDTA, 1% SDS). 500 µl of Phenol-Chloroform-
Isoamylalcohol (25:24:1) pH for RNA extraction (Roth) were then added to the re-suspension, 
mixed and incubated at 65°C for 10 minutes with occasional vortexing. Samples were 
centrifuged at 15000 rpm in a benchtop centrifuge to separate the aqueous and the organic 
phase. The aqueous phase was then isolated and cold precipitated by the addition of 2 volumes 
of 100% Ethanol and 1/10 volume of 3 M NaOAcetate pH 5.2. The RNA pellet was washed 
once with 75% Ethanol, and then re-suspended in DEPC treated water. RNA concentration was 
then measured at the Nanodrop, and samples were normalized to 50-100 ng/ µl for DNAse 
treatment. 50 µl were treated with DNAse I (Roche) at 37°C for 1h. DNAse was then heat 
inactivated at 75°C for 15 minutes.   
100-200 ng of RNA were then used to synthesize cDNA by Reverse Transcription (RT), using 
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SuperscriptIII (Invitrogen) and 1 pmol of each DNA oligo (specific to the genes of interest- in 
this case tdh+, dg and dh repeats) and following the manufacturer protocol.  
RNA levels were subsequently quantified through quantitative PCR (qPCR – later described), 
using the Flash Dynamo SyBR Green Master Mix (Byozim) and the tdh+ gene transcript levels 
for internal normalization. 
 
Chromatin Immunoprecipitation (ChIP) 
 
10 ml yeast cell cultures at OD600 1.3 were cross-linked in 3% formaldehyde (1.3ml of 37% 
formaldehyde in 50 ml YES/EMMc-leu)  at room temperature for 15 minutes as previously 
described (Marasovic et al., 2013). Cross-linking was then quenched with 125 mM Glycine 
(2.5 ml of 2.5M Glycine for 50 ml culture volume) for at least 10 minutes at room temperature. 
Cells were washed once with water and then harvested for flash freezing in liquid nitrogen or 
immediate lysis. For lysis, cell pellets were re-suspended in 1.5M Sodium acetate Lysis buffer 
(50 mM HEPES pH 7.5, 1,5 M Sodium acetate, 5 mM MgCl2, 2 mM EDTA, 2 mM EGTA, 
0.1% NP-40, 20% Glycerol), with the addition of PMSF (Roth) and Complete EDTA Free 
Protease Inhibitors Cocktail (Roche). After throughout re-suspension, 0.25-0.5 mm diameter 
Glass beads (Roth) were added to the mixture and cells were lysed with bead-beating (4 cycles, 
6.5 m/s, 24X2 rotor) with the MP- Biospec Bead beater (MP-Biomedicals). After mechanical 
lysis, cells were sonicated on the Bioruptor Standard (Diagenode) with 35 cycles, 30s ON and 
30s OFF. Lysates were then spun at 13000 rpm at 4°C for 15 minutes, to get rid of the cell 
debris and obtain the fragmented chromatin in the supernatant. Samples were normalized with 
each other according to the total RNA and protein quantity measured on Nanodrop and 50 µl 
of each normalized lysate were used as INPUT. For immunoprecipitation (IP), lysates were 
incubated with the antibodies indicated in Table 5, for 2h to over-night at 4°C. Antibodies were 
incubated, prior to IP, with Protein A Dynabeads (Invitrogen) first for 15 minutes at room 
temperature and then 1 h at 4°C, with constant rotation (Antibody- Dynabeads ratios are 
indicated in Table 5). After IP, beads were washed 5X with 1.5M Sodium acetate Lysis buffer 
and elution was done by adding 150 µl of ChIP Elution buffer (50 mM Tris-HCl pH 8.0, 10 
mM EDTA, 1% SDS) per sample, incubating at 65°C for 15 minutes with mild shaking. Cross-
link was reversed (both INPUTs and IP samples) by addition of RNAseA for 30 minutes at 
37°C, followed by over-night incubation with ProteinaseK at 65°C. De-crosslinked DNA was 
then extracted by adding 1 volume of Phenol:Chloroform:IsoamylAlcohol (25:24:1) with 
subsequent Ethanol precipitation.  
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DNA levels were then quantified with quantitative PCR (qPCR) and normalized to the tdh+ 
constitutive gene DNA levels. Oligonucleotides used for ChIP are listed in Table 1.  
 
 
Quantitative PCR (qPCR or Real-Time PCR) 
 
qPCR was performed on ChIP samples or after reverse transcription (RT) cDNA samples using 
the 2X DyNAmo Flash SyBR Green Master Mix qPCR kit (BioZym) and the TOptical 
thermocycler (Biometra). 10 µl PCR reactions were assembled in a 96-well plate (4titude) 
using 0.4 µM forward and reverse primers (listed in Table 1), 4 µl Template DNA with 1X 
DyNAmo Flash SyBR Green Master Mix. For RT-qPCR, qPCR was performed in duplicate for 
each cDNA sample, with the RNA before reverse transcription as negative control (to detect 
for contaminating DNA species, in the absence of reverse transcription).  For ChIP assays, 
duplicates or triplicates were analyzed for both INPUT DNA and IPs. Normalization for both 
RT and ChIP experiments was done by using primers targeting the tdh+ constitutive gene, 
which is unaffected by H3K9 methylation or transcript levels variation in the mutants analyzed. 
The qPCR protocol applied follows these parameters: an initial step of denaturation at 95°C 
for 3 minutes, followed by 46X cycles (95°C denaturation 10 seconds, 59°C annealing 20 
seconds, 72°C elongation 15 seconds) and final melting temperature calculation step (ramping 
from 60°C to 95°C), for a total duration of 1h and 16 minutes. Oligonucleotides used for qPCR 
in this study are listed in Table 1. 
 
Protein purification 
 
Wild type His6-SUMO-Chp1CD and its mutants were expressed in E.coli BL21(DE3)pLysS 
expression strain from a pET28a expression vector. The construct was designed to introduce a 
Thrombin cleavage site in between the SUMO tag and the His6 tag (Schalch et al., 2009). 
SUMO tag could be removed by using the specific Ulp1 SUMO protease. Cells were induced 
with the addition of 0.2-0.5mM IPTG and grown at 18°C over-night. After induction, cells were 
harvested at room temperature, washed, re-suspended in Lysis buffer (20 mM Hepes pH 7.5, 
150 mM NaCl, 20 mM Imidazole pH 8, 0.5 mM DTT, 1 mM PMSF) and flash frozen in liquid 
nitrogen, to induce the lysis. The re-suspension was thawed in ice cold water and incubated for 
20-30 minutes at 4°C, to allow the Lysozyme to initially break the bacterial cell wall. Cells 
were sonicated on the Branson Sonifier with one 5 minutes cycle (Branson Sonifier, output 4, 
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duty cycle 40) and then harvested by centrifugation at 12000 g for 20 minutes at 4°C. 
Afterwards, the supernatant was incubated with the Ni-NTA Resin (GE Healthcare), already 
pre-equilibrated in Binding buffer (20 mM Hepes pH 7.5, 500 mM NaCl, 20 mM Imidazole 
pH 8, 0.5 mM DTT, 1 mM PMSF), for 30 minutes at 4°C, with end-to end rotation. The binding 
occurs through the specific recognition of the NTA conjugated Nickel atoms of the resin by the 
6 Histidine residue tag of the His6-SUMO-Chp1CD expressed proteins. Imidazole competes 
for the binding by mimicking the Histidine residues (Histidine residues have an Imidazole ring) 
of the tag and causes the elution of the tagged protein at a concentration higher than 200 mM. 
After incubation, the Ni-NTA resin was washed 5 times with Binding buffer and once with 
Wash buffer (20 mM Hepes pH 7.5, 500 mM NaCl, 40 mM Imidazole pH 8, 0.5 mM DTT, 1 
mM PMSF). Proteins were eventually eluted with Elution buffer (20 mM Hepes pH 7.5, 500 
mM NaCl, 300 mM Imidazole pH 8, 0.5 mM DTT, 1 mM PMSF) and then Dialyzed over-night 
in a buffer containing 20 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM DTT. Further purification 
of His6-SUMO-Chp1CD proteins (both wild-type and mutants) was achieved by gel filtration 
(Superdex 75 pg; GE Healthcare). For Nucleosome-Peptide binding assays and EM structural 
studies the Chp1CD was dialyzed in 20 mM HEPES pH 7.5, 75 mM KCl, 0.5 mM DTT. 
Proteins were either used immediately or flash frozen for long-term storage at -80°C. His6-
Swi6-FLAG and His6-Clr4-FLAG for Nucleosome complex assembly were purified according 
to the same Chp1CD experimental procedure, using the same buffer conditions. FLAG-Chp2 
was over-expressed and purified from S.pombe following the conditions described in 
(Marasovic et al., 2013). 
Nucleosome in vitro reconstitution and (H3KC9me3) methylation 
 
Nucleosome were reconstituted by strictly following the Dyer - Luger protocol (Dyer et al., 
2004) with the same Xenopus laevis histone expressing constructs as previously described 
(Luger et al., 1997). For reconstitution, it was used the 601 “Widom/Lowary” sequence as 
previously reported (Lowary and Widom, 1998; Vasudevan et al., 2010). To generate H3K9 
methylated Nucleosomes, we used the protocol devised by Matthew D. Simon (Simon et al., 
2007), that employs the chemical alkylation of an H3K9C mutated residue to generate a 
methyl-lysine analog (MLA analog), having all the biochemical functionality of a H3K9 
methylated residue. Different methylation states (me0, me1, me2 and me3) can be produced by 
the usage of different alkylating agents. The targeting of the mutated cysteine residue (H3K9C) 
is highly specific and histone H3 had to be mutated (H3C110A) to remove its natural cysteine 
and introduce the targeted one.  
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Histone MLA introduction was checked by mass-spec. The mass-spectrum frequently gives 
rise to a +42 peak over the expected 15297 Da mass, that does not reflect a true contaminating 
specie and can be present in the original histone preparation (before alkylation). Once 
alkylated, H3 histones were lyophilized according to the procedure (Simon et al., 2007) and 
then used for Nucleosome reconstitution, following the standard Dyer-Luger protocol (Dyer et 
al., 2004).  
Chp1CD -H3K9me3 MLA Nucleosome in vitro complex formation and elution  
 
5 μg of purified Chp1CD were bound to 15 μl of Ni-NTA Resin (GE Healthcare) in a Binding 
buffer containing 20 mM HEPES pH 7.5, 75 mM KCl, 0.5 mM DTT, 20 mM Imidazole for 30 
min at 4 ºC. 20 mM Imidazole is the minimal concentration required to avoid non-specific 
H3K9me3 Nucleosome sticking to the Ni-NTA Resin. After the initial binding, unbound 
Chp1CD was washed away with 5 volumes of Binding buffer. H3K9me3 MLA (Methyl Lysine 
Analog) Nucleosomes were then added and incubated in binding buffer for 1h on ice in a final 
volume of 20 μl, with throughout re-suspension (every 5 minutes by hand ticking). The resin 
was then centrifuged at slow speed (60g, 10 seconds) and washed for 3 times with at least 5X 
(v/v) Binding buffer. The SUMO-Chp1CD- H3K9me3 MLA Nucleosome complex was eluted 
by the addition of Thrombin (Sigma) for 2 hours on ice and the eluate collected after 
centrifugation through the Micro-BioSpin Columns (Bio-RAD), to separate the Ni-NTA Resin 
from its flow-through. Fractions were then run on a 15% SDS-Acrylamide gel (SDS-PAGE) 
to check for the purity and the concentration of the Chp1CD- H3K9me3 MLA Nucleosome 
complex.  
The complex obtained was then used for Negative-stain and Cryo- EM. The same procedure 
of complex formation was applied also for the biochemical studies involving the Chp1CD 
mutants, to compare their overall affinity for different Nucleosome species. In addition, the 
same experimental procedure and same buffer conditions were applied for the assembly of the 
Swi6-H3K9me3 Nucleosome, Chp2-H3K9me3 Nucleosome and Clr4 -H3K9me3 Nucleosome 
complexes. The affinity FLAG M2 gel (Sigma) was used for anchoring Swi6, Clr4 and Chp2 
for the H3K9me3 Nucleosome pull-down. 
Nucleosome Trypsin digestion  
 
Nucleosome with no histone tails were produced by Trypsin digestion by incubation with an 
immobilized TPCK-Trypsin (Thermoscientific) resin for 2h at room temperature in the 
standard (20 mM HEPES pH 7.5, 75 mM KCl, 0.5 mM DTT) Binding buffer, with a similar 
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procedure as reported in (Lee et al., 1993) (Figures 2.4 A and B).  
Tryptic digestion of nucleosome was already biochemically and structurally characterized 
(Iwasaki et al., 2013). 
 
Chp1CD-Nucleosome binding assays and Western blot 
 
To compare the different affinities of the Chp1CD wild-type and mutant proteins for 
Nucleosomes, binding assays were performed on Ni-NTA Resin as previously described (see 
the section on Chp1CD - H3KC9me3 MLA Nucleosome in vitro complex formation and 
elution). Three different Nucleosome species were used: H3K9me3 Nucleosomes, unmodified 
Nucleosomes and Trypsin digested (Tailless) Nucleosomes, to estimate the contribution of 
Nucleosome core and Histone tails to the Chp1CD interaction.  Binding assay were performed 
in 20 mM HEPES pH 7.5, 100 mM KCl, 0.5 mM DTT, 40 mM imidazole. Resins, Flow-
through and INPUTs were then run on SDS-PAGE 15% polyacrylamide gels and then 
transferred onto a PVDF membrane (Millipore) at 15V constant on a semidry Trans-Blot SD 
transfer apparatus (Bio-RAD) for 30 minutes in Blotting buffer (20% Ethanol, 39 mM Glycine, 
48 mM Tris base, 0.037% SDS). To verify the efficiency of transfer, membranes were stained 
with the Amido-black solution (7.5% Acetic acid, 20% Ethanol, 0.1% Amido black), following 
de-staining in 50% Ethanol and 5% Acetic acid. Stained membranes were imaged and used as 
reference to normalize the Chp1CD protein levels. The membrane was then blocked in 1X 
TBS-T/ 2.5% Milk solution for 30 minutes at room temperature and incubated O/N with anti-
H3 histone (AbCam, 1:1000), or anti-H3K9me3 Antibody (AbCam, 1:1000) at 4°C. Followed 
primary antibody incubation, the membrane was washed 3X 5 minutes in 1XTBS-T and 
incubated for 1h  at room temperature with anti-goat IgG-HRP (BioRad, 1:3000) or anti-rabbit 
IgG-HRP (BioRad, 1:3000). All antibodies were diluted in 1X TBS-T/ 2.5% Milk.  
Protein levels were detected using the ECL Plus Pico solution (Thermoscientific) and images 
were taken using the LAS-3000 Mini Camera.  
All western blots in the study presented were performed following this general procedure. To 
quantify the expression levels of the Chp1CD mutant protein in vivo we run SDS 8% 
polyacrylamide gels and transferred at 15V constant for 1h. To monitor Chp1 protein levels we 
used the anti- Chp1 (Abcam) antibody with O/N incubation at 4°C. As loading control, either 
the Tubulin levels (anti-Tubulin antibody -Santa Cruz) or the Amido-black stained membrane 
were imaged and quantified.  
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Chp1CD-H3K9me3 peptide binding assays 
 
1 μg of H3K9me3 biotinylated peptide, the [Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin) 
peptide from (Eurogentec), was bound for 1 hour at 4°C to 15 μl of Streptavidin Agarose resin 
(Thermoscientific), in the regular binding buffer described previously (20 mM HEPES pH 7.5, 
75 mM KCl, 0.5 mM DTT). The resin was washed once in 5 volumes of the same buffer to get 
rid of the unbound peptide and 5 μg of Chp1CD (wild-type and mutant) were then added and 
incubated for 1 hour on ice under constant mixing. After incubation, the flow-through was 
collected and the resin washed three times (5X volumes each wash). Resin bound fractions and 
flow-through were then run on a 15% polyacrylamide SDS gel and gels were Coomassie 
stained and imaged. Quantification of binding was extrapolated by using the ImageJ software 
from the Coomassie bands intensities. Binding of each mutant was normalized in relation with 
its own INPUT and compared for each assay to the wild-type Chp1CD (assuming that the wild-
type protein binding efficiency would be 100%).  
 
Microscale Thermophoresis (MST) 
 
In order to avoid interference between the SUMO tag and MST measurements and to better 
compare the different Chp1CD mutants, the SUMO tag was enzymatically removed by using 
the Ulp1 protease. Each Chp1CD was treated with Ulp1 O/N at 4°C and the cleaved SUMO 
tag was separated from the cleaved Chp1CD by using the Ni-NTA resin. 100 μg of Chp1CD 
(wild-type and the selected mutants) were fluorescently labeled with the MO-L003 Monolith™ 
Protein Labeling Kit BLUE-NHS (Amine Reactive) following the producer (Nanotemper 
technologies) procedure. With the use of the Nanodrop1000 software feature “Proteins and 
Labels” an estimated ratio 1:1 between Chp1CD protein and fluorescent label was estimated. 
Concentrations of the different labeled Chp1CD proteins were further compared on a 15% 
polyacrylamide SDS gel to normalize them to 0.1mg/ml. In solution peptide and nucleosome 
binding assays were assembled in a total volume of 20 μl, with a constant quantity of 300 ng 
of Chp1CD protein in the MST binding buffer containing 10 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 0.5 mM DTT and 0.05% Tween-20 (for nucleosome binding assays 10% final glycerol 
was supplied). A crescent quantity of [Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin) peptide 
(Eurogentec) was added to the Chp1CD binding reaction to create the binding curve for MST 
measurements: 0 nM, 9 nM, 13 nM, 20 nM, 31 nM, 46 nM, 70 nM, 105 nM, 158 nM, 237 nM, 
355 nM, 530 μM, 800 μM, 1.2 μM, 1.8 μM. For H3K9me Nucleosomes the following NCP 
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dilutions were used: 0 nM, 18 nM, 27 nM, 41 nM, 62 nM, 93 nM, 140 nM, 210 nM, 316 nM, 
474 nM, 711 nM, 1.06 μM, 1.2 μM, 1.4 μM, 1.6 μM, 2.4 μM. Each measurement was done in 
five replicates on the NT.115 Monolith instrument (Nanotemper technologies) using standard 
treated capillaries (Nanotemper Cat#K002). The following settings were applied for each run: 
80%LED and 40%MST power, with 30s Laser On time and 5s Laser Off time. Three 
independent experiments were performed for the wild-type and LOOP1B/2B mutant.  
Data were analyzed with the SigmaPlot software version 13.0 (Systat Software, San Jose, CA, 
USA) and the GraphPad Prism software version 6.00 (GraphPad software, San Diego, CA, 
USA). Following the observed sigmoidal trend, for the peptide binding assay we fitted the 
Richard´s 5 Parameter Logistic Asymmetric Sigmoidal equation, with the software 
automatically calculating the dissociation constant (Kd). In the case of the Nucleosome binding 
assays, were some of the curves were not showing a sigmoidal trend, we fitted the third order 
polynomial (cubic) equation into the raw data points and extrapolated the dissociation constant 
by using the 50% binding value on the Y-axis and the “Interpolation” feature of the GraphPad 
Prism suite.  
 
RNA electrophoretic mobility shift assays (EMSAs) 
 
In vitro transcribed 5´ dephosphorylated 30nt and 100nt centromeric RNAs were radiolabeled 
with 32P by incubating at 37°C with T4 PNK (Roche) for 1h, using [γ-32P] labeled ATP. 
Reactions were then purified by using Microspin G25 Columns (GE Healtcare), to remove the 
excess of radioactive isotope. 0.66 pmols of 30 nt radiolabeled dg RNA were then incubated 
with 10 µM CD-Chp1 (wild-type and mutants) in RNA binding buffer (20 mM Tris-HCl pH 
7.5, 100 mM KCl, 0.5 mM DTT and 3% Glycerol) for 1h on ice. For the 100 nt dg RNA binding 
assay, 2 pmols of radiolabeled RNA were incubated with Chp1CD (wild-type and LOOP1B/2B 
mutant) in the following ratios: 1:1 (2 pmols Chp1CD), 1:5 (10 pmols Chp1CD), and 1:10 (20 
pmols Chp1CD). H3K9me3 peptide (Eurogentec) was added into the binding mix at a 1:1 
H3K9me peptide: CD-Chp1 ratio, to mimic the in vivo binding interaction. Similarly, 
H3K9me3 Nucleosomes were added to saturate the CD-Chp1 in a 1:1 ratio in the RNA pull 
down assays with Nucleosomes. Before performing the EMSA assays, SUMO-Chp1CD 
protein constructs (wild-type and mutants) were digested over-night at 4 °C with the purified 
His6 -Ulp1 enzyme in the binding buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 0.5 mM 
DTT) to remove the SUMO tag. To separate the SUMO tag, the Ulp1 enzyme and the 
undigested SUMO-Chp1CD, 1:1 v/v Fast- flow Ni-NTA resin (GE Healthcare) was added to 
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the samples and incubated 2h at 4°C in the previously described binding buffer. The flow-
through, containing the Chp1CD was then collected, concentrated and run on a 15% acrylamide 
gel SDS-PAGE for purity control. Then, either used immediately or flash-frozen for long term 
storage.  
 For the in vitro RNA pull downs, 1 µg of SUMO-Chp1CD (wild-type and LOOP1B/2B 
mutant) was bound to 15 µl Ni-NTA resin (GE Healthcare) and the H3K9me3 Nucleosome 
were added to assemble the Chp1CD-H3K9me3 Nucleosome complex as previously described 
in this section, under the same buffer conditions (20 mM HEPES pH 7.5, 75 mM KCl, 0.5 mM 
DTT, 20 mM Imidazole). After 3X washing with 50 µl of binding buffer (to wash away the 
unbound H3K9me3 Nucleosomes), 2 pmols of 32P labeled 100nt dg RNA were added and 
incubated with the Chp1CD-Nucleosome resin on ice for 1 hour. The resin was then centrifuged 
at slow speed (60g, 10 seconds) and the flow-through collected. Resin was then washed for 3 
times with at least 3X (v/v) Binding buffer and the Chp1CD-Nucleosome-RNA complex was 
eluted by addition of 300mM Imidazole buffer (20 mM HEPES pH 7.5, 75 mM KCl, 0.5 mM 
DTT, 300 mM Imidazole), incubated for 1 hour on ice with 5 minutes interval mixing (bound 
fraction). In all RNA EMSA experiments, samples were loaded on a 10% TBE Native 
Acrylamide gel (Bis-Acrylamide ratio 1:29) and run for 2 hours at 10 mA constant at 4°C. After 
over-night exposition, gels were then scanned using the TyphoonFLA9000 phosphoimager.  
 
Negative stain Electron microscopy (EM) 
 
3 µl of eluted Chp1CD-H3K9me3 Nucleosome complex were applied on a glow-discharged 1 
nm Carbon coated cupper electron microscopy grid (400 Mesh Cu, Quantifoil). Grids were 
previously glow-discharged at 100V for 45 seconds. After applying the sample onto the carbon 
EM grid for 45 seconds, grids were rinsed with water and stained with 2.5% Uranyl Acetate 
for 15 seconds. Negative stained grids were later screened for image collection on a Morgagni 
transmission electron microscope (FEI Company).  The same procedure was applied for all the 
Negative stain grids shown in this work of Thesis, regardless of the sample type. 
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